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ABSTRACT 
  Parkinson's disease (PD) is a chronic age progressive neurodegenerative 
disease that affects about 1% of people over the age of 60. The hallmark pathological 
features of PD is characterized by the loss of 60-70% dopaminergic neurons, formation of 
Lewy bodies and aggregation of α-synuclein in the substantia nigra of the midbrain 
region. There are multiple factors that contribute to the origin of the disease and also 
these factors further trigger multiple pathways, thus prominently increasing the risk of 
incurring PD. Although the etiopathogenesis  of PD is not very well understood, growing 
evidences suggest that  mitochondrial dysfunction and oxidative stress play a central role 
in pathophysiological processes  of PD. Many years of research has shown that incessant 
chronic exposure to several  pesticides lead to mitochondria dysfunction and degeneration 
of dopaminergicc neuronal cells leading to PD. The primary target and goal of my Ph.D 
thesis was to particularly understand the specific role of mitochondrial complex I class of 
pesticides in causing  dopaminergic neuronal damage. Our recently published study 
demonstrate that  the green house pesticides, tebufenpyrad and pyridaben exposure cause 
a major  adverse effect on  mitochondrial function  in cell based models of Parkinson’s 
disease.  These pesticides are classified as mitochondrial complex I inhibitors and are 
functionally analogous to the Parkinsonian neurotoxicant rotenone, in terms of target and 
mode of action. Herein, we demonstrate that acute exposure of tebufenpyrad or pyridaben 
to the N27 neuronal cells, induced a time dependent loss of  mitochondrial function and 
structural integrity by significant impairment of mitochondrial respiration, ATP 
production and redox status,suggesting that the pesticides neurotoxicity is associated with 
mitochondrial dysfunction oxidative damage in dopaminergic neuronal cells. In an effort 
to understand the molecular mechanisms underlying mitochondria dysfunction mediated 
apoptotic cell death, we examined the role of  PKCδ a pro-apoptotic signaling kinase and 
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its downstream target of phosphorylation. Our results show that tebufenpyrad exposure to 
the dopaminergic neuronal cells, lead to the activation of PKCδ in a caspase-3 dependent 
manner, which was marked by the cleavage of PKCδ and phosphorylation of PKCδ at 
T505. Importantly, we identified that activated PKCδ further  phosphorylateslaminB1 at 
T575, leading to damage of the nuclear membrane integrity. Moreover the activation of 
PKCδ, phosphorylation of laminB1 at T575 and laminB1 loss was also observed in the 
PD substantia nigra brain tissues, but not in the control brains, thereby providing  
translational relevance to our mechanistic findings. . 
To further understand the functional  interplay between mitochondrial dysfunction and 
nuclear events, we examined epigenetic modification mediated  acetylation  of core 
histones in dopaminergic neurons.. Exposure of N27 dopaminergic cells to pyridaben 
induced  a dose and time-dependent increase in acetylation of histones H3 and H4. Also, 
further analysis performed using immuno-fluorescence staining and confocal microscopy 
revealed the site specific AcH3(K23) and AcH4(K5) up-regulation following  rotenone or 
pyridaben exposure in the N27 neuronal cells. Interestingly, pyridaben or rotenone treated 
nuclei also demonstrate a nuclear structural defect in the form of topological alteration or 
chromatin declustering.  Furthermore ,  nuclear morphological change was marked by a 
time dependent loss of HP-1α, a very well studied marker of heterochromatin, suggesting 
the mitochondrial dysfunction initiates chromatin remodeling  in dopaminergic neuronal 
cells. . Transgenic dopaminergic neuronal cells generated by TFAM CRISPR/Cas9 
knockdown also phenocopy the  hyperacetylation of histones H3 and H4 induced 
mitochondrial pesticides, further providing a stronger evidence for mitochondria driven 
nuclear architectural changes during neurotoxic pesticide exposure. . Furthermore, the 
Mitopark transgenic animal model of PD  demonstrated progressive acetylation of 
histones H3 and H4 in a age-dependent manner as well as  AcH3(K23) and AcH4(K5) 
xi 
 
up-regulation and nuclear declustering morphology. Finally, our data was conclusively 
confirmed by the analysis of post-mortem human substantia nigra tissues, which 
demonstrated hyperacetylation of H3 and H4 and formation of  nuclear declustering  in 
the PD brains. The collecgtive  interpretation of these results suggests that histone 
hyperacetylation is a key epigenetic mechanism in the nigral dopaminergic neuronal cells 
following mitochondrial dysfunction and neurotoxicity in the neuronal models of PD. 
Overall, our results suggests that exposure of dopaminergic neuronal cells to 
mitochondrial complex I inhibiting pesticides leads to accentuated PKCδ kinase activity, 
nuclear membrane damage and histone hyperacetylation, resulting in apoptotic 
dopaminergic neuronal cell death. Thus, intervening such molecular mechanisms, merits 
the development of strategies for diagnosis and drug based treatments for PD.    
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CHAPTER I : INTRODUCTION 
Dissertation Organization 
 This dissertation is written by following an alternative thesis format and 
consists of manuscripts in the form of each individual chapters that are being prepared 
for submission and one of them has been already published. The dissertation thesis 
flows in an order as given - general introduction, three research papers, general 
conclusion that will predominantly focus and discuss the overall findings and novel 
concepts from all the chapters, and finally will end with an acknowledgment. After 
each corresponding chapter, its corresponding references are listed. But, with respect 
to the general introduction section, its corresponding references are listed following 
the general conclusions. Chapter I is general introduction and it provides background 
information on PD and the role mitochondrial dysfunction and damage and oxidative 
stress in the pathogenesis of PD. The literature review summarizes the different 
theories established and studied in PD, focussing the susceptibility of dopamingeric 
neurons to oxidative stress and cell death. These concepts will be discussed from the 
perspective of mitochondria and the energy requirements needed for the survival and 
regular homeostatic functioning of the dopaminergic neuronal cells. Also in this 
literature review, a completely novel concept related to dopaminergic neuronal 
susceptibility to mitochondrial complex 1 inhibiting toxicants will be brainstormed 
and introduced for the first time by following a heuristic approach backed by literature 
and published evidences. 
Chapter II, underlines the neurotoxic potential of tebufenpyrad and pyridaben 
in causing alterations in mitochondrial dynamics (functional and structural) in the 
dopaminergic neuronal cell culture model of PD. This manuscript from this chapter 
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has been published in Neurotoxicology. Chapter III, highlights a unique signalling 
pathway that involves the role of PKCδ functioning as a LaminB1 kinase and 
mediating apoptotic dopaminergic neuronal cell death post tebufenpyrad exposure. 
Chapter IV, explores the hyperacetylation of H3 and H4 histones induced by 
mitochondrial inhibiting pesticides pyridaben and rotenone exposure in dopaminergic 
neuronal in vitro , ex vivo and in vivo models of PD. Chapter III and IV will be shortly 
communicated to the Journal of Cell Biology and Nature Neuroscience, respectively. 
This dissertation contains the experimental results obtained by the author 
during his Doctoral studies under the supervision and guidance of his major professor 
and principal investigator, Dr. Anumantha G. Kanthasamy at Iowa State University. 
Introduction 
 Parkinson’s disease (PD) is identified as a progressive, chronic, age-
dependent, neurodegenerative disorder that affects as many as 1.5 million people in 
the United States. It has also statistical predicted and shown that there about 60,000 
newly diagnosed cases each year and than that more than 23,000 die from the disease 
every year (as reported by the Parkinson's Disease Action Network, National Centre 
for Disease Statistics). 
 In this current world with ever increasing population, the occurrence of PD has 
been predicted to increase by two-fold by the year 2040. PD was first identified and 
described by James Parkinson in 1817 as the “shaking palsy”, and it is the second 
most common neurodegenerative disorder after Alzheimer’s disease (Figure 1.1)  
(Lees et al., 2009; Shulman et al., 2011). Studies have suggested that men are more 
prone to develop PD than women (Baldereschi et al., 2000; Van Den Eeden et al., 
2003; Wooten et al., 2004). This difference in variation of incurrence of disease 
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between the two sexes could be attributed to a number of reasons and factors, the 
main ones surmised could be occupational differences and presence of Estrogen 
hormone in women. 
 
 
 
 
 
 
Figure 1.1 Dr. James Parkinson and his book essay on 'Shaking Palsy'.  
 PD was originally for the very first time identified in Ancient India (4500-
1000 B.C) medical system of Ayurveda and it was called as Kampavata (literally 
translated means, tremors due to position or movements). The names for PD in 
ancient ayurvedic texts are vepathu (shaking, off track or being out of alignment), 
prevepana (excessive shaking), sirakampa (head tremor), spandin (quivering) and 
kampana (tremors)(Gourie-Devi et al., 1991; Ovallath and Deepa, 2013).  
 Pathological hallmarks of PD is vividly identified and declared as the gradual 
loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the 
formed existence of Lewy bodies which primarily constitutes the aggregated form of 
α-synuclein and other degradation proteins substances (Dauer and Przedborski, 2003; 
Werner et al., 2008). By the time the symptoms of the disease begin manifest and 
reveal itself, around 80% of striatal dopamine is depleted and 60-70% of 
dopaminergic neurons in the SNpc have already been degenerated and dead. The main 
clinical feature of PD is severe impairment in motor function such as tremors, 
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bradykinesia, rigidity, gait difficulty, and postural instability (Thomas and Beal, 
2007). These are referred as the classical clinical symptoms of PD. Recently, non-
motor symptoms have also been associated with PD. Non-motor symptoms of PD 
include speech abnormalities, sleep difficulties, constipation, olfactory dysfunction, 
depression, and cognitive impairment (Beitz, 2014; Chaudhuri and Schapira, 2009; 
Lotharius and Brundin, 2002).  
 Given below is the correlative plot comparing clinical symptoms and time 
progression of PD as taken from (Kalia and Lang, 2015) (Figure 1.2). 
Figure 1.2 Clinical symptoms and time progression of PD.  
 Although there are many studies and evidences indicating and identifying 
neuroprotective medications for treatment of PD, each of those are for mitigation of 
the symptoms of the disease, but there is no permanent cure for complete eradication 
and stopping of disease progression. The most well accepted and known contributors 
for the etiopathogenesis of PD are environmental exposures and genetic factors. Some 
of the major environmental exposures associated with PD are persistent exposure to 
pesticides and metals, well water and herbicides (Dick et al., 2007; Kanthasamy et al., 
2005; Miller, 2007; Priyadarshi et al., 2001; Richardson et al., 2006; Richardson et al., 
2005). A few very well studied genetic factors linked to PD are genes such as α-
 5 
synuclein, DJ-1, Parkin, LRRK2, PINK1, Uch-L1, FBX07 and ATP13A2. These are 
also classified commonly as PARK genes (Klein and Westenberger, 2012). 
 One of the most well characterized causes associated with several 
neurodegenerative diseases such as PD, are mitochondrial dysfunction and oxidative 
stress (Banerjee et al., 2009; Bose and Beal, 2016; Lin and Beal, 2006; Thomas and 
Beal, 2007). The inhibition of complex I by the action and persistent exposures to 
complex I inhibiting pesticides such as 1-methyl-4-phenylpyridinium (MPP
+
) or 
rotenone is associated with PD pathology and symptoms (Betarbet et al., 2000; 
Duchen, 2004; Greenamyre et al., 2001; Przedborski and Jackson-Lewis, 1998; 
Schapira, 2007). Another side of research in PD that is driving a lot of traction in 
recent years is the aspect of epigenetic changes, in particularly the histone 
modifications. It has been shown in several studies that epigenetic modifications are 
believed to be involved in pathogenesis of chronic neurodegenerative diseases such as 
AD and PD (Klionsky et al., 2016; Mattson, 2003; Migliore and Coppedè, 2009; Song 
et al., 2010). Hence, identifying a critical signalling mechanism which runs a union 
and accounts for the interplay between mitochondrial dysfunction and epigenetic 
modifications, would essentially pave way for a novel line of drug target discovery 
and treatment strategies for PD.  
 Our present study seeks to understand and unravel the linked synergism of 
molecular mechanisms such as pro-apoptotic signalling kinase activation and 
epigenetic changes involved in the neurotoxic effects induced by the action of 
mitochondrial targeted complex I inhibiting toxicants exposures in the dopaminergic 
neuronal cells, thereby implicating etiopathogeneis of PD.   
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Literature Review 
Parkinson's Disease - A mitochondria and gene based investigation 
 This section of the review will cover the mitochondrial dysfunction mediated 
susceptibility of dopaminergic neurons to oxidative stress and apoptosis induced by 
chronic pesticides exposures and the genetics of Parkinson’s disease (PD) focussing 
on the PARK genes.  
 Why are dopaminergic neurons susceptible to oxidative stress ? 
 Many years of molecular and epidemiological research shows the validated 
importance of  chronic persistent exposure to environmental toxicants and its is 
association in causing PD. Even limited exposures have been reported to have 
initiated self perpetuating cascade of events leading to the death of dopamingeric 
neurons. One of the first serendipitous cases reported was of the MPTP intoxication, 
which lead to the development of PD like clinical and pathological features (Langston 
et al., 1983). The oxidized metabolite of MPTP is MPP
+
, is a functionally analogous 
to paraquat (herbicide) and rotenone (mitochondrial poison used to control fish 
population in lakes). Also, paraquat and rotenone exposures have shown development 
of PD in animal models and also in epidemiological studies (Tanner, 1992; Tanner et 
al., 2011). Epidemiologic studies have also brought out an unusual side which states 
that drinking coffee and cigarette smoking minimizes the risk of development of PD 
(Hernán et al., 2002).  
 One version of the answer to the question of why dopaminergic neurons are 
susceptible to oxidative stress, is present in one of the most fundamental elements on 
the planet. Oxygen is the most essential component of eukaryotic organism's 
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existence, sustenance, growth and development. One of its important biological 
relevance is linked to redox potential. The human brain composes of 2% of the total 
body weight but still uses 20% of the total oxygen consumed. Majorly the neurons, 
specifically the dopaminergic neurons require a big load of the oxygen for its regular 
homeostatic function (Gandhi and Abramov, 2012; Halliwell, 2006). It has been 
shown in PD cases and also in animals models of PD post environmental pesticides 
exposure, that is a tremendous increase in the levels of reactive oxygen species  such 
as superoxides, peroxynitrites, hydrogen peroxides and hydroxyl radicals. Also, there 
reported cases of rapidly increased free radicals such as O3, H2O2, 1O2 (Anantharam 
et al., 2002; Cantu et al., 2009; Caudle et al., 2012; Dranka et al., 2010; Hatcher et al., 
2007; Kitazawa et al., 2001; Miller, 2007; Przedborski and Ischiropoulos, 2005; 
Richardson et al., 2006; Sherer et al., 2003). These components of reactive oxygen 
species interfere violently with the dopamingeric neuronal system of cells post their 
generation due to pesticides exposure, thereby affecting the neurons in an oxidative 
stress mediated manner. Another reason for such susceptibility has been theorized 
based on the phenotypic and functional importance of the dopamingeric neuronal 
cells, as given below.  
 Dopaminergic neurons exhibit high oxygen consumption compared to other 
cells of the body. They requires 10X more oxygen than a regular bodily cell.  
 The size of a dopaminergic neuron is around 1000μm of length on an average 
with millions of synaptic connections. Thus making a very strong 
interconnected network using incomparable amounts of energy for 
neurotransmitter release and signal communications.  
 These neurons also have a longer life range as they are non-dividing.  
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Mitochondrial targeted pesticides and mitochondrial dysfunction 
 Mitochondrial dysfunction and damage is one of the most critical trigger of  
pathological and molecular evidences involved in many neurodegenerative disease 
including Parkinon's disease (PD), Alzheimer's disease (AD), Huntington's disease 
(HD), Amyotrophic lateral sclerosis (ALS), and many others. The degree and levels of 
impact on mitochondrial dysfunction depends varies between each diseases. The most 
common mitochondrial dysfunction factors are as follows. 
 Inhibition of mitochondrial respiration 
 Loss of ATP production and calcium dysregulation 
 Mitochondria membrane damage and potential reduction 
 Impaired mitochondrial clearance 
 Structural damage of mitochondria 
 Imbalance in mitochondrial fission and fusion process 
 In the pathogenesis of PD, oxidative stress has been strongly implicated in the 
process of neurodegeneration. Oxidative stress can result from either excessive 
production of ROS or insufficient antioxidant defense and can potentially damage 
cellular lipids, proteins, and DNA (Miller et al., 2009). One of the primary targets of 
the oxidative stress within the cell, is the mitochondria. Postmortem studies have 
consistently revealed high levels of oxidation of lipids, proteins, and nucleic acids in 
the SNpc of sporadic PD brains (Alam et al., 1997; Jenner, 2003; Tsang and Chung, 
2009). Mitochondrial respiratory chain is the main source of ROS, in particular the 
hydrogen peroxide and superoxide anions. These ROS can be converted to even more 
potent ROS, such as the hydroxyl radical and hydroxyl anion in the presence of 
ferrous iron (Winterbourn, 2008). It is worth mentioning that the level of iron is 
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significantly increased in the SNpc of PD brains (Dexter et al., 1989).  In addition to 
mitochondria, auto-oxidation of dopamine, a reaction generates superoxide and 
hydrogen peroxide, as well as reactive dopamine quinones, specifically contributes to 
the cellular ROS in dopaminergic neurons (Hastings, 2009). This dopamine-
dependent oxidative stress could at least partially explain the selective vulnerability of 
dopaminergic neurons in PD. Another important contributor of oxidative stress is 
nitric oxide (NO), which is generated by nitric oxide synthase (NOS) (Jenner, 2003). 
Reaction of ROS with NO produces highly toxic reactive nitrogen species (RNS), 
such as the peroxynitrite and nitro-tyrosyl radicals (Zhang et al., 2000).  
 The toxicants or pesticides models of PD demonstrate significant importance 
of mitochondrial dysfunction mediated by the accentuated generation of oxidative 
stress factors such as superoxides and reactive oxygen species. The process of 
oxidative phosphorylation is the key supplier of energy for the dopamingeric neurons, 
so inhibiting this process triggers loss of mitochondrial function and also leads to the 
death of these population of neurons. Impairment of complex I activity of the 
mitochondrial electron transport chain has been detected in the SNpc, skeletal muscle, 
lymphocytes, and platelets of patients with PD (Barroso et al., 1993; Haas et al., 1995; 
Mizuno et al., 1989; Schapira et al., 1989). Moreover, inhibition of complex 1 has 
also lead to initiating further downstream pro-apoptotic signaling cascades such as 
alterations in mitochondria membrane potential, calcium dysregulation, impaired 
mitochondrial and other protein clearance, imbalance in mitochondrial fission and 
fusion process.  
 MPTP is one of the well studied mitochondrial complex I inhibitor, which has 
a proven ability to selective degenerate dopamingeric neuronal cells in brain leading 
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to PD (Langston, 2017; Nicklas et al., 1987; Przedborski and Jackson-Lewis, 1998; 
Stern et al., 1990). Studies with rotenone another neurotoxic complex I inhibitor, 
shows significant loss of dopaminergic neurons in cell culture, animal models of PD 
and epidemiological studies (Betarbet et al., 2000; Greenamyre et al., 2001; Sherer et 
al., 2007; Testa et al., 2005).  On a general perspective, exposure to complex I 
inhibiting pesticides such as MPTP and rotenone lead to PD and this effect is not 
confined only to the brain, but also could be seen in platelets (Parker et al., 1989; 
Schapira et al., 1990a; Schapira et al., 1990b). The action of such complex I inhibitors 
markedly reduces the production of ATP particularly in the striatum and ventral 
midbrain (regions that are most sensitive to complex I inhibition). Furthermore, 
complex 1 inhibition impairs the mitochondrial potential and mitochondrial 
membrane transport. Thereby, increasing the risk of PD is associated with the 
exposure to mitochondrial target pesticides such as MPTP and rotenone (Dauer and 
Przedborski, 2003; Davey and Clark, 1996; Sherer et al., 2003).  
Overwhelming evidence suggests that mitochondrial dysfunction is an 
important contributor to the neurodegenerative process observed in PD (Onyango, 
2008; Thomas and Beal, 2007). This section of the review highlights the role and 
mechanistic action of complex 1 inhibition mediated intracellular signaling 
perturbation, post exposure to complex 1 inhibitors such as rotenone and MPTP.  
Mitochondrial Complex 1 inhibiting pesticides signaling disruption in Parkinson's 
disease 
In the past several years, we and many other labs have shown the neurotoxic 
potential of complex 1 inhibiting pesticides in dopamingeric neuronal models of PD 
(Anantharam et al., 2007; Charli et al., 2016; Ghosh et al., 2010; Greenamyre et al., 
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2001; Kaul et al., 2003; Parker et al., 1989; Schapira et al., 1989; Sherer et al., 2003). 
Also earlier studies show that in non-familiar sporadic PD, there is a definite 
reduction of 15%–30% in the complex I activity (Schapira et al., 1990a).   
Rotenone  
Among the pesticides associated with PD, rotenone is a well-characterized inhibitor of 
mitochondrial complex I that occurs naturally in tropical legumes (Cabeza-Arvelaiz 
and Schiestl, 2012; Greenamyre et al., 2001). Experimentally, in a number of animal 
models of PD, rotenone has been proven to recapitulate PD pathological features and 
neurochemical hallmarks (Betarbet et al., 2000; Choi et al., 2011; Greenamyre et al., 
2010; Johnson and Bobrovskaya, 2015; Sherer et al., 2003; Testa et al., 2005). In 
addition to the animal models, recent epidemiological evidence has linked pivotally 
the chronic rotenone exposure in humans with PD (Spivey, 2011; Tanner et al., 2011).  
 The pathogenic mechanisms underlying rotenone-induced Parkinsonism are 
not fully understood, but possibly involve inhibition of mitochondrial respiratory 
chains and induction of oxidative damage (Johnson and Bobrovskaya, 2015; Sherer et 
al., 2003). Past couple decades of research has gained traction related to the rotenone-
rat model of PD. It has been shown that rotenone treated rats recapitulated several 
characteristics of PD including hallmark features such as selective loss of 
dopaminergic neuronal cells in the substantia nigra of the mid-brain region, α-
synuclein aggregation, Lewy body formation, reduced levels of dopamine and motor 
deficits (Alam and Schmidt, 2002; Betarbet et al., 2000; Sherer et al., 2003).  Recently 
it was shown that α-synuclein aggregation was promoted upon rotenone exposure in 
the PC12 cells, in a calcium-dependent manner. In a general circumstance, aggregated 
α-synuclein gets degraded by autophagy, but exposure to rotenone impaired this 
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process. Thereby by exacerbating phosphorylation of α-synuclein, leading to 
aggregation. Also, in this studied rotenone attenuated the phosphorylation of AKT and 
GSK3β, hence demonstrating rotenone-induced α-synuclein aggregation is mediated 
by the calcium/GSK3β signaling pathway (Yuan et al., 2015).  Recently it has been 
shown that there is significant biophysical interaction between rotenone and α-
synuclein. Using state of the art electron microscopy and Fourier transform infrared 
spectroscopy, it was confirmed that the direct interaction of α-synuclein and rotenone 
accentuates the fibrillation of α-synuclein leading to PD like pathology (Silva et al., 
2013). Being a complex 1 inhibitor by function, rotenone dysregulates a number of 
mitochondrial functions that is involved in its maintenance. A recent study in neurons 
shows that rotenone induced LC3 activation triggers delivery of the damaged 
mitochondria to autophagosomes and lysosomes, resulting is a mitophagy mechanism. 
This process is mediated through an direct-interaction between LC3 and externalized 
cardiolipin (Chu et al., 2014). A similar study by the same group, Charleen Chu, et al., 
reiterated the importance of cardiolipin and LC3 interaction post rotenone exposure in 
the SH-SY5Y human cells as a signal for mitophagy (Chu et al., 2013). Another study 
shows chronic exposure of rotenone to rats induced mitophagy marked by hallmark 
features of autophagy such as beclin-1 cleavage, LC3 II activation and formation of 
autophagic vacuoles. This phenomena was protected against by the stereotaxic 
injection of DJ-1 expression in the substantia nigra of the rats. Thereby demonstrating 
the role of DJ-1 Protecting against Rotenone-Induced Dopaminergic Neuronal toxicity 
and Apoptosis by Enhancing ERK-Dependent Mitophagy (Gao et al., 2012).  
 There are a number of studies in past several years that has clearly established 
the understanding of rotenone toxicity and its relevance to PD. Rotenone (10-50 nM) 
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exposure on to the postnatal midbrian organotypic slice cultures for weeks of time 
lead to the demonstration of a dose- and time - dependent loss of the substantia nigra 
pars compacta neuron processes, significant reduction in complex 1 activity and 
neuronal loss and decreased expression of the dopaminergic neurons marked by the 
reduction in the expression of Tyrosine Hydroxylase (TH) protein (Testa et al., 2005). 
Another study demonstrated in the  SK-N-MC human neuroblastoma cells exposed to 
rotenone (10 nM to 1 μM), established a dose-dependent ATP depletion, oxidative 
stress, and oxidative damage and hence mediated neuronal cell death (Sherer et al., 
2003).  Rats treated with rotenone demonstrated a significant behavioural impairment, 
loss of TH expression in the substantia nigra, decreased parkin, Hsp70 and DJ1 
expression. Adding on the initiator and executioner caspases 3 and 9 had a 
accentuated increase in the rotenone treated rats. These factors were pronounced as a 
responsible contributors of oxidative damage and neuronal death (Sonia Angeline et 
al., 2012).  rotenone also induces decreases in proteasome activity in the HEK and 
SK-N-MC cells, due to increased degradation of 20S proteasome components 
secondary to oxidative damage. The free radicals nitric oxide and peroxynitrites were 
proven to be the suspected contributors to this proteosome inhibition process (Chou et 
al., 2010).  
MPTP 
 MPTP is a well known and studied complex 1 inhibitor and its exposure leads 
to systemically affecting the dopaminergic neuronal cells population in the midbrain 
region. MPTP first is metabolized by the enzyme MAO-B (monoamine oxidase) to 1-
methyl-4-phenyl-2, 3-dihydropyridium (MPDP
+
), which upon deprotonation 
generates correspondingly the oxidized product of MPP
+
. This makes MPP
+ 
smoothly 
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ass through the blood brain barrier and directing it to the mitochondria (Przedborski 
and Jackson-Lewis, 1998; Smeyne and Jackson-Lewis, 2005). The molecular 
mechanism of MPTP and its oxidized form of MPP
+
 has been very well characterized. 
It plays a very highlighting role in mediating or triggering dopaminergic neuron 
specific toxicity and apoptotic cell death.  
 MPTP causes damage to substantia nigra pars compacta dopaminergic neurons 
as seen in Parkinson's disease (PD). Exposure to MPTP results in its oxidative product 
MPP
+
. The MPP
+
 then accumulates inside the dopaminergic neurons. This process 
exacerbates the generation of free radicals and superoxides leading to the inhibition of 
intracellular ATP production. Also the generated superoxides react with nitric oxide 
resulting in peroxynitrite.  Tyrosine hydroxylase is one such proteins that get nitrated 
by this raction and gets inactive, thereby restricting dopamine production in these 
neurons. In addition, the peroxynitrites damages the DNA leading to action of PARP 
(ADP-ribose polymerase), which further contributes to the energy depletion by using 
up the available ATP. This one of the hallmark mechanistic action of MPTP, making 
it a potential toxin mitigating the etiology of PD (Langston, 2017; Langston et al., 
1983; Langston and Ballard, 1983; Przedborski et al., 2000; Stern et al., 1990). These 
functional insights and specific action on dopaminergic neuronal cells has been 
extensively studied using the MPTP animal models of PD.  
 Recent years of research has hinted a strong linearity between MPTP toxicity 
and α-synuclein. It has been shown that α-synuclein knock down human neuronal 
cells and mouse neurons have a resistance developed for the MPTP or its active 
metabolite MPP
+ 
(Fountaine et al., 2008; Fountaine and Wade-Martins, 2007).  A 
similar trend of protective response against MPTP toxicity and dopaminergic neuronal 
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cell death is observed in the α-synuclein knockout mice. The negative effect of 
knocking down α-synuclein is that it results in significant reduction of synaptic 
vesicles, thereby inhibiting neurotransmitter release and capture (Abeliovich et al., 
2000; Murphy et al., 2000). MPTP mediated α-synuclein aggregation formations is 
also hallmark effect observed in primate and mouse models, eliciting the pathology of 
PD (Anantharam et al., 2007; Ballard et al., 1985; Dauer and Przedborski, 2003; 
Kowall et al., 2000; Meredith and Rademacher, 2011; Przedborski and Vila, 2003).  
 Toxicity induced by MPTP plays a crucial role in triggering downstream 
events in the apoptotic cell death process. One such signaling is autophagy. It has 
been observed accumulation of autophagosomes in the post mortem PD brains, which 
primarily suggested that role of autophagy in the apoptosis of dopaminergic neurons. 
A similar feature of accumulation of autophagosomes, which significantly contributed 
to the pathology of PD and was observed in the MPTP mouse model of PD. Adding 
on it was alos demonstrated that there was an an early decrease in lysosome number 
in dopaminergic neurons as a result of lysosomal membrane destabilization and 
cytosolic release of cathepsins (Dehay et al., 2010; Nixon, 2013). One of the very 
recent interesting findings related to MPTP toxicity and selective loss of midbrain 
dopaminergic neurons, highlights the importance of MicroRNA‐124. levels are found 
to be decreased in the MPTP treated mice mid brain region tissues. Adding on, 
MicroRNA‐124 regulates apoptosis and autophagy processes by targeting Bcl-2 like 
protein 11 (Bim) in the mice injected with MPTP, marking its importance in eliciting 
PD (Wang et al., 2016). The same group also demonstrated that MicroRNA‐124 
regulates neuronal cellular apoptosis and autophagy in the SH-SY5Y cells treated my 
MPP
+
 (100 μM) by protecting the neurons against MPP+ toxicity by the reguilation of 
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the AMPK/mTOR pathway. This is observed by the increased p-AMPK but decreased 
p-mTOR levels, post supression of MicroRNA‐124 prior to MPP+ exposure in the 
dopaminergic neurons (Gong et al., 2016).  
Pyridaben  
 Pyridaben (IUPAC name: 2-tert-butyl-5-[(4-tert-butylphenyl)methylsulfanyl]-
4-chloropyridazin-3-one) is a commonly used acaricide for killing populations of 
mites or ticks in commercial greenhouses (Lümmen, 1998; Schuler et al., 1999).  
Chemically it is classified as a pyridazinone, whose major application is confined for 
usage in greenhouses and vineyards (EPA PC Code- 129105). Similar to rotenone, 
pyridaben has been shown to function as mitochondrial complex I inhibitors 
(classified by the IRAC-Insecticide Resistance Action Committee). as a 
mitochondrial complex I inhibitor.  
 Like rotenone, pyridaben is highly lipophilic and can thus easily cross the 
blood-brain barrier (Gendelman et al.). Considering the link between complex I 
dysfunction and PD, pyridaben likely poses a disease risk, but the epidemiological 
evidence is lacking. We and others have demonstrated that exposure to lower 
concentrations (nano and micromolar doses) of pyridaben induces significant 
neurotoxicity in cultured neuronal cells and midbrain organotypic slices (Charli et 
al., 2015; Sherer et al., 2007). Adding on, the trend in SK-N-MC human 
neuroblastoma cells has previously been shown as pyridaben has a greater and more 
potent cytotoxicity than that of rotenone (Sherer et al., 2007). Not just in a neuronal 
model system, but also in C. elegans exposed to rotenone (50 μM, 1 hr) or  
pyridaben (25 μM, 1 hr) resulted in significant redcution in the mitochondrial 
respiration , this reinstating the ability of these two pesticides to function as a 
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mitochndrial functional disruptor (Schuler et al., 1999). Another study of pyridaben-
treated C57BL mice found a strong correlations between pyridaben exposure and 
both DAergic neuron loss and increased α-synuclein immunoreactivity. The authors 
also performed an RNAseq analysis and reported that mice exposed to certain 
pesticides exhibited gene expression patterns bearing significant correspondence to 
pathways that were well-known in human PD cases (Gollamudi et al., 2012). The 
Washington State Department of Agriculture documented neurological, ocular and 
gastrointestinal symptoms in farm workers poisoned by an off-target exposure to 
pyridaben (Calvert et al., 2015). Besides mitochondrial complex I impairment, thus 
far only a limited number of putative pathogenic mechanisms have been proposed to 
explain the underlying rotenone- and pyridaben-induced neurotoxicity, including 
oxidative stress and UPS dysfunction (Chou et al., 2010; Hoglinger et al., 2003; 
Shamoto-Nagai et al., 2003), which are highly interrelated molecular pathways that 
could synergistically culminate in neuronal death (Branco et al., 2010; Malkus et al., 
2009; Mounsey and Teismann, 2010; Park et al., 2009; Winklhofer and Haass, 
2010). 
Genetics of PD - A brief walk with the PARK genes 
 The common approach in understanding the pathology of sporadic PD is 
focussed on studying about the disease incurred by the influence of exposure to 
environmental pesticides. But around 5-10 % of PD cases are due to genetic changes 
or mutations. There are have been many cell and animal based studies that highlights 
and focusses on the contributions of genetic factors leading to the devlopment of PD. 
Also, there have been a number of epidemological studies, which has helped in 
unraveling the role of gene alterations and their association to PD. Some of the PD 
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genes also known as PARK genes are listed in the figure below as illustrated in (Klein 
and Westenberger, 2012; Pankratz and Foroud, 2007) (Figure 1.3). 
  Figure 1.3  Summary of PD-associated genes (PARK genes) 
 First gene that was identified and associated with PD was SNCA (PARK 1) 
which codes for the α-synuclein protein.  α-synuclein is one of the major components 
in the Lewy bodies in patients with familial and sporadic PD (Spillantini et al., 1997).  
SNCA gene is a autosomal dominant contributor of the disease. There have been three 
identified mutations in the SNCA namely, A53T, A30P and E46K, these were 
discovered in three distinctly different familial PD patients (Kruger et al., 1998; 
Polymeropoulos et al., 1997; Zarranz et al., 2004). The affected members of the 
A53T mutation in the SNCA have similar clinical and pathologic findings to those 
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with idiopathic PD, including a response to levodopa and the presence of Lewy 
bodies (Pankratz and Foroud, 2007). Despite many information related to the three 
mutations of SNCA gene was associated with PD, precise mechanism by which this 
occurs has not been very well understood.  
 The next autosomal dominant gene is LRRK2 gene. This gene is called 
known as PARK8 and codes for the protein which is a kinase called as Leucine rich 
repeat kinase 2 (Mata et al., 2006). Many mutations on this gene have been 
identified in all of its five domains and although size wise it is big, many other 
additional studies have been performed and more mutations have been identified 
(Deng et al., 2005; Hulihan et al., 2008; Orr-Urtreger et al., 2007). One of the most 
common mutations on LRRK2 that is well studied is the G2019S, this is accounted 
in almost 1-2% sporadic and 5-6% of familial PD reported cases.  The mutations 
studied on LRRK2 so far at the molecular level all seem to up-regulate kinase 
activity and increase autophosphorylation (Smith et al., 2005; West et al., 2005). 
 First in the list of autosomal recessive PD genes is parkin. The mutations in 
the parkin gene was reported with autosomal recessive juvenile parkinsonism in 
Japanese families (Hattori et al., 1998).  Patients with parkin mutations have the 
usual classical PD features and symptoms, but the progression of the disease is 
slower. The response to levodopa is very well observed and characterised for 
patients with the parkin gene mutations (Lohmann et al., 2003). The parkin protein 
functions primarily as an E3 ubiquitin ligase and enables the disposal of damaged or 
misfolded proteins via the ubiquitin-proteosomal system (Leroy et al., 1998; Shimura 
et al., 2000). Parkin also has a potential role in maintenance of mitochondrial health 
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and functionally interacts with PINK1 during mitophagy (Deng et al., 2008; Narendra 
et al., 2008; Rothfuss et al., 2009). 
 PINK1 is identified in early onset and autosomal recessive cases of PD. The 
muattions in PINK1  accounts for 1-7% of early onset or autosomal recessive PD. 
Patients diagonsed and tested with PINK1 mutations appear to have clinical 
features that resemble late onset PD (Hatano et al., 2004; Valente et al., 2004). Many 
PINK1 mutations are loss-of-function mutations that affect the kinase domain of the 
protein, suggesting the important role of the kinase activity of PINK1 in the 
pathogenesis of PD (Abou-Sleiman et al., 2006). Recent studies have shown that 
PINK1 functions targeting the upstream of parkin in a common pathway which 
regulates the selective elimination of damaged mitochondria through mitophagy 
(Youle and Narendra, 2011). PINK1 localizes to outer membrane of depolarized 
mitochondria and recruits parkin to initiate mitophagy. In recent years this pathway of 
PNK1 involved in mitophagy has been well characterized. Also, it has been shown 
that PINK1 protects against oxidative stress-induced apoptosis (Petit et al., 2005).  
 Autosomal recessive, early onset PD due to mutations in DJ-1 has been 
identified only seven families worldwide. The reported mutations consist of 
missense mutations, whole exon deletions, a frameshift mutation, and a splice site 
mutation found in either a homozygous or compound heterozygous state. Through 
extensive molecular screening, it is estimated that mutations in DJ-1 account for 
<1% of all cases of early onset PD (Bonifati et al., 2003a; Bonifati et al., 2003b). 
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An unseen dimension  through the chromosomes 
 It all started more than three decades ago, when Dr. Langston attended a 
patient who was identified as a drug abuse case, with excessive use of a drug which 
was a meperidine analog. This was a by product of 1-methyl-4-phenyl-4-
propionoxypiperidine (MPPP) called as  1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP). Through many research studies and heuristic and 
scientific evidences by his group and a few others, it was shown that MPTP was a 
potent causer of PD, upon chronic exposure (Ballard et al., 1985; Langston et al., 
1983; Langston and Ballard, 1983; Lewin, 1984; Stern et al., 1990). A detailed 
prologue of this cases situation and the behavioural details has also been published 
recently in Dr. Langston's paper titled, "The MPTP Story" (Langston, 2017). Over the 
past couple of decades, plethora of groups have almost completely unravelled the 
mechanistic importance of MPTP exposures that leads to the death of dopamingeric 
neuronal cells in the substantia nigra region of the brain leading to PD (Anantharam 
et al., 2007; Blesa et al., 2012; Dauer and Przedborski, 2003; Jin et al., 2015; 
Kanthasamy et al., 1997; Kaul et al., 2003; Nicklas et al., 1987; Przedborski and 
Jackson-Lewis, 1998; Przedborski and Vila, 2003; Schmidt and Ferger, 2001).  
 Previously it has been studied and demonstrated that MPTP acts 
predominantly on the D1 and D2 receptors. It has been also noted that the D1 and D2 
receptors are the most susceptible during  methamphetamine drug abuse. D1 and D2 
receptors are well established and are majorly expressed in the striatum and 
substantia nigra region of the brain and are functionally 50% homologous. It has also 
been characterised that the gene encoding for D1 and D2 receptors are housed in 
chromosome 5 and 11 respectively (Ares-Santos et al., 2013; Betarbet and 
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Greenamyre, 2004; Chang et al., 2007; Goulet and Madras, 2000; Grandy et al., 1989; 
Grandy et al., 1990; Higuchi et al., 1995; Hisahara and Shimohama, 2011; Zhang et 
al., 2016). MPTP is well known as a mitochondria complex I inhibitor. A recent study 
has revealed that rotenone, a famous Parkinsonian toxin, also affects the D1 and D2 
receptor in the striatum and substantia nigra region of the brain (Paul et al., 2010). 
Thus this provides logical interpretation about the receptors that these mitochondrial 
complex I inhibitors, which are highly lipophilic act on the dopamingeric neuronal 
cell population in the mid brain region. We and another group have shown that 
tebufenpyrad and pyridaben, two mitochondrial complex I inhibitors function 
functions similar to rotenone in affecting the mitochondria by impairing 
mitochondrial dynamics in the dopaminergic neuronal cells (Charli et al., 2016; 
Sherer et al., 2007). But, they vary in their potency levels to affect the mitochondria as 
discussed in Chapter 1 of this thesis. Combining these two proof of concepts and set 
of evidences, we here in this review extrapolate this idea, to our mitochondrial 
inhibiting pesticides and complex I inhibitors, tebufenpyrad and pyridaben 
(Hypothesis - Figure 1.4).  
 
 
 
 
 
Figure 1.4 Illustrative hypothesis on the action of mitochondrial complex 1 
inhibitors on D1 and D2 receptors at the synapse of dopaminergic neurons 
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 There are a set of sixteen PARK genes identified so far that are associated 
with the pathogenesis and genetics of PD. We have discussed about some of them as 
mentioned above in this section. The importance pertaining to our line of interest is 
with regard to their positioning and encasement in the chromosomes. The comparative 
speculative analysis, understanding the chromosomal location of these PARK genes 
and the D1 and D2 receptor genes, will enable in surmising and opening clues 
regarding  the susceptibility of dopaminergic neurons to oxidative stress and specific 
apoptotic cell death. The table below briefly highlights the location of each of those 
PARK genes and dopamine receptor genes (receptors D1, D2, D3, D4 and D5) in their 
corresponding chromosomes (Klein and Westenberger, 2012) and 
(https://www.ncbi.nlm.nih.gov/genome/guide/human/) (Table 1.1).  
 
Table 1.1 PARK genes and dopamine receptor genes in corresponding 
chromosomes 
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 As mentioned previously in this review, D1 and D2 receptor specific genes 
DRD1 and DRD2 are located in chromosomes 5 and 11 respectively. Hence 
approaching the idea of susceptibility of dopaminergic neurons to oxidative stress 
mediated by exposure to mitochondrial complex I inhibitors will be the inceptive first 
step for our novel interpretation (Chromosomes of interest - Figure 1.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Pictorial sketch highlighting chromosomes 5 and 11 of  
dopaminergic neurons 
 Chromosome 5 is the fifth largest chromosome of the 23 chromosomal pairs 
in humans and represents nearly 6% of the total DNA and encodes for approximately 
1700 genes (Schmutz et al., 2004). Although D1 receptor gene is encoded in this 
chromosome, there have been no reported PARK genes encoded in chromosome 5. It 
has been shown by Dr. Foroud's group after analyzing the combined data from a very 
large sample of familial PD, that it is unlikely that a PD susceptibility gene is 
located on chromosome 5 (Foroud et al., 2006). This study consisted of analysis of 
genomic data from 1238 affected individuals from 569 multiplex PD families, 
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which were genotyped for a common set of 20 microsatellite markers spanning an 
80 cM region on chromosome 5.  Even with, such an evidence from this conclusive 
study performed a decade back, we suspected the role of certain genes in 
chromosome 5 along with DRD1, to be intuitively involved in manipulating 
dopaminergic neuronal cells susceptible to apoptotic cell death mediated by the 
mitochondrial dysfunction induced post chronic exposure to complex I inhibitor 
such as MPTP,  rotenone, tebufenpyrad and pyridaben. Below are some genes that 
really interests us in our investigation on the susceptibility of dopaminergic 
neurons to oxidative stress mediated through mitochondrial dysfunction.  
 One such suspected candidate gene short listed on chromosome 5 was 
CPLX2. This encodes for Complexin-2 protein. Complexin-2 is a soluble protein 
that regulates the activity of SNARE complexes necessary for vesicle fusion. The 
functional specificity of complexin-2 is dependent on its conformation state 
(Krishnakumar et al., 2011). It has been shown that complexin-2 knock out in mice 
results in 60-70% increase in neurotransmitter release (Hu et al., 2002; Reim et al., 
2001).   A recently in a blood based RNA biomarker study, complexin-1 gene 
CPLX1, has been associated with the risk of PD in the patients affected by PARK4 
mutation (Lahut et al., 2017). It has also been shown recently that protein levels of 
complexin-1 were elevated in midbrain/brainstem tissue of mice with A53T-SNCA 
over-expression and of mice with SNCA-knockout, thus showing its role in alpha- 
synuclein pathology (Gispert et al., 2015).  These existing results suggests that there 
might be a potential role for complexin in contributing to the susceptibility of 
dopaminergic neuronal cell death in terms of interaction and function with respect to 
alpha-synuclein and regulation of neurotransmitter release.  
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 Another instinctively inferred prospective gene candidate on chromosome 5 is 
FASTKD3. FASTKD3 encodes for the protein Fas-activated serine/threonine kinase 
domain 3 (FASTKD3). This protein has recently gained importance as it has been 
recognised to function as a regulator of mitochondrial gene expression through the 
function of an unusual RNA-binding domain named RAP (RNA binding domain). 
Recently it has been shown that in the FASTKD3 knock-out  in the human 
osteosarcoma cells resulted in the increase of mitochondria RNA such as ND2, ND3, 
COX-2 and CYTB. This study also revealed that the RAP domain of the FASTKD3 is 
required for the stability of the mitochondrial mRNA and also FASTKD3 is required 
for efficient COX1 mRNA translation without altering mRNA levels.  Thereby 
suggesting its importance associated with reduced mitochondrial complex IV 
assembly and activity (Boehm et al., 2016). FASTKD3 consists of a N-terminal 
mitochondrial targeting domain and the protein's essential responsibility is regulation 
of cellular respiration (Simarro et al., 2010).  Recently, we had verified the presence 
and abundance of the FASTKD3 gene expression in the control human brains 
(average recorded from 6 different human brains). This study involves simulation of 
human brain using the Brain Explorer 2.0 software and we identified prominent 
expression of FASTKD3 in the substantia nigra and striatum regions of the human 
brain (Data not shown). Since this is more of an insilico/simulation based analysis, we 
are working on a more comprehensive study related to PD and expression of 
FASTKD3 using human and animal models of PD.  These studies and data strongly 
suggests that  FASTKD3 could be one of the most potential target encoded on 
chromosome 5, that might be susceptible to the mitochondrial inhibiting toxicant 
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exposure mediated D1 receptor damage, that could make the dopaminergic neurons 
more susceptible to oxidative stress leading to cell death.   
 In addition to these genes discussed above, there are several others that might 
have some relevant role in the susceptibility of dopamingeric neuronal cells to the 
toxicity and cell death post exposure to mitochondrial complex I inhibiting pesticides. 
These genes are housed in chromosome 5and have a underlying significant role in 
protein trafficking, transport, RNA regulation and binding. Their functional roles are 
summarized as given in the Table 1.2 below. 
Table 1.2 Other important genes housed in chromosome 5 
 Chromosome 11  is an average size chromosome with the most gene and 
disease rich density of content found in the human genome. It houses about 2500 
genes including the about 1500 protein coding genes and around 800 pseudo genes. 
The interesting functional responsibility that lights up is that chromosome 11 
Gene Protein Name Function 
CREBRF CREB3 regulatory factor Controller of mTOR and S-Phase 
cell cycle. 
EGR1 Early growth response protein 
1 
`Transcriptional regulator and 
neuronal plasticity 
FBXL7 F-box/LRR repeat protein 7 Ubiquitin protein ligase complex 
EIF4E1B Eukaryotic translation 
initiation factor 4E family 
member 1B 
mRNA cap binding 
LARP 1 La-related protein 1 or 
La-ribonucleoprotein 1 
Interacts with the 5'mRNA Cap 
and involved in P-Bodies 
formation 
TBCA Tubulin Specific Chaperone A Β-Tubulin stability and 
homeostasis 
SNCAIP Synphilin-1 or  α-synuclein 
interacting protein 
Interaction with α-synuclein in 
the presynaptic region and 
involved in certain specific 
neurodegenerative mechanisms 
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comprises and houses about 40 % of the total of 856 olfactory receptor genes (Taylor 
et al., 2006). Despite this chromosome involved in many disease's contribution, it has 
still not been related or associated to PD or PD-like pathology. One of the noteworthy 
information in this relevance, is housing of DRD2 gene on chromosome 11, which is 
predominantly involved in the dopamine D2 receptor functions. Thus this allows us to 
suspect the role of DRD2 and other genes related to it that are housed on chromosome 
11,  in dopaminergic neuronal cell's precarious susceptibility to mitochondrial 
complex I inhibitor class of environmental pesticides. 
 Our heuristically decifered candidate gene of interest on chromosome 11 is, 
NRGN. NRGN is housed on chromosome 11 and it encodes for the protein called 
Neurogranin. It is a synaptic protein, that belongs to the calmodulin-binding family of 
proteins. It is expressed primarily in the brain, in particular found in the dendritic 
spine and majorly participates in the PKC signalling pathway. In the synaptic region 
functions by regulating the calmodulin availability and orchestrates the binding of 
calmodulin to Ca
+ 
and is dynamically involved in neuronal plasticity. In general, PKC 
mediated phosphorylation lowers the binding ability of neurogranin (Díez-Guerra, 
2010). In PD neurogranin has been demonstrated to possess a noteworthy role in 
terms of synaptic function and cognition. Neurogranin levels were observed to be 
significantly lowered in the CSF correlating with cognitive impairment in the mild to 
moderate PD samples compared to the controls (Selnes et al., 2017). In contrary to 
this finding, an epidemiological study by another group determined the concentration 
of neurogranin in CSF of PD patients using the enzyme-linked immunosorbent 
assay. This study consisted of 139 participants (87 controls and 52 Parkinson's 
disease patients) and they show increased concentrations of neurogranin in the PD 
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patients in a disease specific manner and was associatively linear to cognitive and 
motor symptom severity (Bereczki et al., 2017).  It was identified by RT-PCR that 
neurogranin had a direct expressional increase of 2.5 fold upon over-expressing 
human alpha synuclein in the mouse brain, compared to the control non-transgenic 
mice. Also, co-immunoprecipitation studies using the superior temporal cortex from 
humans confirmed interaction between alpha synuclein and neurogranin. Additionally 
it was noticed that there was decreased interaction between α-synuclein and 
neurogranin in the brains of patients diagnosed with PD compared to the normal 
control brains (Koob et al., 2014).  Regardless of such available plethora of results 
and studies, the fundamental role of neurogranin has not been very well characterised 
with respect to their chromosomal location, gene expression patterns post oxidative 
stress in the brain during PD, interactive response and link with the PARK genes or 
other important protein alterations that are observed markedly in the dopaminergic 
neurons in PD cases. Hence this makes NRGN potential component to study the 
apoptotic pathway simulated and augmented in the dopaminergic neuronal cells 
mediated to dysfunction D2 receptor dynamics post exposure to mitochondrial 
complex I specifically targeting compounds/pesticides such as MPTP, rotenone, 
pyridaben and tebufenpyrad.  
 The table below summarizes some additional genes and their functional role 
housed in chromosome 11 (Table 1.3). These genes were spotted and highlighted 
since, they are involved in a number of protein translational regulation processes, 
mitochondria function and apoptotic signalling. Hence could be targets of 
investigation for our future studies. 
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Table 1.3 Other important genes housed in chromosome 11 
 Although in this review we have predicted and suspected that there are other 
genes part from the PARK genes that might be involved in the pathogenesis and 
progression of PD by targeting the increasing susceptibility of the D2 and D2 
receptors to mitochondrial complex I inhibitor class of pesticides or toxicants. This 
newly moulded concept of an idea needs further data based validation, which is 
exactly our current work in progress.  
 The importance and role of chromosomes in PD pathology and symptoms has 
not been well studied. This may be due to the complexity and the unchartered territory 
in the dark world of the chromosomes containing numerous functional genes, pseudo 
genes and other components such as introns, exons and regulators of gene expression. 
Gene Protein Name Function 
ACAT1 Acetoacetyl-CoA thiolase  Regulator of mitochondrial 
acetylation  
AKIP1 Akinase interacting protein 
1 
cAMP dependent PK signalling on 
NF-κB activation cascade 
FNBP4 Formin binding protein 4 Formin dependent actin 
polymerization 
VPS26B Vacuolar protein sorting 
26B 
Part of the retromer complex along 
with VPS35 and VPS29 
TIMM10 Mitochondrial import 
inner membrane 
translocase subunit Tim10 
Import and binding of protein within 
the mitochondrial inner membrane.  
TH Tyrosine Hydroxylase Conversion of the amino acid L-
tyrosine to L-DOPA in the 
dopaminergic neurons. 
SLC17A6 Solute Carrier Family 17 Vesicular glutamate receptor 
NFRKB Nuclear factor related to 
kappa-B-binding protein 
Regulatory component of chromatin 
remodeling INO80 complex. 
Modulates the deubiquitinase activity 
of UCHL5 in the INO80 complex. 
MADD Map kinase activating 
death domain protein 
Marker of apoptotic cell death  
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Thus these unanswered questions made us culminate and incept an idea in terms of 
D1 and D2 receptor genes DRD1 and DRD2 respectively, for studying the 
susceptibility of dopaminegric neuronal cells to oxidative stress induced by 
mitochondrial complex I inhibiting pesticides/toxicants such as MPTP and rotenone.  
 Further these ideas were extrapolated and predicted for exposures to 
neurotoxic environmental pesticides suchs such as tebufenpyrad and pyridaben in the 
dopaminergic neuronal cells. Additionally, our present review further unravels the 
importance and functional relevance of certain genes (encoding for specific proteins) 
based on their contributions and role in mitochondrial health dynamics, protein 
trafficking, protein disposal machinery and synpatic functions. This novel approach 
enables us to understand the side of the disease from a newer but yet less ventured 
resaerch and diagnostic perspective.   
 We are currently working on testing some of the predicted genes on 
chromosome 5 and 11, as their functions had been discussed above regarding their 
locations on correspondingly housed chromosomes. Our current undergoing studies 
might open up new novel pathways with respect to the mitochondrial dysfunction and 
its earlier detection in PD, hence that will facilitate in the contribution towards 
discovery of intervening drug targets and biomarker inventions and also early 
diagnostic tools for the early diagnose of PD.  
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Abstract 
Tebufenpyrad and pyridaben are two agro-chemically important acaricides 
that function like the known mitochondrial toxicant rotenone. Although these two 
compounds have been commonly used to kill populations of mites and ticks in 
commercial greenhouses, their neurotoxic profiles remain largely unknown.  
Therefore, we investigated the effects of these two pesticides on mitochondrial 
structure and function in an in vitro cell culture model using the Seahorse bioanalyzer 
and confocal fluorescence imaging. The effects were compared with rotenone. 
Exposing rat dopaminergic neuronal cells (N27 cells) to tebufenpyrad and pyridaben 
for 3 h induced dose-dependent cell death with an EC50 of 3.98 μM and 3.77 μM, 
respectively. Also, tebufenpyrad and pyridaben (3 μM) exposure induced reactive 
oxygen species (ROS) generation and m-aconitase damage, suggesting that the 
pesticide toxicity is associated with oxidative damage. Morphometric image analysis 
with the MitoTracker red fluorescent probe indicated that tebufenpyrad and 
pyridaben, as well as rotenone, caused abnormalities in mitochondrial morphology, 
including reduced mitochondrial length and circularity.  Functional bioenergetic 
experiments using the Seahorse XF96 analyzer revealed that tebufenpyrad and 
pyridaben very rapidly suppressed the basal mitochondrial oxygen consumption rate 
similar to that of rotenone.  Further analysis of bioenergetic curves also revealed dose-
dependent decreases in ATP-linked respiration and respiratory capacity. The 
luminescence-based ATP measurement further confirmed that pesticide-induced 
mitochondrial inhibition of respiration is accompanied by the loss of cellular ATP. 
Collectively, our results suggest that exposure to the pesticides tebufenpyrad and 
pyridaben induces neurotoxicity by rapidly initiating mitochondrial dysfunction and 
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oxidative damage in dopaminergic neuronal cells. Our findings also reveal that 
monitoring the kinetics of mitochondrial respiration with Seahorse could be used as 
an early neurotoxicological high-throughput index for assessing the risk that 
pesticides pose to the dopaminergic neuronal system.   
Introduction 
A growing body of evidence suggests that exposure to neurotoxic pesticides in 
agricultural settings is associated with increased risk for developing Parkinson’s 
disease (PD) (Baltazar et al., 2014; Freire and Koifman, 2012; Parron et al., 2011). 
Among the pesticides associated with PD, rotenone is a well-characterized inhibitor of 
mitochondrial complex I that occurs naturally in tropical legumes (Cabeza-Arvelaiz 
and Schiestl, 2012; Greenamyre et al., 2001). Experimentally, exposure to rotenone 
was shown to reliably produce Parkinson's-like pathology in various animal models of 
PD (Betarbet et al., 2000; Greenamyre et al., 2010; Johnson and Bobrovskaya, 2015; 
Testa et al., 2005). Furthermore, recent epidemiological evidence has linked human 
rotenone exposure with PD (Spivey, 2011; Tanner et al., 2011).  
The pathogenic mechanisms underlying rotenone-induced Parkinsonism are 
not fully understood, but possibly involve inhibition of mitochondrial respiratory 
chains and induction of oxidative damage (Johnson and Bobrovskaya, 2015; Sherer et 
al., 2003). Mitochondria are pivotal to the homeostatic functioning of cells and thus 
the central nervous system. The primary role of mitochondria is to provide energy to 
cells via oxidative phosphorylation (Chan, 2006; Hoppins et al., 2007; Jin et al., 
2014a; Zhang and Chan, 2007). Some of the critical biochemical abnormalities 
resulting from mitochondrial dysfunction are increased generation of reactive oxygen 
species (ROS), loss of ATP production during cellular respiration and impaired Ca
2+
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ion channels (Schapira, 2007; Winklhofer and Haass, 2010). Neurotoxic stress also 
induces structural damage to mitochondria including mitochondrial fragmentation and 
mitophagy (Lin et al., 2012; Lin and Beal, 2006).  
Tebufenpyrad (IUPAC name: N-[(4-tert-butylphenyl)methyl]-4-chloro-5-
ethyl-2-methylpyrazole-3-carboxamide) and pyridaben (IUPAC name: 2-tert-butyl-5-
[(4-tert-butylphenyl)methylsulfanyl]-4-chloropyridazin-3-one) are common acaricides 
used to kill populations of mites and ticks in commercial greenhouses. Tebufenpyrad 
is chemically classified as a pyrazole carboxyamide, which is registered for use in 
greenhouses for the protection of ornamental plants (EPA PC Code- 090102). 
Pyridaben is chemically classified as a pyridazinone, whose major application is in 
greenhouses and vineyards (EPA PC Code- 129105). Similar to rotenone, 
tebufenpyrad and pyridaben have been shown to function as mitochondrial complex I 
inhibitors (classified by the IRAC-Insecticide Resistance Action Committee - 
http://www.irac-online.org/modes-of-action/). Although their intended mode of action 
and target toxicity are similar to those of rotenone, both tebufenpyrad and pyridaben 
have not been studied in detail with respect to their neurotoxicity. Therefore, in this 
study, we evaluated the neurotoxic effects of tebufenpyrad and pyridaben in rat 
dopaminergic neuronal cells, with particular emphasis on their effects on 
mitochondrial dynamics and their roles in dopaminergic neuronal cell death. 
Materials and Methods 
Chemicals and Reagents. We purchased tebufenpyrad (96% purity) from AK 
Scientific Inc. (Union City, CA), pyridaben (99.1% purity) from Chem Services (West 
Chester, PA), and rotenone (95-98% purity) and hydrogen peroxide (30 wt. % in H2O) 
from Sigma (St. Louis, MO).  DMSO was purchased from Fisher Scientific (Fair 
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Law, NJ). We purchased RPMI 1640 media, fetal bovine serum (FBS), L-glutamine, 
penicillin, streptomycin and Sytox green nucleic acid fluorescence stain from 
Molecular Probes (Eugene, OR), the Muse® Count &Viability Assay Kit (Catalog # 
MCH100102) from EMD Millipore  (Billerica, MA), and the 5-(and-6)-chloromethyl-
2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) fluorescent probe and 
MitoTracker red CMXROS and MitoTracker green dyes from Invitrogen (Carlsbad, 
CA). The Cell Titer 96® AQueous Non-Radioactive Cell Proliferation assay kit and 
Cell Titer Glo Luminescent Cell Viability assay kit were bought from Promega 
(Madison, WI). The Aconitase assay kit was purchased from Abcam (Cambridge, 
MA). Oligomycin, hydrogen peroxide, carbonyl cyanide 4-trifluoromethoxy-
phenylhydrazone (FCCP) and antimycin A were purchased from Sigma Aldrich (St. 
Louis, MO), and the Seahorse FluxPak calibration solution was bought from Seahorse 
Biosciences (Billerica, MA). 
Cell culture and treatment paradigm. The rat immortalized mesencephalic 
dopaminergic neuronal cell line (1RB3AN27, also known as N27 cells) was a kind gift 
from Dr. Kedar N. Prasad (University of Colorado Health Sciences Center, Denver, 
CO).  These N27 cells have the potential to differentiate and produce dopamine in 
culture when exposed to a suitable cAMP triggering agent, and once the cells are 
differentiated they possess increased tyrosine hydroxylase (TH) expression and 
dopamine levels (Adams et al., 1996; Zhang et al., 2007).  In this study, 
undifferentiated cells were grown in RPMI 1640 medium containing 10% FBS, 2 mM 
L-glutamine, 50 units of penicillin, and 50 µg/ml streptomycin, as described 
previously (Anantharam et al., 2002; Jin et al., 2011c; Prasad et al., 1998). In general, 
cells were plated in a tissue culture plate or flask in accordance to the experimental 
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requirements and was cultured overnight in a humidified atmosphere of 5% CO2 at 
37°C. The cell density plated for each experiment has been provided in the methods 
section. The cells were treated with the specified concentrations of tebufenpyrad and 
pyridaben for 0-3 h in serum-free RPMI media. For all experiments with N27 cells, 
treatments were performed when the cells were 65-70% confluent. The pesticides 
tebufenpyrad and pyridaben are lipophilic in nature and are hence dissolved in 
DMSO. In the ROS generation and aconitase activity experiments, cells were treated 
with 100 µM H2O2 for 45 min as a positive control. Similarly, 1 µM rotenone for 3 h 
was used as a positive control in the SYTOX Green assay, Muse Annexin V/7-AAD 
assay, ATP production, and the mitochondrial dysfunction and damage studies. 
MTS cell viability assays. Cell viability was measured using the Cell Titer 96® 
AQueous Non-Radioactive Cell Proliferation (MTS assay) kit from Promega as 
described previously (Jin et al., 2014b). Briefly, N27 cells were plated at 0.8 x 10
4
 
cells/well in 96-well plates one day before treatment. The next day cells were treated 
in serum-free RPMI media with different concentrations of tebufenpyrad or pyridaben 
(0, 1, 2, 3, 5, 7, 9, 10 and 30 µM) for a time period of 3 h. Following treatment, 10 µl 
of MTS solution reagent mix was added to each plate well and incubated at 37°C for 
45 min. At the end of incubation, the formazan crystals that formed in the live cells 
were dissolved by adding 25 µl of DMSO to each well. Finally, readings were taken 
at a wavelength of 490 nm and another reference reading for each well was taken at 
670 nm to eliminate background. The data were then plotted as a dose-response curve 
(depicting the EC50) using Prism 4.0 (GraphPad Software, San Diego, CA). 
SYTOX Green cytotoxicity assays. Cell death after exposing the N27 cells to 3 µM 
of tebufenpyrad or pyridaben was determined using the SYTOX Green cytotoxicity, 
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as previously described (Jin et al., 2011a; Latchoumycandane et al., 2011a). The 
SYTOX green dye only permits dead cells to produce green fluorescence. In brief, 
N27 cells were grown in 24-well cell culture plates (4 x 10
4
 cells/well) and treated 
with 3 µM of tebufenpyrad or pyridaben along with 1 µM SYTOX Green dye for 3 h. 
Fluorescent images were then taken using fluorescence microscopy (Cytation 3, 
Biotek, Winooski, VT) that was coupled with a 40X objective and Gen5 imaging 
software. For further validation, the green fluorescence was quantitatively measured 
at an excitation wavelength of 485 nm and an emission wavelength of 538 nm with 
the use of a fluorescence microplate reader (Cytation3, Biotek). 
Annexin V/7-AAD apoptosis assay. The cytotoxic effects of tebufenpyrad and 
pyridaben on N27 cells were also analyzed with the Annexin V/7-AAD assays using 
the Muse® Annexin V and Dead Cell Assay kit from Millipore (Billerica, MA). 
Annexin V, which is membrane permeable, labels all cells containing a nucleus. The 
second component of the kit is 7-AAD, which stains the membrane of the cells that 
have been compromised and are dying or dead. This synergistic functioning of the 
two components differentiates between cell populations based on their health (Khan et 
al., 2012; Marusiak et al., 2014). The assay was performed according to 
manufacturer’s protocol. Briefly, N27 cells were grown in 6-well culture plates (3 x 
10
5
 cells/well) and treated with 3 µM of tebufenpyrad or pyridaben for 3 h. Following 
the treatment, cells were pelleted and then resuspended in 100 μl of complete growing 
media, followed by adding 100 µl of Muse Annexin V and Dead Cell Reagent to each 
tube. The tubes were mixed thoroughly and then incubated at room temperature for 20 
min without light exposure. After incubation, the tubes were read individually using 
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Muse™ Cell Analyzer (0500-3115, Millipore). Default gate settings were used to 
distinguish the cells in the live, early-apoptotic, late-apoptotic and dead categories. 
ATP production measurement. ATP was measured using the Cell Titer Glo 
Luminescent Cell Viability assay kit, according to the manufacturer’s instructions. 
N27 cells (0.8 x 10
4
 cells/well) were seeded in a black opaque-walled 96-well cell 
culture plate with transparent top and bottom. Following the treatments with 
tebufenpyrad (3 µM) and pyridaben (3 µM) for 3 h, the plates were equilibrated for 15 
min at room temperature. Once this process was completed, an equal volume of 
CellTiter-Glo 
®
Reagent was added to match the volume of media in each well. The 
plates were uniformly mixed to lyse the cells and were incubated at room temperature 
for 30 min to stabilize the luminescence signal, which was recorded by setting the 
integration time to around 0.25-1 sec per well. 
Measurement of ROS generation. ROS generation was measured using the CM-
H2DCFDA fluorescent probe as previously described (Ghosh et al., 2007; Gordon et 
al., 2010) with minor modifications. The N27 cells were grown (0.8 x 10
4
 cells/well) 
in a 96-well culture plate and the treatments were carried out with tebufenpyrad (3 
µM) and pyridaben (3 µM) for 3 h. Briefly, CM-H2DCFDA was added at a final 
concentration of 10 μM into each treatment well to incubate with the toxicants. By 
following this procedure, the dye gets completely bound to the generated ROS and 
loaded into the cell. After the treatment, cells were washed with Hank’s Buffered Salt 
Solution (HBSS) containing calcium and magnesium to remove the toxicants and 
excess dye. Fluorescence was measured using a fluorescence plate reader (excitation 
488 nm and emission 515 nm). 
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Aconitase activity assay. An aconitase activity assay kit from Abcam was used to 
measure mitochondrial aconitase (m-aconitase) activity levels. N27 cells were grown 
(1 x 10
6
 cells/flask) in a T25 cell culture flask and were exposed to tebufenpyrad (3 
µM) and pyridaben (3 µM) for 3 h. In brief, cells were collected after treatment and 
resuspended in the supplied assay buffer on ice followed by centrifugation at 2000 x g 
for 5 min at 4°C. The resulting supernatant was collected and further centrifuged at 
20,000 x g for 15 min to collect the mitochondrial fraction. The pellet was thoroughly 
mixed with 100 µl of ice-cold assay buffer and sonicated for 15 sec at 4°C. The lysate 
was then used to measure aconitase activity as per the manufacturer’s protocol. 
Measurements were made at a wavelength of 450 nm using a microplate reader. The 
OD values were normalized to the protein concentration of each sample and the 
results were expressed as percentage control.  
Mitochondrial dysfunction assay. Cells were grown (4 x 10
4
 cells/well) in a 24-well 
culture plate and were treated with tebufenpyrad (3 µM) and pyridaben (3 µM) for 3 
h. After treatment, the media was removed and 300 µl of 200 nM MitoTracker green 
dye diluted in serum-free RPMI media was added into each well and incubated at 
37°C for 15 min. Following incubation, a microplate reading was taken at an 
excitation wavelength of 485 nm and an emission wavelength of 520 nm.  
Mitochondria structural depiction assay / Imaging. N27 cells were grown (4 x 10
4
 
cells/well) in a 24-well culture plate on coverslips pre-coated with poly-D-lysine. 
Following treatment with tebufenpyrad (3 µM) and pyridaben (3 µM) for 3 h, cells 
were washed carefully once with PBS. Then 300 µl of 200 nM CMXROS 
MitoTracker red dye diluted in serum-free RPMI media was added and incubated at 
37°C for 12 min. After incubation, wells were gently washed with PBS 3 to 5 times 
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and then fixed in 4% paraformaldehyde (PFA) for 30 min. The wells were washed 
with PBS three times and the coverslips were mounted onto glass slides for 
microscopic imaging using a confocal microscope (model TE2000-U, Nikon) with 
60X magnification. Image analysis used in the mitochondria structural depiction 
assays was performed using ImageJ. Quantification of mitochondrial parameters such 
as mitochondrial length and degree of circularity was accomplished using a macro 
text file plug-in for ImageJ (Dagda et al., 2009). For analyzing the images, 6 images 
per group were quantified and two separate experiments were performed.  
Measurement of mitochondrial oxygen consumption by Seahorse XF96 analyzer. 
Mitochondrial oxygen consumption was measured using a Seahorse XF96 
Extracellular Flux analyzer (Seahorse Bioscience, North Billerica, MA) at the Dr. 
Balaraman Kalyanaraman’s laboratory (Medical College of Wisconsin, Milwaukee) 
as described previously (Dranka et al., 2011; Dranka et al., 2012). The Seahorse XF96 
Extracellular Flux analyzer is a sensitive, high-throughput instrument that makes real-
time measurements of respiration rates of cells with or without oxidative stress. In our 
studies, we employed two different strategies to monitor the effects of tebufenpyrad 
and pyridaben on oxygen consumption rates (OCR) in N27 cells. One was the direct 
injection strategy to test the instantaneous effect on oxygen consumption rates (OCR) 
in N27 cells immediately after tebufenpyrad and pyridaben injections, and the other 
was to analyze the mitochondrial bioenergetics of N27 cells after incubation with 
tebufenpyrad and pyridaben by measuring the OCR at different stages. N27 cells were 
seeded at a density of 2 x 10
4 
per well into a V7-PS culture plate and incubated 
overnight in 5% CO2 at 37°C. For the direct injection method, the Seahorse Flux Pak 
cartridge was equilibrated using the equilibration buffer for one hour and then 
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carefully loaded with different concentrations of tebufenpyrad or pyridaben (0.5, 1, 3 
and 6 µM). Following this process, the V7-PS culture plate cover was replaced with 
the Flux Pak cartridge and the plate was loaded into the Seahorse XF96 analyzer for 
direct injection. For the mitochondrial bioenergetics method, cells were first treated 
with different concentrations of tebufenpyrad or pyridaben (0.5, 1, 3, 6 µM) for 3 h in 
5% CO2 at 37°C. During this time, the Seahorse FluxPak cartridge was equilibrated 
and the corresponding injection ports were loaded with the mito-stressor agents 
oligomycin (1 µg/ml), FCCP (1 µM) and antimycin A (10 µM). Once the mito-
stressors were loaded in their corresponding position in the cartridge, the treated plate 
was introduced into the Seahorse analyzer covered with the Flux Pak cartridge. The 
analyzer was then programmed to measure the basal OCR readouts in five specified 
time intervals before progressing to inject the mito-stressors. These stressors were 
injected after every three cycles of measuring OCR (Fig. 7A). Further calculations of 
ATP-linked respiration and respiratory capacity were performed as described (Dranka 
et al., 2011; Dranka et al., 2012).  
Statistical analysis. All statistical data analyses were performed using Prism 4.0 
(GraphPad Software, San Diego, CA). The EC50 for each of the two pesticides 
tebufenpyrad and pyridaben was determined from the dose-response curve generated 
by Prism 4.0. Data were analyzed using one-way ANOVA with the Tukey-Kramer 
post-test for comparing all treatment groups with that of the control. Differences with 
p < 0.05 were considered significant. 
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Results 
Tebufenpyrad and pyridaben treatments elicit significant neurotoxic response in 
the N27 dopaminergic neuronal cells 
The effect of the two pesticides tebufenpyrad and pyridaben on the viability of 
N27 dopaminergic neuronal cells was evaluated by the MTS cell viability assay. An 
N27 culture comprises a homogenous population of TH-positive dopaminergic 
neuronal cells derived from the rat’s mesencephalic region and are widely used as a 
versatile model of dopaminergic neurodegeneration (Anantharam et al., 2002; 
Harischandra et al., 2014a; Levesque et al., 2010). To generate dose-response curves, 
N27 cells were treated with increasing concentrations of tebufenpyrad or pyridaben 
(0-30 µM) for time periods of 3 h each. These 3-h treatments with tebufenpyrad or 
pyridaben resulted in concentration-dependent cytotoxicity in N27 cells (Figs. 1A-B).  
It is noteworthy that these two pesticides have similar neurotoxic effects on N27 cells 
with EC50 values of 3.98±0.21 µM (95% CI) and 3.77±0.21 µM (95% CI) for 
tebufenpyrad and pyridaben, respectively.  
To further substantiate the cytotoxic effects of the two pesticides on N27 cells, 
we treated N27 cells with 3 µM of tebufenpyrad or pyridaben for 3 h and measured 
cell death using the SYTOX Green cytotoxicity and Muse Annexin V/7AAD assays. 
As a positive control, we treated N27 cells with 1 µM rotenone for 3 h. The SYTOX 
Green dye is a nuclear-specific probe that is excluded from cells with intact 
membranes, while it binds the nucleic acids of cells that have damaged membranes 
(Asaithambi et al., 2014; Roth et al., 1997; Sherer et al., 2003). Similar to rotenone, 
exposure to tebufenpyrad or pyridaben led to significantly greater toxicity in N27 
cells than in control cells (Fig. 1C). Consistent with this, quantification of cell 
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cytotoxicity using the Muse Annexin V/7AAD assay revealed significant loss of cell 
viability occurring in the cells treated with tebufenpyrad or pyridaben compared to the 
control cells (Fig. 1D). A similar toxicity was observed with the rotenone-treated 
positive control cells. Moreover, the Muse Annexin V/7AAD assay also showed that 
cells undergo apoptotic cell (Fig. 1D). Collectively, these data clearly indicate that 
tebufenpyrad and pyridaben induce neurotoxic effects in N27 dopaminergic neuronal 
cells. Based on these results, we chose a working concentration of 3 µM for both 
tebufenpyrad and pyridaben treatments in subsequent experiments. 
Tebufenpyrad and pyridaben induce oxidative damage 
To explore the role of oxidative stress in tebufenpyrad- and pyridaben-induced 
neurotoxicity, we first examined the effect of tebufenpyrad and pyridaben on 
intracellular ROS generation. N27 cells were treated with vehicle, tebufenpyrad or 
pyridaben for 30, 60, and 180 min and the rate of ROS generation was quantified 
using the CM-H2DCFDA fluorescent probe. Hydrogen peroxide was used as a 
positive control in the experiment. Both tebufenpyrad and pyridaben, at a 
concentration of 3 µM, induced a time-dependent increase in ROS production, 
starting as early as 30 min (Figs. 2A-B). At 180 min, both pesticides induced 
approximately a 3-fold increase of ROS levels. These results suggest that ROS 
generation might be an early biochemical change that precedes cell death following 
tebufenpyrad and pyridaben exposure in dopaminergic neuronal cells. To further 
characterize the involvement of oxidative stress in tebufenpyrad and pyridaben 
neurotoxicity, we performed m-aconitase activity assays. Aconitase is a mitochondrial 
protein that catalyzes the conversion of citrate to isocitrate in the TCA cycle.  This 
enzyme complex has an iron sulfur cluster that is very sensitive to oxidative damage 
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(Ghosh et al., 2010; Kalyanaraman, 2013).  The loss of aconitase enzyme activity is 
commonly used as a measure of mitochondrial oxidative damage (Cantu et al., 2009). 
We observed significant reductions of m-aconitase activity in cells treated with 
tebufenpyrad and pyridaben (Fig. 3). Hydrogen peroxide, as a positive control, 
produced similar results. Together, these data indicate that tebufenpyrad and 
pyridaben induce oxidative damage to mitochondria in dopaminergic cells.   
Tebufenpyrad and pyridaben significantly induce mitochondrial structural 
damage and dysfunction in dopaminergic neuronal cells  
To gain further insight into the mechanisms underlying tebufenpyrad- and 
pyridaben-induced dopaminergic cell death, we studied their effects on mitochondrial 
function. We first monitored mitochondrial function by using the cell-permeable 
mitochondria-selective dye MitoTracker green, which passively diffuses across the 
plasma cell membrane and accumulates in active mitochondria. Treatments with 
tebufenpyrad and pyridaben led to about a 40% loss of MitoTracker green 
fluorescence when compared to control cells (Fig. 4), strongly suggesting the loss of 
mitochondrial function.  
 To visualize the structural abnormalities of mitochondria following 
tebufenpyrad and pyridaben exposure, we performed a detailed confocal microscopic 
analysis using MitoTracker red dye in N27 dopaminergic cells. Mitochondria from 
control cells appeared as long, thread-like structures that were well-linked and 
randomly distributed throughout the cells. However, in the tebufenpyrad- and 
pyridaben-treated groups, they appeared as disintegrated circular structures that were 
not connected or linked to one another (Fig. 5A), indicative of mitochondrial fission. 
Using ImageJ analysis, we quantified structural features including mitochondrial 
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length (Fig. 5B) and mitochondrial circularity (Fig. 5C).  In contrast to the control 
group, the mitochondria in tebufenpyrad- and pyridaben-treated cells were 
significantly shorter and more circular, further indicating a striking loss of 
mitochondrial structural integrity post-exposure. Collectively, our data suggest that 
tebufenpyrad and pyridaben exposure induces a profound structural impairment to 
mitochondria in dopaminergic neuronal cells.   
Tebufenpyrad and pyridaben reduce oxygen consumption rates and increase 
mitochondrial stress levels   
After demonstrating that tebufenpyrad and pyridaben induce mitochondrial 
impairment, we directly measured mitochondrial oxygen consumption rates and stress 
levels over time following pesticide exposure. We employed the Seahorse 
mitochondrial analyzer to perform two different sets of experiments. One set involved 
the direct injection method (Figs. 6A) after the measurement of basal respiration, 
which helped us to assess the effects of tebufenpyrad and pyridaben on the 
instantaneous respiration rate of dopaminergic neuronal cells. The second set of 
experiments, using the Seahorse analyzer post-pesticide treatment, involved 
measuring key parameters of mitochondrial bioenergetics (Fig. 7A) including basal 
respiration, ATP-linked respiration and respiration capacity.  
To study the dose-response effect on respiration rates immediately after the 
direct injection process, we injected N27 dopaminergic cells with 0.5, 1, 3 and 6 µM 
of tebufenpyrad and pyridaben, both of which dose-dependently affected respiration 
rates (Figs. 6B and C). The lowest concentration of 0.5 µM tebufenpyrad did not 
affect baseline respiration rates significantly. However, the 1, 3 and 5 µM doses of 
tebufenpyrad significantly decreased the respiration rate immediately following 
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exposure to the pesticide. The pyridaben treatment produced a much more detrimental 
effect on mitochondrial respiration. Even its lowest dose of 0.5 µM induced a steep 
decrease in baseline respiration, and this effect continued to worsen at higher 
exposure concentrations (Fig. 6C). Thus, pyridaben has a more potent effect than 
tebufenpyrad on mitochondrial respiration rate in dopaminergic neuronal cells.  
Measuring mitochondrial respiration kinetics with the Seahorse analyzer 
allowed us to determine the effect of toxic agents on the three critical stages of 
respiration. The first stage involves the addition of an ATP synthase inhibitor, 
oligomycin, which suddenly decreases the oxygen consumption rate (OCR). The next 
stage is the addition of FCCP, which acts as an uncoupler that increases mitochondrial 
oxygen consumption by disinhibiting the flow of protons across the mitochondrial 
inner membrane due to uncoupling of the electron transport chain. The final stage is 
the addition of antimycin A, which is a respiratory chain inhibitor that shuts down 
mitochondrial activity completely. After exposing N27 cells to different 
concentrations of tebufenpyrad (0.5, 1, 3 and 6 µM) and running the bioenergetics 
stages, we calculated ATP-linked respiration and respiratory capacity (Dranka et al., 
2010; Jekabsons and Nicholls, 2004). As depicted in the Seahorse bioenergetics map 
(Fig. 7A), tebufenpyrad-treated cells revealed dramatic changes in all three stages of 
mitochondrial respiration in contrast to control cells.  Quantitative analysis showed a 
dose-dependent decrease in basal respiration, ATP-linked respiration and respiratory 
capacity produced by tebufenpyrad. At the higher doses of 3 and 6 µM tebufenpyrad, 
mitochondrial oxygen consumption did not recover following FCCP treatment, 
indicating that these dose ranges produce irreversible damage to mitochondrial 
function (Figs. 7B-E). Similarly, pyridaben exposure (0.5, 1, 3 and 6 µM for 3 h) also 
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produced a dose-dependent decrease in basal respiration, ATP-linked respiration and 
respiratory capacity, which were all exceedingly low for all doses of pyridaben (Figs. 
7F-I). Comparing the bioenergetics data of tebufenpyrad and pyridaben showed that 
pyridaben was more potent than tebufenpyrad. Collectively, these results show that 
both tebufenpyrad and pyridaben profoundly impair mitochondrial respiration in 
dopaminergic neuronal cells.   
Tebufenpyrad and pyridaben deplete intracellular bioenergy levels in 
dopaminergic neuronal cells    
To further confirm that tebufenpyrad- and pyridaben-induced mitochondrial 
inhibition reduces cellular biogenetics, we employed a highly sensitive luminescence-
based assay to assess the cellular ATP content in N27 neuronal cells.  The cells were 
treated with 3 µM tebufenpyrad or pyridaben for 3 h. We used 1 µM rotenone as a 
positive control under the same experimental conditions, since it is a potent agent for 
shutting down mitochondria and disrupting the electron transport chain (ETC) (Sherer 
et al., 2007). Both tebufenpyrad and pyridaben dramatically depleted intracellular 
ATP in dopaminergic neuronal cells (Fig. 8). The positive control rotenone also 
reduced cellular ATP content. These results suggest that tebufenpyrad and pyridaben 
exposure induces severe energy deficits resulting from mitochondrial impairment in 
dopaminergic neuronal cells.  
Discussion 
 Our study clearly demonstrates that the two greenhouse pesticides 
tebufenpyrad and pyridaben exert noteworthy neurotoxic effects on dopaminergic 
neuronal cells.  Systematic characterization of the toxicological mechanisms 
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underlying tebufenpyrad and pyridaben neurotoxicity reveals that these pesticides 
disrupted mitochondrial dynamics by inducing severe structural, functional, and 
oxidative damage. Our present study provides strong evidence that tebufenpyrad and 
pyridaben induce neurotoxicity by targeting mitochondrial structure and function in 
dopaminergic neuronal cells.  
 Tebufenpyrad and pyridaben are widely used pesticides in greenhouses and 
vineyards.  Despite their widespread use, the potential neurotoxic effects of these 
compounds on the dopaminergic neuronal system are not well studied. But a recent 
study has reported that pyridaben exposure induced a 24% TH neuronal loss in the 
substantia nigra (SN) of mice. The authors also performed an RNAseq analysis and 
reported that mice exposed to certain pesticides exhibited gene expression patterns 
bearing significant correspondence to pathways that were well-known in human PD 
cases (Gollamudi et al., 2012). The results reported above have important implications 
about the neurotoxicological effects that tebufenpyrad and pyridaben might have on 
animal and human dopaminergic neuronal systems. In the present study, we used the 
MTS viability assay to calculate EC50 values of 3.98 and 3.77 µM for tebufenpyrad 
and pyridaben, respectively (Figs. 1A-B). Further cytotoxicity studies using the 
SYTOX Green and Muse Annexin V/7-AAD assays revealed that tebufenpyrad and 
pyridaben at a concentration of 3 µM elicit a similar toxicity to that of rotenone (1 
µM) in N27 cells (Figs. 1C-D). An overview study using bovine and rat mitochondria 
demonstrated the mitochondrial complex I-specific inhibitory actions of tebufenpyrad 
and pyridaben with respect to their potency as it related to rotenone (Degli Esposti, 
1998). Adding on, the cytotoxicity trend in SK-N-MC human neuroblastoma cells has 
previously been shown to be: pyridaben > rotenone > tebufenpyrad (Sherer et al., 
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2007). In our study, exposing N27 dopaminergic neuronal cells to tebufenpyrad or 
pyridaben showed similar inhibitory effects on mitochondrial respiration, ATP 
production and oxidative damage. Variation in the toxicity and the effects of 
mitochondrial dysfunction induced by tebufenpyrad and pyridaben in different studies 
might be based on cell type, their species of origin, the organ of localization of the 
cells to which the pesticides are targeted and other factors such as concentrations and 
duration of treatment. The results from MTS and ATP production assays also showed 
that these environmental toxicants cause significant dopaminergic neuronal cell death 
at certain doses and durations of exposure. Clearly, further investigations examining 
exposure routes and risk levels in vivo are needed to better understand the 
environmental risk posed by these two compounds. Another noteworthy result 
contributing to the significant dopaminergic toxicity of tebufenpyrad and pyridaben 
was the rapid, time-dependent generation of reactive oxygen species (Fig. 2). 
Additionally, tebufenpyrad and pyridaben treatments reduced m-aconitase activity 
(Fig. 3), which is a clear sign of oxidative damage instigated by the production of 
superoxides (Gardner, 2002). M-aconitase is a major iron-sulfur enzyme that has been 
used as a marker of oxidative damage following various neurotoxic chemical 
exposures including pesticides (Cantu et al., 2009; Drechsel and Patel, 2008). To our 
knowledge, this is the first report demonstrating the sensitivity of mitochondrial 
aconitase to the greenhouse pesticides tebufenpyrad and pyridaben.  
 Both tebufenpyrad and pyridaben are considered to be mitochondrial inhibitors 
(by IRAC). Our experimental evidence supports this classification by demonstrating 
the potent effects of the pesticides on mitochondria in dopaminergic neuronal cells. 
Exposure of N27 cells to tebufenpyrad and pyridaben for 3 h induced a remarkable 
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loss of mitochondrial function and ATP production (Figs. 4 and 8).  Similar studies 
with other complex-1 inhibitors such as rotenone have been shown to cause PD-like 
symptoms through neuronal loss and apoptosis (Greenamyre et al., 2001). We 
microscopically observed a clear structural morphological change in the mitochondria 
after exposure to tebufenpyrad and pyridaben when compared to the healthy control 
group (Fig. 5). This provided clear evidence of structural damage occurring apart 
from the mitochondrial dysfunction induced by the greenhouse toxicants. Thus, 
tebufenpyrad and pyridaben are both potently able to cause extensive mitochondrial 
damage leading to dopaminergic neuronal cell death. These results advance our 
understanding of the detrimental effects of tebufenpyrad and pyridaben as 
mitochondrial complex-1 inhibitors in inducing selective neuronal damage to the 
nigrostriatal dopaminergic system similar to rotenone exposure in animal models. Our 
analysis of mitochondrial respiration kinetics using the high-throughput Seahorse 
XF96 analyzer provided valuable information regarding the extent of the 
mitochondrial dysfunctional response to these pesticides. The Seahorse Bioanalyzer 
facilitates the precise measurement of oxygen consumption rates of intact live cells 
using a set of highly sensitive and specialized electrodes. This makes it a high-
throughput system requiring a minimal number of cells and is also more efficient 
when compared to the traditional polarographic methods (Dranka et al., 2011; Rogers 
et al., 2011; Sauerbeck et al., 2011). Direct injection of the pesticides using the 
Seahorse XF96 analyzer clearly showed an instantaneous reduction in respiration 
rates after exposing N27 dopaminergic cells to different concentrations of 
tebufenpyrad and pyridaben (Figs. 6A-C). Further analysis of Seahorse respiration 
curves revealed that the pesticides induced severe mitochondrial stress characterized 
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by impaired basal respiration, ATP-linked respiration and respiratory capacity (Fig. 
7). Notably, the Seahorse analyzer findings revealed pyridaben to be more potent than 
tebufenpyrad even at lower doses, suggesting that analysis of mitochondrial function 
by the high-throughput Seahorse system will be an invaluable tool to determine rank-
order potency of pesticides having potential mitochondrial toxicity. Incorporating 
such analyses in pesticide development will minimize the off-target toxicity to the 
human nervous system. Overall, our study provides pivotal neurotoxicological data 
demonstrating that these two neurotoxicants cause significant damage to the 
dopaminergic neuronal oxygen consumption system, thereby leading to significant 
mitochondrial dysfunction and oxidative damage. 
A very recent report by the Washington State Department of Agriculture 
(WSDA) stated that there were 20 farm workers working in a cherry orchard who had 
been poisoned by an off-target exposure to a mixture of pesticides that were being 
applied in a neighboring pear orchid. Interestingly, one of the components of the 
pesticide mixture was revealed to be pyridaben. The affected farmers were medically 
treated for neurological, respiratory, ocular and gastrointestinal symptoms (Calvert et 
al., 2015). In terms of human exposure studies in greenhouse settings, female workers 
exposed to an organophosphate exhibited longer reaction times and reduced motor 
stability when compared to an unexposed group of women. Adding to these 
symptoms, the affected group also suffered from depression, hypertension and fatigue 
(Bazylewicz-Walczak et al., 1999).  A 2006 study of the school children of 
greenhouse workers in Ecuador demonstrated a long-term maternal effect from 
prenatal exposure to greenhouse pesticides causing deficits in their motor 
coordination and visual memory (Grandjean et al., 2006). The evidence from these 
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greenhouse epidemiological studies suggests that pesticide exposure in greenhouses 
might have a significant effect on the human nervous system, thereby instigating a 
number of neurodegenerative symptoms. Keeping in mind the neurotoxic effects of 
exposure to pesticides in greenhouses, the results from our experimental studies 
suggest that persistent exposure to complex 1 inhibitors, such as tebufenpyrad and 
pyridaben, represents a neurological occupational hazard that could adversely affect 
greenhouse workers. Since tebufenpyrad and pyridaben have a terrestrial field 
dissipation half-life of about 50 and 11 days, respectively (TOXNET and NLM - 
CASRN: 119168-77-3 and CASRN: 96489-71-3), persistent exposure in closed 
environments such as a greenhouse setting likely poses a risk to humans. Several 
screening methodologies using cell model systems have been explored recently for 
rapid identification of adverse effects of environmental pesticide contaminations 
(Heusinkveld et al., 2014; Meijer et al., 2014). 
 In summary, we report here an interesting finding that the neurotoxic effects of 
tebufenpyrad and pyridaben are mainly manifested as damage to both structural and 
functional aspects of mitochondria in dopaminergic neuronal cells. The extent to 
which these greenhouse pesticides alter the mitochondrial dynamics could be used as 
a marker of in vitro pesticide neurotoxicity. Considering the enhanced vulnerability of 
dopaminergic neuronal cells to mitochondrial impairment produced by tebufenpyrad 
and pyridaben in our study, chronic exposure to these greenhouse pesticides may have 
implications in environmentally-linked PD.  Further studies in animal models and 
epidemiological studies in greenhouse workers will clarify the potential risk of 
greenhouse pesticides in the etiology of PD.  
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Figures 
Table 1: Comprehensive evaluation comparing tebufenpyrad and pyridaben. 
Both tebufenpyrd and pyridaben functions based on similar modes of action and they 
target similar system, but they slightly differ in their functional aspects, area of usage 
and molecular weights.   
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Figure 1: Dose-dependent cytotoxic effect on N27 dopaminergic neuronal cells 
post-exposure to tebufenpyrad and pyridaben 
N27 cells were treated with varying concentrations (0, 1, 2, 3, 5, 7, 9, 10 and 30 µM) 
of tebufenpyrad (A) and pyridaben (B) for 3 h and then assayed for MTS cell 
viability, expressed as a percentage of controls. The results represent two individual 
experiments performed in octuplicate. (C) The N27 cells were treated with 
tebufenpyrad (3 µM) and pyridaben (3 µM) for 3 h, and the cytotoxic effect was 
measured using SYTOX Green assays. Representative SYTOX Green staining images 
are shown. The top view of the SYTOX Green images is also shown as a 3D surface 
plot in the left bottom panel. Asterisks ***p < 0.001 for control versus pesticide-
treated groups. The results represent the mean ± S.E. of two individual experiments 
performed in quadruplicate. (D) Muse Annexin V/7-AAD assays were additionally 
performed to measure the cytotoxicity of tebufenpyrad (3 µM) and pyridaben (3 µM) 
for 3 h on N27 cells. Asterisks ***p < 0.001 for control versus pesticide-treated 
groups. The results represent the mean ± S.E. of two separate experiments performed 
in quadruplicate. 
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Figure 2: Tebufenpyrad and Pyridaben increased ROS generation in a time-
dependent manner 
N27 cells were exposed to 3 µM of tebufenpyrad (A) and pyridaben (B) for 30, 60 
and 180 min. Cells were then assayed for intracellular ROS production using H2-
DCFDA dye. Hydrogen peroxide (100 µM for 45 min) was used as a positive control.  
Asterisks ***p < 0.001 for control vs treated groups, represented as the mean ± S.E. 
of three separate experiments performed in hexaplicate. 
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Figure 3: Effect of tebufenpyrad and pyridaben on mitochondrial aconitase 
enzyme activity in N27 dopaminergic cells 
N27 cells were treated with 3 µM of tebufenpyrad and pyridaben for 3 h in serum-free 
RPMI media. Aconitase activity was measured post-exposure using an aconitase 
activity kit. Hydrogen peroxide (100 µM) treatment for 45 min was used as a positive 
control. Aconitase activity is expressed as a percentage of controls. Asterisks ***p < 
0.001 for control vs treated groups, represented as the mean ± S.E. of three separate 
experiments performed in hexaplicate. 
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Figure 4: Effect of tebufenpyrad and pyridaben on mitochondrial function in 
N27 dopaminergic cells 
N27 cells were treated with 3 µM of tebufenpyrad and pyridaben for 3 h and assayed 
for mitochondrial function using the MitoTracker green dye assay. Rotenone (1 µM 
for 3 h) was used as a positive control. After treatment and incubation with the 
MitoTracker green dye, readings were taken using a plate reader at an excitation 
wavelength of 485 nm and an emission wavelength of 520 nm. Values are expressed 
as relative mitochondrial activity. Asterisks **p < 0.01 for control versus treated 
groups, represented as the mean ± S.E. of three separate experiments performed in 
hexaplicate. 
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Figure 5: Tebufenpyrad and pyridaben induced significant structural damage to 
the mitochondria of N27 cells 
(A) N27 cells were exposed to 3 µM tebufenpyrad and pyridaben for 3 h. Rotenone (1 
µM for 3 h) was used as a positive control. Structural changes to mitochondria were 
then stained by MitoTracker red dye. Images were obtained using a confocal 
microscope (60 X magnification). Mitochondrial length (B) and degree of circularity 
(C) were quantified using ImageJ. Asterisks **p < 0.01 and ***p < 0.001 for control 
versus pesticide-treated groups, represented as the mean ± S.E. of two separate 
experiments performed in hexaplicate.  
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Figure 6: Direct injection of tebufenpyrad and pyridaben to N27 cells leads to 
plummeting oxygen consumption rates (OCR) 
(A) Schematic representation of direct injection method was employed to analyze 
instantaneous effects on N27 dopaminergic cells after injecting different 
concentrations of tebufenpyrad and pyridaben. N27 cells grown in a V7-PS culture 
plate one day prior to the treatment were injected with different concentrations of 
tebufenpyrad and pyridaben (0.5, 1, 3 and 6 µM) under serum-free conditions. 
Immediately post-injection, the OCR value was measured using the Seahorse XF96 
analyzer. (B and C) Quantification of the output OCR post-injection. Asterisks *p < 
0.05 and ***p < 0.001 for control versus treatment groups, represented as the mean ± 
S.E. of two separate experiments performed in quadruplicate.     
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Figure 7: Effect of tebufenpyrad and pyridaben on mitochondrial stress level in 
N27 dopaminergic cells 
(A) Schematic representation of the bioenergetics study to measure and analyze the 
dose-related effects of tebufenpyrad and pyridaben on mitochondrial dynamics in N27 
cells. The dopaminergic neuronal cells were incubated with different concentrations 
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of tebufenpyrad or pyridaben (0.5, 1, 3 and 6 µM) in serum-free RPMI for 3 h and 
then the plate was de-gassed and made ready for the OCR measurement using the 
Seahorse XF96 analyzer. Mitochondrial dynamics were measured using three-stage 
injection of mito-stressors. Stage 1 injected 1 µg/ml oligomycin, Stage 2 injected 1 
µM FCCP and Stage 3 injected 10 µM antimycin A (see Figs. 7B and F). Throughout 
these stages the analyzer continuously measures OCR. (C-E) Different parameters like 
basal respiration, ATP-linked respiration and respiratory capacity were estimated 
from the output OCR values after completion. (G-I) Experiments were repeated under 
the same conditions with pyridaben. Asterisks ***p < 0.001 for control versus 
treatment groups, represented as the mean ± S.E. of two separate experiments 
performed in quadruplicate.   
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Figure 8: Tebufenpyrad and pyridaben treatment significantly reduced cellular 
ATP production in N27 dopaminergic cells 
N27 cells were exposed to 3 µM of tebufenpyrad or pyridaben for 3 h in serum-free 
RPMI media. Cell viability was measured with respect to the amount of cellular ATP 
produced using the Luminescent Cell Viability assay kit and was represented as raw 
luminescence units (RLU). Rotenone (1 µM for 3 h) was used as a positive control. 
Asterisks ***p < 0.001 for control versus treated groups, represented as the mean ± 
S.E. of three separate experiments performed in hexaplicate.  
 
 
 
 
 
 
 
 
 
Figure 9: A schematic comparison between Control and Pyridaben or Tebufenpyrad 
treated N27 cells illustrating the significant effect of tebufenpyrad and pyridaben on 
mitochondrial function, structure and bioenergetic dynamics. Drawing was created by 
A.Charli using biomedical PowerPoint toolkit from Motifolio. 
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Abstract 
 Chronic exposure to neurotoxic pesticides is implicated in the etiopathogenesis 
of Parkinson's disease (PD). Dopaminergic neurons are highly vulnerable to the 
neurotoxic effects of mitochondrial complex-1-inhibiting pesticides, however, the 
cellular and molecular mechanisms are not well understood. Previously, we 
demonstrated novel PKC isoform PKCδ is highly expressed in dopaminergic neurons 
and plays a key role in their pesticide-induced apoptosis via caspase-3-mediated 
proteolytic activation. Herein, we further characterized the downstream molecular 
events of PKCδ signaling that govern dopaminergic neuronal cell death induced by 
the mitochondria-impairing pesticide Tebufenpyrad (Tebu). Tebu (0.01-10µM) 
induced dose- and time-dependent neurotoxicity in the N27 dopaminergic neuronal 
cells; rotenone was used as a positive control.  Tebu-induced cell death was 
accompanied by PKCδ phosphorylation of T505 activation loop phosphorylation and 
caspase-3-dependent proteolytic activation of the kinase. In silico analyses identified 
that the threonine site on laminB1 (T575) is likely to be phosphorylated by PKCδ, 
suggesting that laminB1 serves as a key downstream target of the kinase.  High 
resolution 3D confocal microscopic analysis revealed co-localization of activated 
PKCδ and laminB1 as well as structural defects in the nuclear membrane in Tebu-
exposed N27 cells. Interestingly, Tebu did not induce any PKCδ activation, and thus 
no laminB1 phosphorylation, in N27 cells stably expressing the PKCδ cleavage 
resistant mutant. Furthermore, CRISPR/Cas9-based stable knockdown of PKCδ 
significantly attenuated Tebu-induced laminB1 phosphorylation when compared to 
control CRISPR/Cas9 N27 cells. Also, upon replacing threonine with glycine using 
site-directed mutagenesis on LaminB1, the phosphorylation of LaminB1 by the 
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activated PKCδ post teubufenpyrad exposure in the N27 cells was blocked. Another 
interesting evidence was obtained using the organotypic slice of midbrain from 
PKCδ-/- pups, which demonstrated absence of LaminB1 damage and phosphorylation 
of LaminB1 (T575) post tebufenpyrad exposure when compared to the PKCδ+/+ 
pups. We observed PKCδ activation, LaminB1 phosphorylation  and LaminB1 loss in 
nigral dopaminergic neurons from PD brains, but not control brains, thus providing 
translational relevance. Collectively, our data reveal that PKCδ functions as laminB1 
kinase to disassemble the nuclear membrane during the dopaminergic neuronal cell 
death process triggered by exposure to mitochondrial complex-1-inhibiting pesticides.  
This mechanistic insight may have important implications for the etiology of 
environmentally-linked PD.  
Introduction 
 Parkinson’s disease is a chronic progressive neurodegenerative disorder and is 
expressed by serious movement difficulties, affecting about 1% of adults older than 
60 years. The disease is attributed to selective loss of neurons in the substantia nigra, 
which results in drastic depletion of dopamine in the striatum region and  its cause is 
unclear in most individuals (Samii et al., 2004). The main clinical features of PD 
include akinesia, tremors, rigidity, bradykinesia, walking difficulties and postural 
instability. The etiology of PD is not well understood, but it is a multi-factorial 
contribution from various environmental, genetic, epigenetic and inflammatory 
factors. (Levy et al., 2009). Of all these factors, environmental influence triggering 
PD is being well studied in recent years, to minimize the risk of using certain 
pesticides and also to prevent any off target reactions which might lead to detrimental 
end points. It is well known that the mitochondria plays a pivotal role in the 
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homeostatic functioning of a cell by providing energy via oxidative phosphorylation 
(Jin et al., 2014a; Zhang and Chan, 2007). Hence aberrant mitochondrial dysfunction 
and changes in its dynamics due to persistent pesticides exposure would lead to 
impairment of cell functions and resulting in apoptosis (Charli et al., 2016; Lin et al., 
2012; Schapira, 2007). Chronic pesticides exposure have also been shown to cause a 
number of protein modifications and outcomes in overwhelming epidemiological 
cases of PD (Corrigan et al., 2000; Fleming et al., 1994; Priyadarshi et al., 2000; 
Spivey, 2011; Tanner et al., 2011). We in this chapter primarily will be focusing on 
the activation of the Protein kinase Cδ (PKCδ) mediated through the oxidative stress 
induced by the exposure of mitochondrial complex 1 inhibiting pesticide on the 
dopaminergic neuronal cells.  
 We have extensively studied about PKCδ and its role in apoptotic signaling 
leading to PD in the past two decades. PKCδ, a member of the novel PKC family, is a 
well known and characterized redox-sensitive kinase and it is present in various cell 
types. Oxidative stress activates the PKCδ kinase by translocation, tyrosine 
phosphorylation, or proteolysis. During proteolysis, caspase-3 cleaves the native 
PKCd (72–74 KDa) into 41-kDa catalytically active and 38-kDa regulatory fragments 
marking the activation of the kinase. The proteolytic activation of PKCδ also plays a 
key role in promoting apoptotic cell death in various cell types, including neuronal 
cells. PKCδ is also said to amplify apoptotic signalling via positive feedback 
activation of the caspase cascade. Thus, the dual role of PKCδ as a mediator and 
amplifier of apoptosis may be important in the pathogenesis of major 
neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease and 
Huntington disease (Kanthasamy et al., 2003a). The Caspase dependent activation of 
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PKCδ is one of the most well studied activation mechanisms. It has been shown that 
MPP
+
, an oxidized  product of the reaction between MPTP (mitochondrial complex I 
inhibitor) and monoamine oxidase B in the brain has got the ability to potentiate 
caspase-3 dependent proteolytic activation of PKCδ in dopaminergic neuronal cells 
(Kaul et al., 2003; Wiemerslage et al., 2013). We have also reported previously that 
dieldrin, an organochloride form of a pesticide could promote PKCδ mediated 
dopaminergic neuronal apoptosis (Saminathan et al., 2011). Interestingly, we have 
demonstrated previously that PKCδ proteolytic cleavage by a caspase-3 cleavage-
resistant mutant (PKCδ-CRM) N27 cells were resistant to manganese, MG-132 and 6-
OHDA mediated apoptosis (Latchoumycandane et al., 2011a; Latchoumycandane et 
al., 2005; Sun et al., 2008). Thus showing PKCδ activation plays a critical role 
oxidative stress in apoptosis. Previously it is reported that,  activation of PKCδ in the 
HL60 post ara-C was observed in a caspase-3 dependent mechanism with concomitant 
lamin B phosphorylation and proteolysis. This same study also also noted that the 
inhibition of PKCδ delayed lamin proteolysis (Cross et al., 2000). Despite such 
evidences, role of PKCδ functioning as a potential laminB1 kinase has not been  well 
understood during the environmental linked neurotoxicant exposure mediated  
oxidative stress and mitochondrial dysfunction leading to neurodegeneration.  
 We have previously demonstrated the activation mechanisms of PKCδ and its 
downstream targets leading to pro-apoptotic signaling in various neurotoxicants cell 
culture and animal models of PD (Kanthasamy et al., 2003b; Kaul et al., 2005; Kaul et 
al., 2003; Saminathan et al., 2011; Sun et al., 2008). The present study aimed to 
investigate the activation of PKCδ post exposure to mitochondrial complex 1 
inhibiting pesticide tebufenpyrad in dopamingeric neurons. Here we also show that 
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activation of PKCδ prior to tebufenpyrad exposure  and its potential to cause lamin 
damage by phosphorylation of laminB1 at T575.  
Materials and Methods 
Chemicals and Reagents. We purchased tebufenpyrad (96% purity) from AK 
Scientific Inc. (Union City, CA), DMSO and GeneArt™ Site-Directed Mutagenesis 
System Kit (A13282) was purchased from Fisher Scientific (Fair Law, NJ). We 
purchased RPMI 1640 media, fetal bovine serum (FBS), L-glutamine, penicillin, and 
streptomycin from Molecular Probes (Eugene, OR), Mission Lentiviral Packaging 
Mix (SHP001; Sigma-Aldrich), Lenti-X p24 Rapid Titer Kit (632200; Clontech, 
Mountain View, CA), puromycin (Sigma-Aldrich), PKCδ, phospho-PKCδ (T505), 
laminB1 from  Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), phospho-laminB1 
(T575) Cell Signaling Technology (Danvers, MA), Caspase-3 substrate, Ac-DEVD-
AMC, was purchased from Bachem Biosciences, Inc. (King of Prussia, PA).  
Cell culture and treatment paradigm. The rat immortalized mesencephalic 
dopaminergic neuronal cell line (1RB3AN27, also known as N27 cells) was a kind gift 
from Dr. Kedar N. Prasad (University of Colorado Health Sciences Center, Denver, 
CO).  These N27 cells have the potential to differentiate and produce dopamine in 
culture when exposed to a suitable cAMP triggering agent, and once the cells are 
differentiated they possess increased tyrosine hydroxylase (TH) expression and 
dopamine levels (Adams et al., 1996; Zhang et al., 2007).  In this study, 
undifferentiated cells were grown in RPMI 1640 medium containing 10% FBS, 2 mM 
L-glutamine, 50 units of penicillin, and 50 µg/ml streptomycin, as described 
previously (Anantharam et al., 2002; Jin et al., 2011c; Prasad et al., 1998). In general, 
cells were plated in a tissue culture plate or flask in accordance to the experimental 
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requirements and was cultured overnight in a humidified atmosphere of 5% CO2 at 
37°C. The cell density plated for each experiment has been provided in the methods 
section. The cells were treated with the specified concentration 3 µM of  tebufenpyrad 
for 0-3 h in serum-free RPMI media. For all experiments with N27 cells, treatments 
were performed when the cells were 65-70% confluent. The pesticides tebufenpyrad 
is lipophilic in nature and are hence dissolved in DMSO. 
Cleavage Resistant Mutant - Protein Kinase Cδ (CRM- PKCδ). The CRM- PKCδ 
stable N27 cell line was created as previously explained in detail and published by 
(Sun et al., 2008).  
CRISPR/Cas9-based knockout of PKCδ in N27 cells. The lentivirus-based 
CRISPR/Cas9 KO plasmid, pLVU6gRNA-Ef1aPuroCas9GFP-PKCδ, with the PKCδ 
gRNA target sequence GCGTCGTCCTCCGCCTGCAGGG), was purchased from 
Sigma-Aldrich. To make lentivirus, the lenti-CRISPR/Cas9 PKCδ KO plasmid and 
control plasmid were transfected into 293FT cells using the Mission Lentiviral 
Packaging Mix (SHP001; Sigma-Aldrich) according to the manufacturer’s 
instructions. The lentivirus was harvested 48 h post-transfection and titers were 
measured using the Lenti-X p24 Rapid Titer Kit (632200; Clontech, Mountain View, 
CA). For stable KD of PKCδ in N27 cells, six-well plates containing 0.1 X 106 /well 
had lentivirus added the following morning to the media at an MOI of 100. After 24 h, 
fresh media supplemented with puromycin (50 μg/ml) was added to the cells for 
stable cell selection. 
Caspase-3 activity assay. Caspase-3 activity were determined as previously 
described (Anantharam et al., 2002; Kanthasamy et al., 2008).  N27 cells in a density 
of 1 x 10
6 
cells per T25 cell culture flask were seeded the previous day, and briefly the 
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following day after exposure to tebufenpyrad, the cells were washed once with PBS 
and re-suspended in lysis buffer containing 50 mM Tris/HCl (pH 7.4), 1 mM EDTA, 
10 mM EGTA, and 10 μM digitonin. Cells were then incubated at 37°C for 20–30 
min to allow complete lysis. Lysates were quickly centrifuged and cell-free 
supernatants were incubated with 50 μM Ac-DEVD-AMC (caspase-3 substrate) at 
37°C for 1 hr. Caspase activity was then measured using a microplate reader 
(Molecular Devices Corp., Sunnyvale, CA) with excitation at 380 nm and emission at 
460 nm. Caspase activity was calculated as fluorescence unit (FU) per mg protein per 
hr and was presented as percentage of control. 
Site - Directed Mutagenesis. The site directed mutagenesis was performed on the 
N27 cells for replacing the threonine with glycine at 575 in LaminB1. mCherry-
LaminB1-10 was a gift from Michael Davidson (Addgene plasmid # 55069) and was 
used as template. GeneArt™ Site-Directed Mutagenesis System Kit (A13282) 
purchased from Fisher Scientific and was used in accordance to the manufacturer's 
protocol and instructions to mutate threonine, at position 575, into glycine. The 
synthesis primers used were as follows: 
GAGGAAGAACTTTTCCACCAGCAGGGAGGCCCAAGAGCATCCAATAGAA
GCTG (Forward primer) and 
CACAGCTTCTATTGGATGCTCTTGGGCCTCCCTGCTGGTGGAAAAGTTCTT
CCTC (Reverse primer). The resulting PCR product was purified using PCR 
Purification Kit (Qiagene) and transformed into DH5alpha E. coli. (Invitrogen). Five 
positive colonies were randomly picked and expanded to harvest DNA plasmid. The 
plasmids from each colony were sequenced by Sanger sequencing to confirm 
mutation at position 575 and the correct plasmids were transfected into 293FT cells. 
 77 
The highest-expressing plasmid, judged by brightness of mCHERRY (Excitation = 
587; Emission = 610) was chosen for transfection into N27 cells for making the 
mutant. 
Phospho-Site identification and Analysis. The Phosphosite analysis was performed 
on LaminB1, firstly to identify the presence of susceptible site on LaminB1 which are 
prone to undergoing phosphorylation mediated through an activated kinase. NetPhos 
2.0 server (online tool) was used for the identification of phosphorylation sites on 
LaminB1. Further analysis was performed using PhosphoPICK Site analysis (online 
tool) to identify the kinase that drove the phosphorylation of the specific site on 
LaminB1. The procedure for running the  PhosphoPICK online service tool was 
followed as previously performed by (Patrick et al., 2017; Patrick et al., 2015). 
Protein sequence data for LaminB1 and PKCδ were obtained from the repository of 
Protein Data Bank (PDB).   
NetPhos 2.0 server - http://www.cbs.dtu.dk/services/NetPhos-2.0/ 
PhosphoPICK Site analysis - http://bioinf.scmb.uq.edu.au/phosphopick/snpanalysis 
Organotypic slice culture. All the experiments involving animals followed 
protocols approved by Iowa State University’s Institutional Animal Care and Use 
Committee (IACUC). Organotypic slice culture was prepared as previously 
described (Falsig and Aguzzi, 2008; Harischandra et al., 2014b; Kondru et al., 
2017)
. 
In brief, brain slices were prepared from 9- to 12-day-old mouse pups from 
PKCδ+/+ and PKCδ-/- colony using a microtome (Compresstome™ VF-300, 
Precisionary Instruments). After dissecting out the whole brain, the brain was 
oriented in the coronal plane in the Compresstome’s specimen tube, which had 
been prefilled with 2% low-melting-point agarose. The agar was quickly solidified 
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by clasping the specimen tube with a chilling block, and then the specimen tube 
was inserted into the slicing reservoir filled with freshly prepared, ice-cold Gey’s 
balanced salt solution supplemented with the excitotoxic antagonist, kynurenic acid 
(GBSSK). To prepare GBSS, we added the following in solution in the following 
order from 10x stocks to obtain the final concentrations per liter: 8 g NaCl, 0.37 g 
KCl, 0.12 g Na2HPO4, 0.22 g CaCl2 ∙ 2H2O, 0.09 g KH2PO4, 0.07 g MgSO4 ∙ 7H2O, 
0.210 g MgCl2 ∙ 6H2O, 0.227 g NaHCO3. The compression lip located in the cutting 
chamber helps stabilize the brain specimen while obtaining 300-μm thick slices 
with the blade set at a medium vibration speed. Slices were collected at the 
specimen tube’s outlet and transferred to another plate with fresh prefilled GBSSK. 
The slices were washed twice in 6 ml ice-cold GBSSK, transferred to Millicell 6-
well plate inserts (3-5 slices per insert) and were incubated in a humidified 
atmosphere of 5% CO2 at 37 °C. Culture media was exchanged every other day for 
10-14 days with fresh media. Slice cultures were harvested post treatments with 
tebufenpyrad (20 nM for 24 hrs) by washing twice in 2 ml of ice-cold PBS. The 
whole cell lysates was performed as mentioned in the below method section on 
western blot analysis. Finally the Western blot and Immuhisto-chemical analysis 
for these slices were performed as described below.  
Human Post-mortem PD brain samples. We obtained frozen substantia nigra tissue 
samples and cryostat sections from the brains of confirmed post-mortem human PD 
patients and age-matched neurologically normal individuals from the brain banks at 
the Miller School of Medicine, University of Miami, FL and the Banner Sun Health 
Research Institute, AZ. For western blot experiments, the whole cell lysates were 
prepared as mentioned below in the method section on western blot analysis. 
 79 
Substantia nigra tissue sections were fixed with 4% paraformaldehyde (PFA) solution 
(in 0.1 M phosphate-buffered saline, pH 7.4). Cryostat sections were used for 
immuno-histochemistry experiments as described below. All human post-mortem 
samples were procured, stored and distributed according to the applicable regulations 
and guidelines involving consent, protection of human subjects and donor anonymity. 
Since the post-mortem human brain tissues were obtained from approved national 
brain banks, Institutional Review Board (IRB) approval from Iowa State University 
was not required.  
Western blot Analysis.  N27 dopaminergic neuronal cells were seeded (5 x 10
6 
cells 
per T175 cell culture flask). Post treatment of N27 cells with tebufenpyrad (3 μM- 3 
h) in a T175 flasks, cell lysates for western blotting analysis were prepared using 
modified RIPA buffer, as previously described (Kanthasamy et al., 2006b; 
Latchoumycandane et al., 2011b). Equal amounts of protein (30-35 μg) were loaded 
for each sample and separated on using 12% SDS-PAGE gels. Proteins were then 
transferred to a nitrocellulose membrane (BioRad) for immunoblotting and blocked 
using a blocking buffer specifically formulated for fluorescent Western blotting 
(Rockland Immunochemicals). The nitrocellulose membrane was subjected to primary 
antibodies overnight incubation, followed by secondary IR dye-800 conjugated anti-
rabbit dye or Alexa Flour 680 conjugated anti-mouse IgG for 1 h at room temperature. 
Primary antibodies against PKCδ, phospho-PKCδ (T505), laminB1 or phospho-
LaminB1 (T575) in blocking buffer solution were then added to the membranes and 
incubated overnight at 4°C. After another four to five washes, an infrared dye-tagged 
secondary antibody was added for 1 h. β-Actin was used as a loading control. Western 
blot images were captured with Odyssey IR Imaging system (LICOR) and data were 
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analyzed using Odyssey 3.0 software. Similar methodology as mentioned above for 
western blot analysis and tebufenpyrad treatment was followed and performed on the 
Control CRISPR/Cas9, PKCδ CRISPR/Cas9 knockdown N27 cells and PKCδ-CRM 
N27 cells. 
Immuno-cytochemistry analysis. Immunofluorescence studies in N27 dopaminergic 
neuronal cells were performed according to previously published protocols with some 
modifications (Gordon et al., 2011; Gordon et al., 2016). Briefly, 4 x 10
4
  N27 cells 
were grown on poly-D-lysine-coated coverslips and treated the following day. At the 
end of treatment with tebufenpyrad, cells were fixed with 4% PFA, washed in PBS 
and incubated in blocking buffer (PBS containing 2% BSA, 0.5% Triton X-100 and 
0.05% Tween 20) for 1 h at room temperature. The coverslips were then incubated 
overnight at 4°C with respective primary antibodies diluted in PBS containing 2% 
BSA. Samples were then washed several times in PBS and incubated with Alexa 488 
and 555 dye-conjugated secondary antibodies. The nuclei were labeled with Hoechst 
stain (10 μg/mL) and coverslips were mounted with Fluoromount medium (Sigma 
Aldrich) on glass slides for visualization.  
Immuno-histochemistry analysis. Immunohisto-chemistry (IHC) studies were 
performed on sections from the substantia nigra midbrain region of human post 
mortem brains as described previously (Ghosh et al., 2013; Gordon et al., 2016; Jin et 
al., 2011b; Sarkar et al., 2017). Briefly, the fixed brain sections were subjected to 
antigen retrieval using citrate buffer (10 mM sodium citrate, pH 8.5) for 30 min at 
90°C. Sections were then washed several times in PBS and blocked with PBS 
containing 2% BSA, 0.2% Triton X-100 and 0.05% Tween 20 for 1 h at room 
temperature. Sections were then incubated with primary antibodies overnight at 4°C 
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and washed 7 times in PBS on a Belly Dancer Shaker (SPI supplies). The sections 
were incubated with Alexa 488 and 555 dye-conjugated secondary antibodies for 60-
75 min at room temperature and their cell nuclei were stained with Hoechst dye. 
Sections were mounted on slides using Prolong antifade gold mounting medium 
(Invitrogen) or using with Fluoromount medium (Sigma Aldrich) according to the 
manufacturers’s instructions. Samples were visualized finally visualized and analyzed 
using Leica DMIRE2 confocal microscope. For the slice culture samples similar 
staining strategic method was employed, but with mild modifications in the 
methodology and experimental conditions as previously described in detail and 
illustrated by (Aguzzi and Falsig, 2012; Harischandra et al., 2014b; Kondru et al., 
2017; Sonati et al., 2013). 
Confocal imaging and Z stack image capturing and 3D reconstruction. Confocal 
imaging was performed at the Iowa State University Microscopy Facility, using a 
Leica DMIRE2 confocal microscope with the 63X oil objectives and Leica Confocal 
Software. For the cells, one optical series of Z-stack covered 5-7 optical slices of 0.5 
µm thickness each. For slices culture tissue sections and human sections of midbrain 
region we had employed 12-15 optical slices of 0.5 µm thickness each. The IMARIS 
software 10.0 was used to analyze the Z stack images. The surface reconstruction 
wizard in the IMARIS software version 10.0 was used to make 3-D reconstructed 
images for seeing architectural changes and picture definition. Further details to the 
images marking topographic alterations were reconstructed using modules in IMARIS 
such as Normal Shading and 3D surface developer.  
Statistical data analysis. All in vitro data were determined from at least 2-3 
biologically independent experiments, each done with a minimum of three biological 
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replicates. Data analysis was performed using Prism 4.0 software (GraphPad 
Software, San Diego, CA). Data were analyzed using one-way ANOVA with the 
Tukey-Kramer post-test for comparing all treatment groups with that of the control. 
Differences with p < 0.05 were considered statistically significant.  
Results 
Tebufenpyrad triggers PKCδ activation and increase in caspase-3 activity in the 
dopaminergic neuronal cell culture model of PD 
 In our previous years of research, we have shown that MPP
+
 and dieldrin 
induced PKCδ activation in dopaminergic neuronal cells. This activation is depicted 
by the cleavage of PKCδ into two fragments, one is regulatory and the other is 
catalytic fragment. Also, phosphorylation of PKCδ at threonine residue position 505, 
further confirms the activated form of PKCδ (Kaul et al., 2003; Saminathan et al., 
2011). Since tebufenpyrad is also a neurotoxic toxicant we wanted to investigate its 
role in acting as a caspase-3 dependent and PKCδ activation initiator. N27 cells were 
treated with tebufenpyrad (3 µM) for 1-3 hr and the whole cell lysates were made for 
performing western blots as shown in our previous studies (Asaithambi et al., 2014; 
Ay et al., 2015; Carvour et al., 2008; Kitazawa et al., 2001). To show the activation of 
PKCδ, we have checked for the hallmark signs of cleavage of activated PKCδ and 
also phosphorylation of PKCδ at T505 using the western blot analysis. These two 
evidences clearly demonstrated the significant activation of PKCδ triggered by 
tebufenpyrad exposure in the N27 cells (Figure 1A). Also, to prove the role of 
caspase-3 in activating PKCδ, we had performed the caspase-3 activity assay on the 
N27 cells treated with tebufenpyrad (Figure 1B). The caspase-3 assay was carried out 
as mentioned in our previous studies (Afeseh Ngwa et al., 2009; Carvour et al., 2008; 
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Gordon et al., 2012; Kanthasamy et al., 2008; Sun et al., 2008). Cumulatively, our 
results suggested that tebufenpyrad exposure mediated the PKCδ activation in the 
N27 cells in an caspase-3 dependent manner.  
Activated PKCδ phosphorylates laminB1 and modulates lamin damage 
 PKCδ is a well studied kinase that is known to phosphorylate other proteins 
(Kanthasamy et al., 2003a; Weng et al., 2015; Xue et al., 2015).  So, keeping that in 
mind we wanted unravel some sites on laminB1 that could be phosphorylated by 
activate PKCδ. LaminB1 was our target protein of interests primarily because it was 
known and shown almost two decades ago that PKCδ functioned as a potential 
apoptotic  Lamin Kinase (Cross et al., 2000). We studied this idea of activated PKCδ 
being a prospective kinase that phosphorylates LaminB1 in the N27 cell model system 
using two online insilico tools that will enable the identification and analysis of  
phosphorylation sites on LaminB. Firstly, NetPhos 2.0 server was used to identify the 
sites on LaminB1 that were predicted to be susceptible to kinase action and 
phosphorylation. The results from NetPhos 2.0 server analysis vividly projected a 
picture on site Threonine 575 (T575) of LaminB1. The predicted hit for T575 was 
marked to a scale of 0.975 (Fig. 2A). Furthermore, the analysis using the 
PhosphoPICK Site analyzer online, it was identified that PKCδ exclusively had 
promising effect of functioning as a valid and potential kinase for LaminB1. In other 
words, it was determined that activated PKCδ functioned as a very dependable kinase 
to phosphorylate LaminB1 (predicted p-value = 0.000392) (Fig. 2A). Additional 
validation and verification of this prediction was confirmed using the invitro model of 
PD. The western blot analysis showed that post exposure of N27 cells to tebufenpyrad 
(3 µM) for 1-3 h, there was prominent upregulation of phospho-LaminB1 (T575). 
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This phosphorylation of LaminB1 further marked the damage of the nuclear 
membrane by expressing a decrease in LaminB1 levels (Fig.2B). Adding on, further 
visual investigation was carried out using the immuno-cytochemistry analysis and 
confocal microscopy. These analysis demonstrated loss of LaminB1 architecture and 
integrity and activation of PKCδ marked by phosphorylation of PKCδ (T505) (Fig. 
3A and B).  Also, an interesting observation using the confocal microscopy was that 
the activated PKCδ localised on with the damaged/damaging nuclear membrane 
marked using LaminB1 (Fig. 3A) on the N27 dopaminergic neuronal cells.  
This study lead to the identification of site T575 on LaminB1 as one of the high 
targets of activated PKCδ. We treated the N27 cells with and observed by western 
blot analysis the significant increase in phospho-laminB1 (T575) and also loss of 
laminB1. Thus showing that PKCδ might be involved in phosphorylating laminB1 at 
T575 and acting as a lamin kinase thereby inducing laminb1 loss.  
PKCδ cleavage resistant mutant N27 cells (PKCδ- CRM) and Stable PKCδ 
CRISPR/Cas9 Knockdown N27 cells were resistant against tebufenpyrad 
induced PKCδ activation and laminB1 phosphorylation 
 Cleavage of PKCδ is one the hallmarks demonstrating its activity. Hence 
blocking its caspase-3 dependent cleavage inhibits its activation during oxidative 
stress (Latchoumycandane et al., 2011a; Sun et al., 2008). In order to study the role of 
PKCδ in acting as a lamin kinase and causing laminB1 damage we exposed the 
PKCδ-CRM N27 cells with tebufenpyrad (3 µM) for 3 hr. Following the treatment the 
cells were collected and the whole cell lysates were made as described above. We first 
checked for the caspase-3 dependent PKCδ cleavage and phospho-PKCδ (T505) for 
activation. We found that there was no change in either of these two proteins, thereby 
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showing tebufenpyrad exposure onto the PKCδ-CRM N27 cells did not activate PKCδ 
(Fig 4D). Adding on, we were further interested in checking for laminB1 and 
phospho-laminB1(T575). Doing so, we found that there no laminB1 loss or 
phosphorylation of laminB1 (Fig 4E). Furthermore, we had tested a similar strategy 
using the CRISPR/Cas9 based PKCδ knockdown N27 stable cell system to validate 
the importance and role of activated PKCδ in phosphorylating LaminB1. 
 Control CRISPR/Cas9 and PKCδ CRISPR/Cas9 Knockdown N27 cells were 
treated tebufenpyrad (3 µM) for 3 hr. Following the treatment the cells were collected 
and the whole cell lysates were made as described above and previously. The PKCδ 
CRISPR/Cas9 Knockdown N27 cells possessed a 90% message level knockout of 
PKCδ compared to the Control CRISPR/Cas9. This stable knockdown was developed 
using the CRISPR/Cas9 methodology as described in the methods section. It was 
observed that the PKCδ CRISPR/Cas9 Knockdown N27 cells post tebufenpyrad 
treatment did not have any observable phosphorylation of PKCδ at T505 and as a 
consequence no activation of PKCδ (Fig 4C). Adding on, the inhibition in the 
activation of PKCδ also lead to restricted LaminB1 damage and phosphorylation of 
LaminB1 at T575 in the PKCδ CRISPR/Cas9 Knockdown compared to the Control 
CRISPR/Cas9 N27 cells post treatment with tebufenpyrad (Fig 4A and B). The 
immuno-cytochemistry analysis performed using fluorescent labeled antibodies and 
confocal microscopy, also revealed concordantly that the PKCδ CRISPR/Cas9 
Knockdown compared to the control CRISPR/Cas9 N27 cells, did not show any 
activation of PKCδ and LaminB1 loss (nuclear membrane damage) (Fig. 4F). This 
results also states that there was no clear phosphorylation of LaminB1 at T575, which 
is mark for nuclear membrane damage.  
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 Cumulatively, it is very comprehendible that PKCδ activation is essential in 
functioning as a lamin kinase and also in causing lamin damage. Hence the inhibition 
of PKCδ activation might play a very crucial role in mediating the prevention of lamin 
damage.  
Site-directed mutagenesis of T575 on LaminB1 prevented its phosphorylation 
based activation and damage post tebufenpyrad induced oxidative stress in the 
N27 dopaminergic neuronal cells 
 An efficient molecular strategy of site-directed mutageneis was employed for 
lucidly describing the role of threonine 575 site specific phosphorylation of LaminB1 
by activated PKCδ upon tebufenpyrad exposure in the dopaminergic neuronal cells. 
Here in this techniques (as previous mentioned in the methods section), the threonone 
site at 575 was replaced by glycine, a smaller amino acid which keeps the protein in 
its stable conformation. Now we have a LaminB1 which possess glycine at 575 
instead of threonine in the N27 cell line system. Post treatment of these N27 cells 
which have prior undergone site-directed mutageneis with tebufenpyrad (3 µM) for 3 
hr, there was no phosphorylation of LaminB1 at site 575 and also no LaminB1 loss 
was observed (Fig. 5 A and B). This clearly demonstrates the important role of site 
575 on LaminB1, which contributes for the destruction of nuclear membrane upon 
phosphorylation at 575. Therefore, amalgamation of this result suggests the important 
role of site 575 on LaminB1 as a specific site of phosphorylation triggered by the 
activated PKCδ post exposure of the dopaminergic neuronal N27 cells to the 
mitochondrial inhibiting toxicant tebufenpyrad.  
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Organotypic slice culture of PKCδ-/- pups  demonstrates protection against 
LaminB1 loss and LaminB1 phosphorylation (T575) 
 Organotypic slice culture has been developing as a promising technique in 
recent years in brain related research. Although it has been in existence for several 
decades, its translational importance and usage as an exvivo method for validating , 
proving hypotheses and toxicity studies, has made it a potential and implacable tool 
(Harischandra et al., 2014c; Humpel, 2015; Kondru et al., 2017; Testa et al., 2005; 
Ullrich and Humpel, 2009). We have employed the organotypic slice culture 
methodology to understand the LaminB1 phosphorylation mechanism and the role of  
PKCδ function as a LaminB1 kinase in the midbrain post exposure to mitochondrial 
inhibiting pesticides tebufenpyrad, translating the model system from invitro to 
exvivo. In our present study, we had prepared the organotypic slices (350 μm 
thickness) from the midbrain of 9-12 day old PKCδ+/+ and PKCδ-/- pups as 
described in detail in the methods section above. These slices were treated with 
teubfenpyrad at a dose of 20 nM for 24 hrs. The western blot analysis and 
immunofluorescence suing confocal microscopy post tebufenpyrad treatment reveal 
that the PKCδ-/- pups demonstrate protection against LaminB1 loss and also 
phsophorylation of LaminB1 at T575. Whereas the PKCδ+/+ post tebufenpyrad 
exposure, shows susceptibility to LaminnB1 damage or loss and also visual 
noteworthy LaminB1 phosphorylation (T575) was observed (Fig. 6 A and B). This 
data suggests a specific role of PKCδ as a LaminB1 kinase, mediating the damage of 
LaminB1 and nuclear membrane in a exvivo model system post exposure to the 
mitochondrial toxicant such as tebufenpyrad. Thus marking a functional target of 
PKCδ kinase activity. 
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LaminB1 phosphorylation and PKCδ activation in substantia nigra of 
postmortem  Parkinson’s disease brains 
 The above results from data it is suggested that PKCδ upon activation by 
oxidative stress induced by tebufenpyrad exposure, functions as a LaminB1 kinase, 
phosphorylating LaminB1 at threonine 575. It has been shown previously through 
many epidemiological studies and animal models of PD that oxidative stress is one of 
the critical factors associated with the loss of dopaminergic neurons by apoptosis 
(Banerjee et al., 2009; Bose and Beal, 2016; Dauer and Przedborski, 2003; 
Kanthasamy et al., 2010; Przedborski and Ischiropoulos, 2005). Hence we in this 
study developed a translational evidence subtitling the function of activated PKCδ as 
a LaminB1 kinase. In this study we had employed 11 control and 11 PD post mortem 
substantia nigra tissues for our analysis. The western blot analysis revealed a 
significant augmentation of phospho- PKCδ (T505) compared to the control brains. 
This upregulation of phospho- PKCδ (T505), marked the activated state of PKCδ (Fig 
7A) (Afeseh Ngwa et al., 2009; Kanthasamy et al., 2006b; Kanthasamy et al., 2003b). 
Further analysis demonstrated, the loss of LaminB1 and upregulation of phospho- 
LaminB1 (T575) in the PD post mortem substantia nigra compared to the control 
brain samples (Fig 7A). Adding on, the immuno-histochemical staining study on 
human midbrain sections, demonstrated a loss in LaminB1 expression and also 
structural impaired or damage nuclear membrane damage in the PD samples 
compared to the controls (Fig 7B). Cumulatively, this data observed by the analysis of 
PD and control substantia nigra tissues and sections, depicts and shows similar trend 
of mechanism of PKCδ functions as a LaminB1 kinase, from our above shown invitro 
and exvivo studies. Thus suggesting and highlighting the importance of functional of 
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role of activated PKCδ as a LaminB1 kinase, post oxidative stress induced in 
dopaminergic neuronal cells.  
Discussion 
 In our present study, we have attempted to elucidate the role of activated 
protein kinase cδ (PKCδ), in functioning as a LaminB1 kinase and henceforth 
initiating the process of nuclear membrane damage prior to exposure to tebufenpyrad 
in the N27 neuronal cells. Although, a similar idea had been demonstrated couple 
decades ago in an oncological setting, the exact mechanism and the cause for PKCδ 
functioning as a lamin kinase still remained unexplained and in the dark. Our study, 
demonstrated the accentuated ability of tebufenpyrad mediated oxidative stress, 
causing a caspase-3 dependent PKCδ activation. Furthermore, the activated PKCδ 
also lead to the phosphorylation of LaminB1 at T575, thereby leading to LaminB1 
loss and nuclear membrane damage.  
 It has been very well studied in the past decades, the effect of mitochondrial 
dysfunction post pesticides exposure causes changes in oxidative phosphorylation, 
alterations in mitochondrial DNA replication, functional dynamics and respiration. 
These have all been noted prominently as critical contributing factors for the 
pathogenesis of Parkinson's disease (PD)(Greenamyre et al., 2001; Lin and Beal, 
2006; Sherer et al., 2007) (Afeseh Ngwa et al., 2011; Kitazawa et al., 2004; Kitazawa 
et al., 2001). Our toxicant of interest here is tebufenpyrad, a greenhouse pesticide in 
the United States of America and many other parts of the world (EPA PC Code- 
090102). It is primarily used for the protection of ornamental plants against the action 
of mites and spiders. Tebufenpyrad has been classified as a mitochondrial complex 1 
inhibitor by the Insecticide Resistance Action Committee (IRAC). We have recently 
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shown significant alterations in mitochondrial functional dynamics and structure, post 
exposure to tebufenpyrad in the N27 dopmaniergic neuronal cells, thereby underlining 
tebufenpyrad's potent neurotoxic effects (Charli et al., 2016).  
 In this chapter we have extended our studies, in searching for answers 
regarding the ability of tebufenpyrad exposure to initiate PKCδ activation, LaminB1 
loss and nuclear membrane damage in the dopaminergic neurons. Our lab in several 
of our previous studies have shown that exposure of dopaminergic neuronal cells to 
dieldrin and MPP
+
, lead to caspase-3 dependent exacerbated activation of PKCδ, 
thereby triggering a cascade pro-apoptotic signaling (Kaul et al., 2003; Saminathan et 
al., 2011; Wiemerslage et al., 2013). In this present study, we had treated the N27 
dopaminergic neuronal cells with tebufenpyrad (3 µM) for 3 hr and observed the 
activation of PKCδ. The activation of PKCδ was confirmed by the hallmark 
proteolytic cleavage and phosphorylation of PKCδ at T505 (Fig. 1A). Additionally we 
had observed the significant increase in caspase-3 activity post tebufenpyrad 
treatment, hence making the PKCδ activation a caspase-3 dependent mechanism (Fig. 
1B). Following these studies, the novel idea of identifying the specific target for 
activated PKCδ to function as an activated kinase was systematically unraveled using 
online phosphosite analysis tools such as NetPhos Server 2.0 and PhosphoPICK site 
analysis. These tools unopened an interesting target of LaminB1. It was predicted 
being one of the most susceptible target for PKCδ upon its activation by oxidative 
stress conditions induced by tebufenpyrad exposure. The NetPhos Server2.0, 
predicted the site on LaminB1 that was most prone to phosphorylation modeification ( 
predicted value - 0.975) and the PhosphoPICK Site analysis enabled to determine 
predicted effect of activated PKCδ on the LaminB1. After meticulous analysis and 
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prediction it was identified that T575 on LaminB1 was the most susceptible site for 
phosphorylation induced by the activated PKCδ (Fig. 2A). Further study using the 
western blot analysis method, we had demonstrated LaminB1 down-regulation and 
increase in phospho-LaminB1 (T575) post tebufenpyrad exposure in the N27 cells 
(Fig. 2B). Adding on, similar study using immuno-cytochemistry staining and 
confocal microscopy was performed in order to obtain a visual perspective detail. It 
was observed using confocal microscopy that the activated PKCδ localized on the 
nuclear membrane stained with LaminB1 in the form of a crown like structure and 
also the activation of PKCδ was confirmed by the phosphorylation of PKCδ at T505 
(Fig. 3A and B). Further carefully inspection provided us the evidence of loss 
LaminB1, thereby visually depicting the nuclear membrane damage in the N27 cells 
post tebufenpyrad exposure. Thus confirming the tebufenpyrad induced activation of 
PKCδ and LaminB1 loss.     
 In our study, PKCδ' s activation plays a vital part in functioning as a lamin 
kinase post the exposure of N27 cells with tebufenpyrad. In order to further strength 
this hypothesis, we had generated the PKCδ-CRM N27 cells and PKCδ CRISPR/Cas9 
knockdown stable N27 cell lines. Previously, it has been shown that PKCδ functions 
as an apoptotic lamin kinase in the HL-60 cells (Cross et al., 2000). Hence, proving 
the kinase function of activated  PKCδ targeted to the phosphorylation of LaminB1 in 
the dopaminergic neuronal cells is an crucial factor. We have shown previously using 
the PKCδ-CRM N27 cells that the important step of PKCδ proteolytic cleavage marks 
its activation and kinase functional role (Sun et al., 2008). In this present study, the 
first cell culture model system  we had employed was the PKCδ-CRM N27 cells 
treated with tebufenpyrad as mentioned above. It was vividly observed that the PKCδ-
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CRM N27 cells post tebufenpyrad treatment did not demonstrate PKCδ activation, 
further analysis also revealed that PKCδ-CRM N27 cells also did not demonstrate any 
LaminB1 loss or phosphorylation of LaminB1 at T575. Thus this result suggested that 
PKCδ is indeed a critical component in functioning as a LaminB1 kinase and nuclear 
membrane damage (Fig. 4D and E). The second invitro model system that we had 
employed was the PKCδ CRISPR/Cas9 knockdown stable N27 cells.  As mentioned 
above, the control PKCδ CRISPR/Cas9 and PKCδ CRISPR/Cas9 knockdown stable 
N27 cells were treated with tebufenpyrad and was then compared to the 
corresponding untreated groups. Upon treatment with tebufenpyrad the PKCδ 
CRISPR/Cas9 knockdown stable N27 cells did not express any noteworthy 
upregulation of phospho- PKCδ (T505) compared to the corresponding control 
CRISPR/Cas9 N27 cells that were exposed to tebufenpyrad. This meant that there was 
no observed activation of PKCδ in the PKCδ CRISPR/Cas9 knockdown stable N27 
cells. As a result, there was also no observed LaminB1 loss and phosphorylation of 
LaminB1 (T575) (Fig. 4 A, B, C and F).  
 Using the site-directed mutageneis approach we highlighted the site specific 
phosphorylation of LaminB1 triggered by PKCδ activation. The method was driven 
by replacing the threonine site at 575 on LaminB1 with glycine. Thus manipulating 
the LaminB1, with destructing its protein level integrity. This study was carried post 
the mutation by treating the wildtype N27 cells and mutant N27 cells with 
tebufenpyrad and it was compared with their corresponding controls. It was observed 
that the mutant did not exhibit any loss of LaminB1 or phosphorylation of LaminB1 at 
site 575 post tebufenpyrad exposure compared to its control. Whereas, the wildtype 
corroboratively showed LaminB1 loss and phosphorylation at site 575, prior to 
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tebufenpyrad treatment. Thus iterating that post tebufenpyrad exposure in the N27 
cells, the activated PKCδ further functions as a LaminB1 kinase, phosphorylating 
LaminB1 at T575 and thereby leading to LaminB1 loss and nuclear membrane 
damage. Also, adding on, evidences from the organotypic slice culture studies of 
PKCδ+/+ and PKCδ-/- pup midbrains and from the control and PD post mortem 
substantia nigra tissues analyzes, demonstrated the function of activated PKCδ as a 
LaminB1 kinase (Fig 6A, 6B, 7A  and 7B). 
 Cumulatively, our data demonstrate that the mitochondrial complex 1 
inhibiting greenhouse pesticide tebufenpyrad is able to induce a caspase-3 dependent 
PKCδ activation. The activated PKCδ further functions as a kinase phosphorylating 
LaminB1 at T575, resulting in the loss of LaminB1 and hence destructing the 
structural integrity of nuclear membrane resulting in the apoptotic cell death of the 
N27 dopaminergic neuronal cells. The highlight and critical take from this study is, 
LaminB1at T575 serves as a susceptible target for activated PKCδ and leads apoptotic 
neuronal cell death post exposure of mitochondria inhibiting pesticide tebufenpyrad. 
Thus untangling this novel mechanism would enable to build a bridge to further 
explore some innovative drug targets and prospective small molecules that could be 
used against the dopaminergic neuronal degeneration involved in PD. 
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Figures 
 
 
 
 
 
 
 
Figure 1: PKCδ activation triggered by oxidative stress induced by tebufenpyrad 
in N27 cells 
(A) Proteolytic cleavage dependent activation of PKCδ and phosphorylation of PKCδ 
at T505 induced by tebufenpyrad - N27 cells were treated with tebufenpyrad (3 µM) 
for 3 hr and cell lysates were prepared and subjected to Western blot analysis. 
Representative immunoblots of PKCδ and phospho- PKCδ (T505) as shown above in 
section A. (B) Tebufenpyrad induced significant caspase-3 activity in the N27 cells - 
The cells were then exposed to tebufenpyrad (3 µM) for 3 hr. Cells were collected and 
assayed for caspase-3 activity using the Ac-DEVD-AMC caspase-3 substrate. Data 
shown represent mean ± SEM from two independent experiments performed in 
quadruplicate (***p<0.001). 
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Figure 2: Activated PKCδ functions as a lamin kinase, initiating laminB1 
phosphorylation and orchestrates lamin damage 
(A) In-silico and phospho site matching analyses shows PKCδ site targets on 
laminB1- Online analysis tools NetPhos Server 2.0 and PhsphoPICK Site analysis 
tool was used for the above study. (B) PKCδ phosphorylates laminB1 at T575 and 
induces lamin damage - N27 cells were treated with tebufenpyrad (3 µM) for 3 hr and 
cell lysates were prepared and subjected to Western blot analysis. Representative 
immunoblots of LaminB1 and phospho- LaminB1 (T575).  
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Figure 3: Immuno-cytochemistry shows localisation of activated PKCδ and 
lamin B1  
(A) Localisation of PKCδ onto laminB1 on the nuclear membrane post tebufenpyrad 
exposure on N27 dopaminergic neuronal cells - N27 cells were treated with 
tebufenpyrad (3 µM) for 3 hr (B) and were fluorescently stained for PKCδ (green) and 
LaminB1 (red). phosphorylates laminB1 at T575 and induces lamin damage - N27 
cells were treated with tebufenpyrad (3 µM) for 3 hr (B) and were fluorescently 
stained for PKCδ (red) and phospho- PKCδ (T505)  (green). The z-stack images were 
captured on using a 63X oil immersion lens of the Leica Confocal Microscopy system 
and the processing of images were performed using IMARIS 10.0 software.  
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Figure 4: Stable PKCδ CRISPR/Cas9 Knockdown N27 cells and the PKCδ 
cleavage resistant mutant N27 cells (PKCδ- CRM) were resistant against 
tebufenpyrad induced PKCδ activation and laminB1 phosphorylation 
The cells were treated with tebufenpyrad (3 µM) for 3 hr and cell lysates were 
prepared and subjected to Western blot analysis. Representative immunoblots of 
phospho- PKCδ (T505), LaminB1 and phospho- LaminB1 (T575),  and β-Actin was 
used as a loading control for all the western blot analysis. (A-C) Depicted the 
resistance of PKCδ CRISPR/Cas9 Knockdown N27 cells to tebufenpyrad induced 
PKCδ activation and laminB1 phosphorylation. (D and E) Depicted the resistance of 
PKCδ-CRM N27 cells to tebufenpyrad induced PKCδ cleavage and activation and 
also LaminB1 phosphorylation and LaminB1 loss. (F) Immunocyto-chemistry 
analysis using confocal microscopy showed resistance of PKCδ CRISPR/Cas9 
Knockdown N27 cells to tebufenpyrad induced PKCδ activation and laminB1 
phosphorylation compared to the resistance of control CRISPR/Cas9 N27 cells post 
tebufenpyrad exposure. 
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Figure 5: Site-directed mutagenesis of T575 on LaminB1 prevented its 
phosphorylation based activation and damage post tebufenpyrad induced 
oxidative stress in the N27 dopaminergic neuronal cells 
Wildtype and mutant N27 cells were treated with tebufenpyrad (3 µM) for 3 hr and 
cell lysates were prepared and subjected to Western blot analysis. Representative 
immunoblots of LaminB1 and phospho- LaminB1 (T575),  and β-Actin was used as a 
loading control for all the western blot analysis.  
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Figure 6 : Absence of PKCδ protects against LaminB1 loss and phosphorylation 
of LaminB1 (T575) in the organotypic slice culture. The organotypic slices of 
PKCδ+/+ and PKCδ-/- pups were sectioned (350 µm thickness) and were maintained 
for 10-14 days and were treated with tebufenpyrad (20 nM for 24 hr). (A) Whole cell 
lysates were prepared and subjected to Western blot analysis. Representative 
immunoblots of LaminB1 and p-LaminB1(T575) as shown in section A. β-Actin was 
used as a loading control. Post treatments the slices were fixed and processed for 
immuno-histochemistry analysis and microscopy. (B) LaminB1 fluorescently stained 
(green), p-LaminB1(T575) (red) and Hoechst (blue). The z-stack images were 
captured on using a 63X oil immersion lens of the Leica Confocal Microscopy system 
and the processing of images were performed using IMARIS 10.0 software.  
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Figure 7 : Absence of PKCδ activation, LaminB1 loss and phosphorylation of 
LaminB1 (T575) in the substantia nigra of postmortem PD brains. (A) Substantia 
nigra of postmortem control and PD brain tissues, were obtained from the brain bank 
at Miller School of Medicine, University of Miami, FL.  Whole cell lysates were 
prepared and subjected to Western blot analysis. Representative immunoblots of 
LaminB1, p-LaminB1(T575) and p- PKCδ (T505) as shown. β-Actin was used as a 
loading control. (B) Sections of Substantia nigra from postmortem control and PD 
brains were obtained from the brain bank at Banner Sun Health Research Institute, 
AZ. The fluorescent staining was performed for LaminB1 (green) and anti-TH (red). 
The z-stack images were captured on using a 63X oil immersion lens of the Leica 
Confocal Microscopy system and the processing of images were performed using 
IMARIS 10.0 software (Images depicted in normal shading formats one below the 
other respectively). Data for western blot analysis shown represent mean ± SEM from 
11 control and 11 PD individual humans post mortem in total for each group 
(*p<0.05). 
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Figure 8 : A schematic illustrating the caspase-3 dependent activation of  PKCδ 
mediating phosphorylation of LaminB1 at T575 and nuclear membrane damage and 
destruction, in the N27 cells post treatment with mitochindrial inhibiting pesticide 
tebufenpyrad. Drawing was created by A.Charli using biomedical PowerPoint toolkit 
from Motifolio. 
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Abstract 
Growing evidence implicates continual exposure to environmental pesticides in the 
etiopathogenesis of Parkinson's disease (PD). Previously, we demonstrated that 
dysregulation of histone acetylation homeostasis induced by environmental pesticides 
exposure increases the susceptibility of dopaminergic neurons to degenerative 
processes. Using confocal microscopy and Seahorse bioanalyzer, we recently showed 
that exposing N27 dopaminergic neuronal cells to the greenhouse pesticide pyridaben 
induced significant neurotoxicity by affecting mitochondrial structure and function. 
These observations promoted us to examine whether pyridaben-induced 
mitochondrial dysfunction influences epigenetic histone acetylation. Western blot 
analysis revealed that exposure of N27 cells to pyridaben (3 µM) drastically increased 
histone (specifically H3 and H4) acetylation. The classic mitochondrial complex-1 
inhibitor rotenone also induced histone H3/H4 acetylation. Immunocytochemical 
analysis revealed that pyridaben and rotenone exposure preferentially acetylate lysine 
sites K23 and K5 on H3 and H4, respectively. 3D-reconstruction of confocal 
microscopy images performed using IMARIS demonstrated vivid architectural 
changes in nuclear morphology. Further analysis by means of mitochondria-defective 
N27 dopaminergic stable cells obtained by CRISPR/Cas9-based knockdown of 
TFAM protein also revealed hyperacetylation of histone H3/H4 compared to the 
control CRISPR/Cas9 N27 cells. Similar results of histone H3/H4 hyperacetylation 
and also, site-specific acetylation of H3 (K23) and H4 (K5) were observed in the 
transgenic MitoPark mouse model of PD, that is deficient of mitochondrial function 
and also an age-progressive disease model. Importantly, western blotting and 
immunohistochemical analysis unraveled hyperacetylation of histone H3/H4 in the 
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nigral dopaminergic neurons from PD brains. Collectively, our data reveal a novel 
interplay between mitochondrial dysfunction and epigenetic dysregulation of core 
histone acetylation, which together may play a critical role in the etiology of 
environmentally-linked PD. 
Introduction 
 Sporadic Parkinson’s disease (PD) is a major environmentally-linked 
neurodegenerative disease, affecting more than one million people from the United 
States and imposing an enormous economic burden on patients, their families and 
society. This chronic and progressive disease is characterized mainly by the loss of 
dopaminergic (DAergic) neurons in the ventral mesencephalic substantia nigra pars 
compacta (SNpc), leading to a striatal dopamine deficit, and formation of Lewy body 
aggregates. PD is characterized as a multi-factorial disease, wherein the components 
that contribute are more than one to identify. Despite extensive research, the cause of 
PD remains elusive largely due to a poor mechanistic understanding of the increased 
susceptibility of nigral DAergic neurons to the degenerative process, but exposure to 
environmental pesticides, metals, and other chemicals has been implicated in PD’s 
etiology (Benedetto et al., 2009; Goldman, 2014; Kieburtz and Wunderle, 2013; 
Obeso et al., 2010). Several gene mutations have been identified whose defects 
account for <10% of total PD cases. The vast majority of PD cases might be 
associated with environmental chemical exposures (Bonifati, 2014; Lubbe and Morris, 
2014; Trinh and Farrer, 2013), with the agrochemical pesticide rotenone being of 
particular concern, based on epidemiological and experimental studies (Betarbet et al., 
2000; Cannon et al., 2009; Dhillon et al., 2008; Drolet et al., 2009; Greenamyre et al., 
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2003; Johnson and Bobrovskaya, 2015; Panov et al., 2005; Spivey, 2011; Tanner et 
al., 2011).  
 Rotenone was widely applied as a garden insecticide and has a long history of 
use in the US as a major pesticide to eradicate invasive species of fish.  Recent 
Epidemiological studies have suggested rotenone exposures significantly increases the 
risk of incurring PD (Dhillon et al., 2008) (Spivey, 2011; Tanner et al., 2011). In the 
laboratory, chronic administration of rotenone in rats causes selective dopaminergic 
neuronal death and cytoplasmic α-synuclein (αSyn)-positive Lewy body-like 
inclusions in surviving dopaminergic neurons, as well as many of the motor features 
of PD (Betarbet et al., 2000; Cannon et al., 2009; Drolet et al., 2009; Greenamyre et 
al., 2003; Greenamyre et al., 2010; Inden et al., 2011; Inden et al., 2007; Johnson and 
Bobrovskaya, 2015; Pan-Montojo et al., 2010; Panov et al., 2005; Sherer et al., 2003). 
Despite its ban in the U.S since 2007, rotenone is still widely used worldwide in large 
quantities. Mechanistically, inside the cell rotenone acts as a high-affinity and specific 
inhibitor of mitochondrial complex I causing bioenergetic deficits (Charli et al., 2015; 
Drolet et al., 2009; Greenamyre et al., 2010; Greenamyre et al., 2001; Johnson and 
Bobrovskaya, 2015; Tanner et al., 2011). Both experimental and human evidence has 
suggested a prominent role for mitochondrial complex I impairment in the 
pathogenesis of PD (Greenamyre et al., 2001; Johri and Beal, 2012; Lin and Beal, 
2006; Mullin and Schapira, 2015).  
 The pyridaben functioning as an acaricide is used to control populations of 
mites and ticks in commercial greenhouses, is also classified as a mitochondrial 
complex I inhibitor. Like rotenone, pyridaben is highly lipophilic and can thus easily 
cross the blood-brain barrier (BBB). Considering the link between complex I 
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dysfunction and PD, pyridaben likely poses a disease risk, but the epidemiological 
evidence is lacking. We and others have demonstrated that exposure to micromolar 
concentrations of pyridaben induces significant neurotoxicity in cultured neuronal 
cells and midbrain organotypic slices (Charli et al., 2015; Sherer et al., 2007). Another 
study of pyridaben-treated C57BL mice found a strong correlations between 
pyridaben exposure and both DAergic neuron loss and increased αSyn 
immunoreactivity (Gollamudi et al., 2012). A recent interesting case report was 
reported in ' The Washington State Department of Agriculture' and this report had 
documented the occurrence of neurological, ocular and gastrointestinal symptoms in 
farmworkers poisoned by an off-target exposure to pyridaben (Calvert et al., 2015).  
 Recent studies have identified various epigenetic changes, particularly histone 
modifications, as important cellular and molecular correlates of a variety of brain 
disorders involving significant neuronal loss and dysfunction, especially in stroke, 
fragile X-associated tremor/ataxia syndrome, and Huntington’s and Alzheimer’s 
diseases (Habibi et al., 2011; Kwok, 2010; Marques et al., 2011). Epigentic alterations 
, in particular histone modifications, including methylation, phosphorylation, 
acetylation, and ubiquitination, has been linked to many human diseases in recent 
years (Somech et al., 2004). The acetylation modification in specifically has been 
associated to be triggered because of the  imbalance of histone acetyltransferase 
HATs and HDACs in the system. This in recent years seems to approached as a 
critical component in the that suggestively contributes to neurodegenerative diseases 
(Rouaux et al., 2003; Saha and Pahan, 2006). We have previously demonstrated that 
exposure to dieldrin or paraquat in the dopamingeric neuronal invitro or invivo 
models, triggers hyperacetylation of histones H3 and H4 , which further results in 
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DNA fragmentation and apoptotic cell death of dopamingeric neuronal cells (Song et 
al., 2010; Song et al., 2011).  
  However, histone acetylation has not yet been explored as a potential 
mechanism linking mitochondria-inhibiting pesticides exposure to PD pathogenesis. 
Therefore, in this  present study, we demonstrate novel effects of the mitochondria-
inhibiting pesticides rotenone and pyridaben on core histones acetylation 
modifications in various models of PD. Our results improves the understanding of the 
effect of mitochondrial impairment on neurodegenerative processes in PD. Also, we 
show a mechanistic insight into the structural alterations of the chromatin structure 
and nuclear architecture changes exhibited by the site specific histones H3 and H4 
acetylation post pestcicides exposure.  
Materials and Methods 
Chemicals and Reagents. We purchased pyridaben (99.1% purity) from Chem 
Services (West Chester, PA), and rotenone (95-98% purity). DMSO and Pierce NE-
PER extraction kit was purchased from Fisher Scientific (Fair Law, NJ). We 
purchased RPMI 1640 media, fetal bovine serum (FBS), L-glutamine, penicillin, 
streptomycin and Sytox green nucleic acid fluorescence stain from Molecular Probes 
(Eugene, OR). Histone Acetyltransferase (HAT) Assay kit, anti-acetyl lysine 
antibody, Anti-histone3 (H3) antibody and Millicell 6-well plate inserts (Biopore 
filter CM, PTFE inserts 30-mm diameter and 0.4-um pore size, Cat No. 
PICM03050), from Millipore (Billerica, MA), and the Acetylated H3(K23) and 
Acetylated H4 (K5) antibodies from Santa Cruz Biotechnology Inc.(Santa Cruz, CA). 
Anti- HP-1α antibody was bought from Abcam (Cambridge, MA). Caspase-3 
substrate, Ac-DEVD-AMC, was purchased from Bachem Biosciences, Inc. (King of 
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Prussia, PA). BCA protein estimation Kit, Protease and Phosphatase Inhibitor 
Cocktail, Hoechst nuclear stain from Life Technologies (Gaithersburg, MD). 
Dieldrin, Dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA), 45% 
glucose, kynurenic acid, proteinase K (PK), sodium chloride (NaCl), Tris-HCl and 
Triton X-100, Cell Death Detection ELISA Plus Assay Kit, Oligomycin, glucose and 
Anacardic acid were purchased from Sigma Aldrich (St. Louis, MO), and the 
Seahorse FluxPak calibration solution was bought from Agilent Technologies (Santa 
Clara, CA). 
Cell culture and treatment paradigm. The rat immortalized mesencephalic 
dopaminergic neuronal cell line (1RB3AN27, also known as N27 cells) was a kind gift 
from Dr. Kedar N. Prasad (University of Colorado Health Sciences Center, Denver, 
CO).  These N27 cells have the potential to differentiate and produce dopamine in 
culture when exposed to a suitable cAMP triggering agent, and once the cells are 
differentiated they possess increased tyrosine hydroxylase (TH) expression and 
dopamine levels (Adams et al., 1996; Zhang et al., 2007).  In this study, 
undifferentiated cells were grown in RPMI 1640 medium containing 10% FBS, 2 mM 
L-glutamine, 50 units of penicillin, and 50 µg/ml streptomycin, as described 
previously (Anantharam et al., 2002; Jin et al., 2011c; Prasad et al., 1998). In general, 
cells were plated in a tissue culture plate or flask in accordance to the experimental 
requirements and was cultured overnight in a humidified atmosphere of 5% CO2 at 
37°C. The cell density plated for each experiment has been provided in the methods 
section. The cells were treated with the specified concentrations of pyridaben and 
rotenone for 0-3 h in serum-free RPMI media. For all experiments with N27 cells, 
treatments were performed when the cells were 65-70% confluent. The pesticides 
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pyridaben and rotenone are lipophilic in nature and are hence dissolved in DMSO. In 
the histones H3 and H4 site specific immuno-staining microscopy analysis and in the 
pyridaben dose study western blot analysis, N27 cells were treated with 100 µM 
Dieldrin for 25 min as a positive control. For cytotoxicity studies using the SYTOX, 
Caspase-3 activity and DNA fragmentation assays the cells were treated with 
pyridaben (3 µM for 3 hr) or rotenone (1 µM for 3 hr) or pre-treated and co-treated 
with anacardic acid (8.5 µM for 1 hr) along with each of the pesticides pyridaben or 
rotenone. 
CRISPR/Cas9-based knockdown of TFAM in N27 cells. The CRISPR/Cas9-based 
knockdown experiments were performed as described previously (Langley et al., 
2017). The lentivirus-based CRISPR/Cas9 TFAM knockdown (KD) plasmid, 
pLVU6gRNA-Ef1aPuroCas9GFP-TFAM, with the TFAM gRNA target sequence 
directed against the exon 1 sequence (CPR555e5e4099bf84.98), was purchased from 
Sigma-Aldrich. To make lentivirus, the lenti-CRISPR/Cas9 TFAM KD plasmid and 
control lentiviral vector were transfected into 293FT cells using the Mission Lentiviral 
Packaging Mix (SHP001; Sigma-Aldrich) according to the manufacturer’s 
instructions. The lentivirus was harvested 48 h post-transfection and titers were 
measured using the Lenti-X™ p24 Rapid Titer kit (Cat# 632200; Clontech, Mountain 
View, CA). For stable knockdown of TFAM in N27 cells, cells were plated at 0.1 x 
10
6
 cells/well in 6-well plates one day before transduction and then incubated with the 
TFAM KD lentivirus at an MOI of 100. After 24 h, fresh media supplemented with 
puromycin (50 μg/ml) was added to the cells for stable cell selection. Our qRT-PCR 
analysis confirmed that transduction of N27 cells with CRISPR/Cas9-based TFAM 
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knockdown lentivirus resulted in >80% loss in TFAM mRNA levels relative to 
control cells.  
SYTOX Green cytotoxicity assay. Cell death after exposing the N27 cells to 3 µM 
of pyridaben or 1 µM  of rotenone or along with 8.5 µM pre-treatment and co-
treatment with anacardic acid was determined using the SYTOX Green dye, as 
previously described (Jin et al., 2011a; Latchoumycandane et al., 2011a). The 
SYTOX green dye only permits dead cells to produce green fluorescence. In brief, 
N27 cells were grown in 24-well cell culture plates (4 x 10
4
 cells/well) and treated 
with pesticides alone or along with pre-treatment and co-treatment with anacardic acid 
(8.5 µM for 1 hr) and the pesticides. Fluorescent images were then taken using 
fluorescence microscopy (Cytation 3, Biotek, Winooski, VT) that was coupled with a 
40X objective and Gen5 imaging software. For further validation, the green 
fluorescence was quantitatively measured at an excitation wavelength of 485 nm and 
an emission wavelength of 538 nm with the use of a fluorescence microplate reader 
(Cytation3, Biotek). The results were finally presented as a percentage of control. 
Caspase-3 activity assay. Caspase-3 activity were determined as previously 
described by (Anantharam et al., 2002; Kanthasamy et al., 2008).  N27 cells in a 
density of 1 x 10
6 
cells per T25 cell culture flask were seeded the previous day, and 
briefly the following day after exposure to pyridaben or rotenone or with the 
anacardic acid pre-treatment, the cells were washed once with PBS and re-suspended 
in lysis buffer containing 50 mM Tris/HCl (pH 7.4), 1 mM EDTA, 10 mM EGTA, 
and 10 μM digitonin. Cells were then incubated at 37°C for 20–30 min to allow 
complete lysis. Lysates were quickly centrifuged and cell-free supernatants were  
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incubated with 50 μM Ac-DEVD-AMC (caspase-3 substrate) at 37°C for 1 hr. 
Caspase activity was then measured using a microplate reader (Molecular Devices 
Corp., Sunnyvale, CA) with excitation at 380 nm and emission at 460 nm. Caspase 
activity was calculated as fluorescence unit (FU) per mg protein per hr and was 
presented as percentage of control.  
DNA fragmentation. Cell Death Detection ELISA Plus Assay Kit was used to 
measure the levels of DNA fragmentation, as described previously (Anantharam et al., 
2002; Kanthasamy et al., 2006a; Kitazawa et al., 2002; Reyland et al., 1999). Briefly, 
N27 cells (30,000 cells) were subcultured in 24-well culture plates the previous day. 
The following day cells were exposed to pyridaben or rotenone or along with the 
anacardic acid pre-treatment. At the end of 3 hr, cells were processed to determine the 
extent of DNA fragmentation. Quantitative determination of the amount of 
fragmented DNA retained by anti-DNA-HRP in the immunocomplex was determined 
spectrophotometrically with ABTS as an HRP substrate (supplied with the kit). 
Colorimetric measurements were made at 405 and 490 nm using a SpectroMax 190 
spectrophotomer (molecular Devices; molecular Probes; Sunnyvale, CA). The 
magnitude of DNA fragmentation in the cell lysate was quantified by measuring the 
difference in absorbance between OD405 and OD490 nm. The results were finally 
presented as a percentage of control and compared. 
Organotypic slice culture technique. All the experiments involving animals 
followed protocols approved by Iowa State University’s Institutional Animal Care 
and Use Committee (IACUC). Organotypic slice culture was prepared as 
previously described (Falsig and Aguzzi, 2008; Harischandra et al., 2014b; Kondru 
et al., 2017)
. 
In brief, brain slices were prepared from 9- to 12-day-old mouse pups 
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from wild-type (WT, C57BL/6) using a microtome (Compresstome™ VF-300, 
Precisionary Instruments). After dissecting out the whole brain, the brain was 
oriented in the coronal plane in the Compresstome’s specimen tube, which had 
been prefilled with 2% low-melting-point agarose. The agar was quickly solidified 
by clasping the specimen tube with a chilling block, and then the specimen tube 
was inserted into the slicing reservoir filled with freshly prepared, ice-cold Gey’s 
balanced salt solution supplemented with the excitotoxic antagonist, kynurenic acid 
(GBSSK). To prepare GBSS, we added the following in solution in the following 
order from 10x stocks to obtain the final concentrations per liter: 8 g NaCl, 0.37 g 
KCl, 0.12 g Na2HPO4, 0.22 g CaCl2 ∙ 2H2O, 0.09 g KH2PO4, 0.07 g MgSO4 ∙ 7H2O, 
0.210 g MgCl2 ∙ 6H2O, 0.227 g NaHCO3. The compression lip located in the cutting 
chamber helps stabilize the brain specimen while obtaining 300-μm thick slices 
with the blade set at a medium vibration speed. Slices were collected at the 
specimen tube’s outlet and transferred to another plate with fresh prefilled GBSSK. 
The slices were washed twice in 6 ml ice-cold GBSSK, transferred to Millicell 6-
well plate inserts (3-5 slices per insert) and were incubated in a humidified 
atmosphere of 5% CO2 at 37 °C. Culture media was exchanged every other day for 
10-14 days with fresh media. Slice cultures were harvested post treatments with 
pyridaben or rotenone (20 nM for 24 hrs) by washing twice in 2 ml of ice-cold 
PBS. The histone extraction was performed as mentioned in the below method 
section on Histone Extraction. Finally the histones extracts were analyzed for 
histones acetylation levels expression using Western blot analysis.  
Mitopark Animals.  24-weeks-old MitoPark and corresponding littermate age match 
control (C57BL/6) mice were housed under standard conditions: constant temperature 
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(22±1 °C), humidity (relative, 30%), and a 12 h light/dark cycle. Mice were given free 
access to food and water. Animal care and protocol procedures were approved and 
supervised by the Institutional Animal Care and Use Committee (IACUC) at Iowa 
State University (Ames, IA). At the age of 24 weeks old, the mice were sacrificed and 
the substantia nigra brain tissue was collected for further biochemical experiments 
verifying histone acetylation expression analysis and one set of animals were 
sacrificed by perfusion method for immuno-histochemistry staining study. The 
mitopark and littermate control animals were handled and maintained as previously 
described by (Ay et al., 2017; Ekstrand et al., 2007; Gordon et al., 2016; Langley et 
al., 2017).   
Human Post-mortem PD brain samples. We obtained frozen substantia nigra tissue 
samples and cryostat sections from the brains of confirmed post-mortem human PD 
patients and age-matched neurologically normal individuals from the brain banks at 
the Miller School of Medicine, University of Miami, FL and the Banner Sun Health 
Research Institute, AZ. For western blot experiments, the total histones extracts were 
prepared as mentioned below in the method section of histone extraction. Substantia 
nigra tissue sections were fixed with 4% paraformaldehyde (PFA) solution (in 0.1 M 
phosphate-buffered saline, pH 7.4). Cryostat sections were used for immuno-
histochemistry experiments as described below. All human post-mortem samples 
were procured, stored and distributed according to the applicable regulations and 
guidelines involving consent, protection of human subjects and donor anonymity. 
Since the post-mortem human brain tissues were obtained from approved national 
brain banks, Institutional Review Board (IRB) approval from Iowa State University 
was not required.  
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Histone Extraction. The total histones were extracted as previously described by 
(Song et al., 2011). After treatment, cells were collected by scraping and were washed 
thrice with ice-cold PBS. Whole histones were extracted with the PIERCE “NE-PER” 
kit and eventually dissolved into 0.2N HCl. Briefly, cell pellets were incubated with 
CERI buffer (supplied by NE-PER kit) plus 0.5% Triton X-100 for 10 min. Nuclei 
were collected by centrifugation at 2000 × g for 5 min. Then the pellet was 
resuspended in 0.2 N HCl and incubated on a rotator for 3 h at 4°C. After centrifuging 
for 10 min at maximum speed in a microfuge, supernatant was collected for further 
analysis and the histones protein concentrations was determined using the BCA 
method of estimation following the manufacturer's instructions. Exactly similar 
method of histones extraction was carried for the mid-brain organotypic slice culture 
samples, animal substantia nigra tissues from the mitopark and human post-mortem 
control and parkinson's disease substantia nigra tissues.  
Western blot Analysis.  N27 dopaminergic neuronal cells were seeded (5 x 10
6 
cells 
per T175 cell culture flask). Post treatment of N27 cells with pyridaben or rotenone (1 
- 10 μM ) for 3 hr in a T175 flasks, the whole cell lysates for western blotting analysis 
were prepared using modified RIPA buffer, as previously described (Kanthasamy et 
al., 2006b; Latchoumycandane et al., 2011b). The total global histones extracts lysates 
were prepared as mentioned above. Equal amounts of protein (35 μg) in the whole cell 
lysates or histones proteins (20 μg) fractions were loaded for each sample and 
separated on using 10-15% SDS-PAGE gels. Proteins were then transferred to a 
nitrocellulose membrane (BioRad) for immunoblotting and blocked using a blocking 
buffer specifically formulated for fluorescent Western blotting (Rockland 
Immunochemicals). The nitrocellulose membrane was subjected to primary antibodies 
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overnight incubation, followed by secondary IR dye-800 conjugated anti-rabbit dye or 
Alexa Flour 680 conjugated anti-mouse IgG for 1 h at room temperature.   Primary 
antibodies against anti-acetyl lysine, anti AcH3(K23) and anti AcH4 (K5) and HP-1α 
diluted in blocking buffer solution were then added to the membranes and incubated 
overnight at 4°C. After another four to five washes, an infrared dye-tagged secondary 
antibody was added for 1 h. β-Actin (for whole cell lysate) or Anti-H3 (for histones 
fractions) was used as corresponding loading control. Western blot images were 
captured with Odyssey IR Imaging system (LICOR) and data were analyzed using 
Odyssey 3.0 software.  
 Immunocyto-chemistry analysis. Immunofluorescence studies in N27 dopaminergic 
neuronal cells were performed according to previously published protocols with some 
modifications (Gordon et al., 2011; Gordon et al., 2016). Briefly, 4 x 10
4
  N27 cells 
were grown on poly-D-lysine-coated coverslips and treated the following day. At the 
end of treatment with pyridaben or rotenone or dieldrin, cells were fixed with 4% 
PFA, washed in PBS and incubated in blocking buffer (PBS containing 2% BSA, 
0.5% Triton X-100 and 0.05% Tween 20) for 1 h at room temperature. The coverslips 
were then incubated overnight at 4°C with primary antibodies against AcH3(K24) and 
AcH4(K5), diluted in PBS containing 2% BSA. Samples were then washed several 
times in PBS and incubated with corresponding Alexa 488 and 555 dye-conjugated 
secondary antibodies. The nuclei were labeled with Hoechst 44432 stain (10 μg/mL) 
and coverslips were mounted with Fluoromount medium (Sigma Aldrich) on glass 
slides for visualization using the Leica DMIRE2 confocal microscope. 
Immuno-histochemistry analysis. Immunohisto-chemistry (IHC) studies were 
performed on sections from the substantia nigra midbrain region as described 
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previously (Ghosh et al., 2013; Gordon et al., 2016; Jin et al., 2011b; Sarkar et al., 
2017). Briefly, mice were anesthetized with a mixture of 100 mg/kg ketamine and 10 
mg/kg xylazine and then perfused transcardially with freshly prepared 4% 
paraformaldehyde (PFA) and PBS solution. Extracted brains were post-fixed in 4% 
PFA for 48 h and 30-µm sections were cut using a freezing microtome (Leica 
Microsystems). Antigen retrieval was performed in citrate buffer (10 mM sodium 
citrate, pH 8.5) for 30 min at 90°C. Sections were then washed several times in PBS 
and blocked with PBS containing 2% BSA, 0.2% Triton X-100 and 0.05% Tween 20 
for 1 h at room temperature. Sections were then incubated with primary antibodies 
overnight at 4°C and washed 7 times in PBS on a Belly Dancer Shaker (SPI supplies). 
The sections were incubated with Alexa 488 and 555 dye-conjugated secondary 
antibodies for 60-75 min at room temperature and their cell nuclei were stained with 
Hoechst dye. Sections were mounted on slides using Prolong antifade gold mounting 
medium (Invitrogen) or using with Fluoromount medium (Sigma Aldrich) according 
to the manufacturers’s instructions. Samples were visualized finally visualized and 
analyzed using Leica DMIRE2 confocal microscope. An exact similar method of 
staining and imaging technique was used for the human post-mortem PD brain 
samples. For the slice culture samples similar staining strategic method was 
employed, but with mild modifications in the methodology and experimental 
conditions as previously described in detail and illustrated by (Aguzzi and Falsig, 
2012; Harischandra et al., 2014b; Kondru et al., 2017; Sonati et al., 2013).  
Confocal imaging and Z stack image capturing and 3D reconstruction. Confocal 
imaging was performed at the Iowa State University Microscopy Facility, using a 
Leica DMIRE2 confocal microscope with the 63X oil objectives and Leica Confocal 
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Software. For the cells, one optical series of Z-stack covered 5-7 optical slices of 0.5 
µm thickness each. For slices culture tissue sections, animals and human sections of 
midbrain region we had employed 12-15 optical slices of 0.5 µm thickness each. The 
IMARIS software 10.0 was used to analyze the Z stack images. The surface 
reconstruction wizard in the IMARIS software version 10.0 was used to make 3-D 
reconstructed images for seeing architectural changes and picture definition. Further 
details to the images marking topographic alterations were reconstructed using 
modules in IMARIS such as Normal Shading, Maximum Intensity Projections (MIP) 
and 3D surface developer.  
Measurement of mitochondrial oxygen consumption by Seahorse XFe24 
Bioanalyzer. Mitochondrial oxygen consumption was measured using a Seahorse 
XFe24 Extracellular Flux analyzer (Agilent Technologies (Santa Clara, CA) as 
described previously in detail by (Charli et al., 2015; Dranka et al., 2011; Dranka et 
al., 2012). The Seahorse XFe24 Extracellular Flux analyzer is a sensitive, high-
throughput instrument that makes real-time measurements of respiration rates of cells 
with or without oxidative stress. In our studies, we employed two different strategies 
to monitor the effects of Control CRISPR/Cas9 and TFAM CRISPR/Cas9 stable 
knockdown N27 cells on oxygen consumption rates (OCR). The experimental strategy 
was to analyze the mitochondrial bioenergetics of Control CRISPR/Cas9 and TFAM 
CRISPR/Cas9 stable knockdown N27 cells by measuring the OCR and ECAR as a 
function of time. The cells were seeded at a density of 3 x 10
4 
per well into a V7-PS 
culture plate and incubated overnight in 5% CO2 at 37°C and the Seahorse Flux Pak 
cartridge was equilibrated using the equilibration buffer overnight at 37°C at 0% CO2. 
Following this process, the next day, the V7-PS culture plate cover was replaced with 
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the Flux Pak cartridge with corresponding injection port loaded with the mito-stressor 
agents oligomycin (1 µg/ml). Once the mito-stressor was loaded in the corresponding 
position in the cartridge, the cell plate was introduced into the Seahorse analyzer 
covered with the Flux Pak cartridge. The analyzer was then programmed to measure 
the basal OCR and ECAR readouts in 3 specified time intervals before progressing to 
inject the mito-stressors. These stressor was injected after every three cycles of 
measuring OCR (Fig. 7A). Further calculations of basal acidification rate, glycolysis 
rate, basal respiration rate and ATP-linked respiration were performed as described 
(Charli et al., 2015; Dranka et al., 2011; Dranka et al., 2012; Langley et al., 2017).  
Statistical data analysis. All in vitro data were determined from at least 2-3 
biologically independent experiments, each done with a minimum of three biological 
replicates. Data analysis was performed using Prism 4.0 software (GraphPad 
Software, San Diego, CA). Data were analyzed using one-way ANOVA with the 
Tukey-Kramer post-test for comparing all treatment groups with that of the control. 
Differences with p < 0.05 were considered statistically significant.  
Results 
Pyridaben (3µM) induce dose and time – dependent histone H3 and H4 
hyperacetylation in N27 dopaminergic cells 
In our previous studies we have shown that exposure of N27 to pesticide compounds 
such as dieldrin and paraquat, induces hyperacetylation of histones H3 and H4 (Song 
et al., 2010; Song et al., 2011). Also, we have shown previously that pyridaben is a 
potent inhibitor of mitochondrial dynamics, functional and structural attributes when 
exposed to dopaminergic neuronal cells in culture (Charli et al., 2015).  Therefore in 
our present study we have demonstrated the effect of pyridaben in modulating 
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hyperacetylation of H3 and H4 in the N27 cells. Here we had treated the N27 cells 
with 1-10 µM of pyridaben for 1-6 hr. Post the treatment, the cells were scraped and 
collected, and the histones fractions were extracted for further studies using western 
blot analysis. It was observed visually and using the statistical densitometeric analysis 
that pyridaben (3 µM ) and at a 3 hr time point demonstrated promising potential in 
trigger hyperacetylation of H3 and H4 in the N27 cells (Fig. 1A and B). Adding the 
hyperacetylation of H3 and H4 was also noteworthily increased in a dose-dependent 
manner post exposure of pyridaben. Treatment of N27 cells with dieldrin (100 µM) 
for 25 minutes, was used as a positive control, in order to compare the effect of 
pyridaben to trigger histones acetylation.     
Significant increase in Ac-H3(K23) and Ac-H4(K5) expression and altered 
nuclear morphology following pyridaben and rotenone treatments in N27 cells 
 To enable better understanding of the process of histones H3 and H4 
acetylation, we had depicted this phenomena using immufluorescence staining and 
confocal microscopy. Previously we had shown dieldrin induces acetylation of H3 
and H4 in the N27 cells post its exposure and hence in this dieldrin treatment was 
used as a positive control for comparative purposes. The N27 cells were treated with 
pyridaben and rotenone using a dose and time paradigm as mentioned above in the 
methods section. Prior to these treatments it was observed that there was siginificant 
increase in Ac-H3 (K23) and Ac-H4 (K5) expressions. This was visualized with the 
help of confocal microscopy and maximum intensity projection method of image 
representation. Further, these acquired images were quantified using ImageJ software 
and represented as line and 3D surface plots (Fig. 2A, B and C). Interestingly, one of 
the prominent observations using the confocal microscopy and IMARIS image 
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processing was the development of voids or architectural imperfections in the nucleus 
of the pyridaben and rotenone treated groups compared to the control. These 
morphological anomalies were depicted using a tool called Surface Shading in the 
IMARIS software. This enables the representation of topographical changes on a cell 
by aligning all the Z-Stack of images captured. These nuclear structural changes were 
surmised to be chromatin remodeling or fragmentation mark post exposure of 
pyridaben or rotenone to the N27 dopaminergic neuronal cells. Similar changes in 
nuclear structure and up-regulation of Ac-H3 (K23) and Ac-H4 (K5) were also 
observed after treatment with dieldrin (Fig. 2A, B and C).  
TFAM knockdown CRISPR/Cas9 N27 exhibit reduced respiration rate and 
acidification rate and induces histones  H3 and H4 acetylation 
 The TFAM knockdown CRISPR/Cas9 N27 cells is a transgenic invitro model of 
mitochondrial impairment, which we had created using the CRISPR/Cas9 system. 
Previously, we had shown and described that TFAM knockdown CRISPR/Cas9 N27 
cells demonstrate an impaired system of mitochondrial respiration and structural 
damage (Langley et al., 2017). Similarly reiterating our findings, we have 
demonstrated that the TFAM knockdown CRISPS/Cas9 N27 cells express a reduced 
oxygen consumption rate depicting mitochondrial respiration deficit and loss in extra 
cellular acidification rate which represented the reduction in cellular metabolism 
compared to the Control CRISPR/Cas9 N27 cells (Fig. 3A). Further calculations from 
the Seahorse XFe24 bioanalyzer showed that there was also loss in ATP-Linked 
respiration and Glycolysis rates in the TFAM knockdown CRISPS/Cas9s compared to 
the Control CRISPS/Cas9 N27 cells (Fig. 3A). Since the TFAM knockdown 
CRISPR/Cas9 N27 cells are potentially exhibiting their mitochondria dysfunctional 
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qualities, we further tested this model for the expression of H3 and H4 acetylation. 
Our western blot analysis revealed a very fresh and new result that demonstrates the 
inherent quality of TFAM knockdown CRISPR/Cas9 N27 cells to express increased 
levels of H3 and H4 hyperacetylation comapred to the Control CRISPR/Cas9 N27 
cells (Fig. 3B). This results suggests that mitochondrial dysfunction mediated stress 
might be a critical factor in triggering acetylation of H3 and H4 in the dopaminergic 
neuronal cells.  
Pyridaben and rotenone exposure mediates loss of heterochormatin marker HP-
1α in the nucleus of N27 cells 
  HP-1α (heterochromatin protein-1α) functions primarily as a regulator of the 
heterochromatin structure and is constitutively conserved in almost all eukaryotic 
cells (Dialynas et al., 2007; Singh et al., 1991). The HP family of protein usually are 
associated with the chromatin through the histones H3 (trimethylated at lysine 9) and 
functions as either a gene repressor or activator depending on the stress conditions and 
triggering causatives (de Wit et al., 2007; Eissenberg and Elgin, 2000; Hediger and 
Gasser, 2006). Considering these concrete evidences about HP-1α and it's important 
role in functioning as a marker of heterochromatin, we had tested to check the protein 
expression levels of HP-1α in the N27 cells post pyridaben or rotenone exposure. The 
N27 cells were firstly treated with pyridaben or rotenone for varying time interval 
points (1-3 hrs) and following this exposure the cells were collected and processed for 
further analysis using western blotting. It was observed that the protein level 
expression of HP-1α decreased significantly in a time-dependent manner (1-3 hrs) 
post the pyridaben or rotenone exposure on the N27 dopaminergic neuronal cells (Fig. 
4 A and B). This results suggests that there might be possible propensity for the 
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nucleus of the dopaminergic neuronal cells to undergo a conformational change or 
structural alteration prior to treatment with pyridaben or rotenone, marked by a loss in 
HP-1α levels and as seen above using microscopic evidences.  
Augmented HAT activity post pyridaben rotenone and TFAM knock down in 
the N27 cells 
 HATs are histone acteyltransferases that primarily function by modifying 
(promoting acetylation) chromatin histones and also have a pivotal role in modulation 
of transcription programs. HATs have also known to acetylate non-histone proteins in 
different cell systems and are divided into several sub-classes (Legube and Trouche, 
2003). In our study HATs may play a promising role in accentuating the 
hyperacetylation of H3 and H4 post the mitochondrial inhibiting pesticides exposure. 
In order to test this surmise, we had treated the N27 cells with pyridaben and rotenone 
for 3 hrs and subjected the treated cells to measuring the HAT activity using the 
methodology and kit as mentioned in the methods section. We had also included the 
TFAM CRIPSR/Cas9 knockdown N27 cells for this spectro-photometric analysis and 
readout of measuring HAT activity. It was observed that the pyridaben, rotenone 
treated N27 cells have demonstrated quantitatively higher levels of H3 and H4 
directed HAT activity. Similarily, TFAM CRIPSR/Cas9 knockdown N27 cells also 
shows an inherent higher expression of HAT activity. This HAT activity 
augmentation data implies that the mitochondrial stress and dysfunction induced by 
the pesticides exposure or by TFAM knockdown triggers HAT activity in the N27 
cells compared to the corresponding controls.   
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HAT inhibitor anacardic acid attenuates pyridaben - and rotenone induced 
dopaminergic neurotoxicity 
 In the previous set of experiment we had shown the functional importance of 
HAT activity in triggering acetylation of histones H3 and H4, here we propounded to 
check for the functional intervention and role of HAT inhibitor to attenuate pyridaben 
or rotenone induced dopaminergic neuronal toxicities. Firstly, the cytoxicity leading 
to apoptotic cell death was measured as a function of caspase-3 activity post the 
pesticides treatment in the N27 cells. Anacardic acid, a very well studied HAT 
inhibitor was pre-treated and co-treated along with pyridaben or rotenone as explained 
comprehensibly in the methods section. It was observed that anacardic acid was 
significantly attenuating the caspase-3 activity induced by pyridaben or rotenone (Fig. 
6A). Adding, another readout for neurotoxicity was performed as a function of DNA 
fragmentation quantification. Here too, anacardic acid proved to me a potent protector 
against pyridaben or rotenone induced neurotoxic cell death in the N27 dopaminergic 
neuronal cells (Fig. 6B). As a final point, the conformation of the caspase-3 activity 
and DNA fragmentation was reiterated and demonstrated using the SYTOX green dye 
that enables the measurement of cytotoxic cell death.  SYTOX green cytotoxicity 
assay shows that the anacardic acid pre- and co-treatment significantly ameliorated 
the toxicity induced by pyridaben or rotenone exposure in the N27 cells. This was also 
visualized and depicted as fluorescence images that showed fewer green fluorescence 
spots in the anacardic acid pretreated groups compared to the pesticides exposed 
groups (Fig. 6C). Adding on, anacardic acid at 8.5 μM dose was not toxic, thus making 
re-emphasizing the usage was toxicologically relevant. Cumulatively, anacardic acid 
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functioning as a HAT inhibitor demonstrated creditably significant protection against 
pyridaben or rotenone toxicity in the N27 dopaminergic neuronal cells.  
Organotypic slice culture of mouse midbrain demonstrates prominent increase 
in acetylation of H3 and H4 post pyridan and rotenone exposures 
 One of the impact creating tools that have been used in recent years for brain 
research is the organotypic slice culture.  This technique although exists since the 
1950s and 60s, started to attain traction in the past decade. Previously there have been 
many groups including us who have successfully employed this exvivo method for 
validating and proving hypotheses (Harischandra et al., 2014c; Humpel, 2015; Kondru 
et al., 2017; Testa et al., 2005; Ullrich and Humpel, 2009). We have employed the 
organotypic slice culture methodology in order to understand the expressional 
changes in histones H3 and H4 acetylation in the midbrain post exposure to 
mitochondrial inhibiting pesticides pyridaben or rotenone, translating the model 
system from invitro to exvivo. Here in our present study, we had prepared the 
organotypic slices (300 μm thickness) from the midbrain of 9-12 day old control mice 
pups as described in detail in the methods section above. These slices were treated 
with pyridaben or rotenone at a dose of 20 nM for 24 hrs. This resulting slices 
following treatment expressed note worthily increase in the levels of H3 and H4 
acetylation of histones, which was demonstrated using the western blotting analysis  
(Fig. 7A). Furthermore, we had also tested for the site specific acetylation of H3 and 
H4 at K23 and K5 respectively in the organotypic brain slice culture model, using 
immuno-fluorescence staining and confocal microscopy. The images captured by the 
confocal microscope in a maximum intensity projection configuration revealed, 
appreciable increase in the levels of acetylated H3 (K23) and H4 (K5). Interestingly, 
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the nuclear structure on a topographic perspective was visualized to be damage or 
altered in the brain slices post treatment with pyridaben or rotenone compared to the 
control (Fig. 7 B and C). The suggestive images were processed using IMARIS by 
developing 3D-surfaces of the nucleus and by the surface shading tools.  These 
mounting results with the mid-brain slice culture model illustrates a connection and 
similarity to our previous data with the immuno- fluorescence staining on the N27 
cells (Fig. 2 A and B) in terms of the increased levels of H3 and H4 acetylation and 
also the conspicuous nuclear structural and architectural alterations. The nuclear 
structure damage seems a promising marker that occurs visually appealing along with 
the accentuated H3 (K23) and H4 (K5) hyperacetylation in the dopaminergic neuronal 
cells. These results suggests and throws the spot-light on details towards the further 
connection between histones acetylation and chromatin damage or nuclear damage in 
the dopaminergic neuronal cells post exposure to mitochondrial complex-1 inhibiting 
pesticides pyridaben and rotenone.   
Progressive hyperacetylation of H3 and H4 in transgenic MITOPARK mouse 
model  
The MitoPark model has been recently developed as an animal model of PD 
by conditional inactivation of TFAM specifically in dopaminergic neurons (Ekstrand 
et al., 2007). MitoPark mouse recapitulates several aspects of human PD, such as 
adult-onset, progressive degeneration of dopaminergic neurons, protein inclusion in 
nigral tissues, and responsiveness to levodopa (Galter et al., 2010). Thus making the 
MitoPark mouse a very useful model for further studying the molecular mechanism 
underlying and functioning  as an important causative of the disease and also for 
testing potential neuroprotective agents/drugs for the treatment of PD. In our present 
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study the primary hypothesis overarches and encircles on mitochondrial dysfunction 
mediated histones H3 and H4 acetylation, hence testing this hypothesis using the 
mitochondrial defective mitopark transgenic mouse model would be a purposefully 
directed study. We have demonstrated progressive age (8 to 23 weeks ) dependent 
acetylation of histones H3 and H4 in substantia nigra of the mitopark mice (Fig. 8A). 
This data provided the well suited impetus for the study as the mitopark mouse is a 
progressive age dependent animal model portraying the motor and non-motor 
symptoms of the disease. It has been previously demonstrated by number studies that 
the mitopark mice at 24 weeks of age suffers from severe motor and non-motor 
behavioral and neurochemical deficits, along with significant loss of TH positive 
neurons in the substantia nigra region of the mid brain (Branch et al., 2016; Cong et 
al., 2016; Ekstrand et al., 2007; Langley et al., 2017). Thus we checked site specific 
acetylation of H3 and H4 in the 24 week old mitopark mice. These animals exhibited 
significant increase in the acetylation of H3 (K23) and H4 (K5) (Fig. 8B) compared to 
the 24 week littermate age match control. Further analysis and visualization of the TH 
neurons and H3 and H4 components of the nucleus in the 24 week mitopark and 
littermate controls were performed using immuno-fluorescence staining and confocal 
microscopy. The 3D reconstructed images were generated using the IMARIS software 
prior to acquisition of the Z-stack series images from the confocal microscopy and  
post immuno-fluorescence staining with TH and AcH3 (K23) or AcH4 (K5). These 
final set of images revealed possible nuclear relaxation and nucleoplasmic 
declustering in the mitopark mice compared to the corresponding age matched 
controls. These topographically viewed and reconstructed structures looked similar 
and in trend with our previous finding of pyridaben and rotenone treated organotypic 
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slice culture and in the pesticides treated N27 cells. Thus these data together strongly 
suggests the occurrence of the nuclear architectural changes accompanying the 
process of histone H3 and H4 acetylation triggered by mitochondrial inhibition and 
dysfunction in the dopaminergic neuronal cells.  
Hyperacetylation of H3 and H4 in the substantia nigra of postmortem  
Parkinson’s disease brains 
 Histone acetylation phenomena has been observed recently in various brain 
disorders involving noteworthy loss of neurons and dysfunction. Also, these 
epigenetic modifications correlates to potential molecular and cellular alterations in 
the cell system (Habibi et al., 2011; Kwok, 2010; Marques et al., 2011). Despite many 
studies in the past and upcoming studies , the importance of hyperacetylation of 
histones H3 and H4 in the dopmainergic neuronal cells and its role in pathogenesis of 
PD has not been very well understood till date. In this current study, we have directed 
our interests in unravelling this novel epigenetic process in the post mortem PD brain 
substantia nigra tissues. Firstly, using western blot analysis and comparing 11 
Control and 11 PD substantia nigra tissues (total of 22 samples), we have 
demonstrated significant hyperacetylation of histones H3 and H4 (Fig. 9A). This 
result implanted the impact of acetylation of histones H3 and H4 and propounded the 
importance of this particular epigenetic change in the apoptotic cell death of 
dopaminergic neurons. Additionally the immuno-histochemistry and confocal 
microscopy study of the sectioned control and PD substantia nigra region further 
revealed the up-regulation of acetylated H3(K23) and H4(K5) (Fig. 9B). Detailed 
additional microscopic analysis using IMARIS software creating 3D reconstructed 
images, we were able to demonstrate the nuclear declustering process in the PD brain 
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sections. These obtained results from the human post mortem brains follows similar 
trends with our previously tested data from mitopark mouse model, exvivo slice 
culture and pyridaben or rotenone treated N27 cells invitro model, in terms of up-
regulation of AcH3(K23), AcH3(K23) and nuclear structural changes.    
Discussion 
 The results of the present study addresses and provides novel evidences on 
mitochondria inhibiting pesticides induced histone hyperacetylation as a key 
neurotoxicological mechanism in environmentally-linked neurodegenerative 
processes of the dopaminergic neuronal cell system. We also show that there is 
conspicuous changes in the nuclear architecture or in other words nuclear declustering 
process that involves disturbing the chromatin structure, whose occurrence is 
accompanied along with the histone H3 and H4 acetylation.  
Chronic exposure to mitochondria-impairing neurotoxic pesticides is a major public 
health problem around the world and has been linked to many disease conditions 
including Parkinson’s disease. Despite the established link, the cellular and molecular 
mechanisms central to the role of mitochondria-impairing pesticide exposure in the 
pathogenesis of Parkinson’s disease remain unidentified. We primarily focus our 
study on the exposure and effects of rotenone or pyridaben leading histones H3 and 
H4 acetylation and enabling the progression of dopaminergic neuronal apoptotic cell 
death.   
 In the current study firstly, we start by identifying the appropriate dose and 
time at which pyridaben causes significant appreciable histones acetylation. N27 cells 
treated with pyridaben (1-10 µM) for 1-6 hrs, showed noteworthy levels of histones 
H3 and H4 acetylation at the 3 µM for 3 hrs (Fig. 1 A and B). Also, the 
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immunocytochemistry analysis using immuno-fluorescence staining and confocal 
microscopy, revealed the significant site specific up-regulation of acetylated H3 (K23) 
and H4(K5), observed in the N27 cells post pyridaben or rotenone exposure for 3 hrs 
(Fig. 2 A and B). These results were compared to the positive control group treated 
with dieldrin, which has been previously shown by us as a potent contributor of 
hyperacetylation of H3 and H4 in the dopaminergic neuronal cells (Song et al., 2010). 
Further processing of the acquired images using 3D reconstruction and surface 
shading technique using the IMARIS software, unearthed a serendipitous observation. 
N27 cells treated with the mitochondrial inhibiting pesticides pyridaben or rotenone, 
demonstrated a disturbance in their nuclear structures. These nucleus seem to be 
declustered which is a chromatin dysregulation phenomena. This data suggests that 
there is subsequent nuclear chromatin dysrgulation and declustering occurring in 
consensus to the hyperacetylation histones H3(K23) and H4 (K5) in the N27 cells 
prior to the exposure of pyridaben or rotenone. Similar type of declustering process 
was also studied in the H2B-GFP expressing mice, revealing that accumulation of 
H2BGFP causes dramatic changes in the nuclear architecture of pyramidal neurons, 
including chromocenter declustering and loss of peripheral heterochromatin. 
Further this process lead to transcriptional defects and behavioural abnormalities in 
the animal, contributed by alerations associated with serotonin (5-HT) dysfunction 
(Ito et al., 2014). Rotenone in many cases proven to be potent contributors of 
neurotoxicity leading to neurological symptoms and neuro-pathological diseases. For 
example, a case-control study based on self-reported exposure to rotenone in an East 
Texas population reported a >10-fold increase in PD risk (Dhillon et al., 2008). More 
recently, another study carefully examined a large population (110 PD cases and 358 
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controls) and found that rotenone exposure is associated with a 2.5 times greater risk 
of PD (Spivey, 2011; Tanner et al., 2011). Like rotenone, pyridaben is highly 
lipophilic and can thus easily cross the blood-brain barrier (BBB). Considering the 
link between complex I dysfunction and PD, pyridaben likely poses a disease risk, but 
the epidemiological evidence is lacking. We and others have demonstrated that 
exposure to micromolar concentrations of pyridaben induces significant neurotoxicity 
in cultured neuronal cells and midbrain organotypic slices (Charli et al., 2015; Sherer 
et al., 2007). Another study of pyridaben-treated C57BL mice found a strong 
correlations between pyridaben exposure and both DAergic neuron loss and increased 
αSyn immunoreactivity (Gollamudi et al., 2012). 
 We were focused on creating a transgenic invitro model that posses an 
inherently altered dynamics in mitochondrial function, health and structure. This 
model could also potentially serve as a tool for studying mitochondrial dysfunction 
and for screening neuroprotective compounds. Thus this made us create the TFAM 
CRISPR/cas9 knock down stable N27 cells. TFAM was our target protein mainly 
because it is involved in a plethora of mitochondrial function and maintenance. 
Mitochondrial transcription factor A also known as TFAM, is a nuclear-encoded 
mitochondrial protein that promotes the production of mitochondrially encoded genes 
by regulating the mtDNA and ATP production maintenance (Alvarez et al., 2008; 
Duchen, 2004). Recent studies also indicate that TFAM-mediated mtDNA regulation 
places a crucial role in PD (Gaweda-Walerych et al., 2010; Gaweda-Walerych and 
Zekanowski, 2013). Another important role of TFAM is its ability to be an important 
aspect during mitochondrial biogenesis. In general mitochondrial biogenesis is 
regulated by the TFAM and mtDNA interactions, which is modulated by the 
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expression and binding of TFAM (Kanki et al., 2004; Picca and Lezza, 2015). It has 
been well noted and understood that mitochondrial biogenesis is down-regulated 
during the process of complex 1 inhibition driven PD (Thomas et al., 2012). We have 
previously shown that the TFAM CRISPR/cas9 knock down N27 cells exhibited a 
lowered mitochondrial function and significant mitochondria structural damage 
(Langley et al., 2017). In our present study we have shown using the seahorse XFe24 
bioanalyzer that TFAM CRISPR/cas9 knock down N27 cells compared to the Control 
CRISPR/cas9 N27 cells inherently possessed an inhibited mitochondrial oxygen 
consumption rate, ATP-Linked respiration, glycolysis rate and basal acidification 
rates (Fig. 3A). Thereby demonstrates the incompetence of the TFAM CRISPR/cas9 
knock down N27 cells to function as a regular control due to its defective 
mitochondrial function and altered respirational dynamics. Interestingly, we had 
observed that the TFAM CRISPR/cas9 knock down N27 cells also exhibits significant 
basal inherent histones H3 and H4 acetylation compared to the control CRISPR/cas9 
N27 cells (Fig. 3B). Another interesting finding by using our N27 cells exposed to 
pyridaben and rotenone, was that a time dependent significant decrease in the 
hetereochromatin marker, HP-1α (Fig. 4 A and B). HP-1α is a very well known 
marker of heterchromatin that primarily functions as a vital component involved in 
the formation of transcriptionally inactive heterochromatin. In a precise context, HP-
1α plays a role in chromatin packaging and gene regulation (Norwood et al., 2004). 
Hence our data suggesting time dependent reduction in the expression of HP-1α post 
pyridaben or rotenone treatments in the N27 cells, suggests a probable loss in the 
integrity of the heterochromatin structure, mediated through the acetylation of H3 and 
H4. 
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 We have also shown that the HAT activity has a significant effect of increase 
in the N27 cells post the pesticides exposure and in the TFAM CRISPR/Cas9 
knockdown N27 cells (Fig. 5). This rightfully suggests the pronounced impact of 
HAT activity leading to the acetylation of histones H3 and H4. Although we have not 
looked into the type of HATs that get regulated exclusively, the global HAT activity 
increase is definitely a good start in this study. We and many other groups have 
shown the potential role of anacardic acid and its function as a HAT inhibitor in a 
number of studies involving various cell types and disease models (Song et al., 2011; 
Sun et al., 2006; Sung et al., 2008; Yasutake et al., 2013). Here in our current study, 
we pre-treated and co-treated anacardic acid (8.5 μM) along with pyridaben or 
rotenone treatments in the N27 cells, to understand the protective role of anacardic 
acid against the neurotoxic effects of the two pesticides. Anacardic acid shows 
significant protection against the pesticides toxicity which was measured as a readout 
interns of caspase-3 activity, DNA fragmentation and SYTOX dye (Fig. 6 A, B and 
C).   
 Organotypic slice culture an exvivo study model was performed and was used 
as a  translational model from the invitro N27 studies. In recent years, we and other 
research groups have demonstrated neurotoxic molecular studies by employing the 
slice culture technique. In this present study the midbrain slice were cultured in media 
for 10-14 days and finally were treated with pyridaben or rotenone (20 nM) for 24 hrs. 
Western blot analysis showed that there was appreciable histones acetylation in the 
pesticides treated slices compared to the control slices (Fig. 7 A). The immuno-
histochemistry by fluorescence staining and confocal microscopy, vividly 
demonstrated the acetylation of H3(K23) and H4 (K5) in the pyridaben and rotenone 
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treated slices. Adding on, the IMARIS software generated 3D reconstructed images 
that depicts the nuclear declustering structures post pesticides treatment (Fig. 7 B and 
C). This data re-illustrates and confirms our findings from the nuclear imaging studies 
using the N27 cells.  
 Another highlight finding of this study is the mitopark mice age dependent 
increase in histones acetylation and also the acetylation of H3(K23) and H4 (K5) in 
the 24 week compared to the corresponding age match controls. In recent years, 
MitoPark animal model of PD, in which the TFAM is selectively removed in 
midbrain dopamine neurons has been developed for many studies especially involving 
neuroprotective drug discovery. This animal model recapitulates many of the hallmark 
features of PD, such as adult-onset progressive dopaminergic neurodegeneration, 
protein aggregation in nigral tissues, L-dopa responsive motor deficits and disease 
symptoms in an age progressive manner (Branch et al., 2016; Cong et al., 2016; 
Ekstrand and Galter, 2009; Ekstrand et al., 2007; Langley et al., 2017). We observed 
that in the substantia nigra region of the mitopark mice starting from an age of 8 
weeks and until 24 weeks, there was increased hyperacetylation of histones H3 and 
H4 in an age progressive manner. Also the 24 week mitopark mice also showed 
significant H3(K23) and H4 (K5) acetylation compared to the age match littermate 
controls (Fig. 8 A and B). Further analysis immunohistochemical analysis and 
confocal microscopy also demonstrated the hyperacetylation of H3 (K23) and H4 
(K5) in the 24 week old mitopark mice. Also, the alterations in the nuclear 
arhcitecture seen as declustered structures were also distinctly observed in the 24 
week old mitoparks (Fig. 8 C), suggesting that a mitochondrial defective animal 
model can promote acetylation of histones H3 and H4.  
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 Finally the study results were confirmed by analyzing human post mortem 
substantia nigra brain tissues. We had employed the use of 11 controls and 11 PD 
brain tissue samples for this study. We identified using western blotting and immuno-
histochemical analysis that the PD brains had significant increase in H3 and H4 
acetylation compared to the control patients brains (Fig. 9A and B). IHC studies also 
revealed the site specific hyperacetylation of H3(K23) and H4 (K5). Moreover, close 
obervation using confocal microscopy and IMARIS image 3D reconstruction, we 
were also able to unanimously commend on the formation of nuclear declustered 
structures in PD substantia nigra brains sections. This completely lies in trend with 
our above underlined findings in invitro, exvivo and invivo models of PD, suggesting 
the creditability of the occurrence of the nuclear structural alterations driven by the 
acetylation of histones in the dopaminergic neuronal cells.   
 In summary, the above findings obtained from neurotoxicity models of PD 
suggests that histone hyperacetylation is a key epigenetic mechanism in the nigral 
dopaminergic neruonal cells following pyridaben or rotenone-induced mitochondrial 
neurotoxicity. Overall, believe that further systematic characterization of specific 
histones acetylation sites and HAT regulators and identification of dysregulated genes 
in response to pesticides-induced histone modification in animal models will 
undoubtedly provide new insights into the molecular mechanism associated with 
environmentally-linked PD.  
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Figure 1: Pyridaben induce dose and time – dependent histone H3 and H4 
hyperacetylation in N27 dopaminergic cells 
(A) Dose dependent histones H3 and H4 hyperacetylation - N27 cells were treated 
with pyridaben (1-10 µM) for 3 hr and histones extracted lysates and subjected to 
Western blot analysis. Representative immunoblots of anti-acety lysine as shown 
above in section A. (B) Time dependent histones H3 and H4 hyperacetylation - N27 
cells were treated with pyridaben (3 µM) for 1-6 hr and histones extracted lysates and 
subjected to Western blot analysis. Representative immunoblots of anti-acety lysine as 
shown above in section B. Anti-H3 was used as a loading control in sections A and B. 
Dieldrin (100µM-25 mins) was used as the assay positive control for sections A and 
B. Data shown represent mean ± SEM from two independent experiments performed 
in triplicate (*p<0.05 and **p<0.01). 
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Figure 2: Immunocytochemistry shows increased Ac-H3(K23) and Ac-H4(K5) 
immunoreactivty and altered nuclear morphology following pyridaben and 
rotenone treatments in N27 cells 
N27 cells were treated with pyridaben (3 µM) or rotenone (1 µM) for 3 hr. (A) 
Acetylation of H3(K23) fluorescently stained for AcH3(K23) (green) and Hoechst 
(blue). (B) Acetylation of H4(K5) fluorescently stained for AcH4(K5) (green) and 
Hoechst (blue). (C) 3D surface plots representing the increase in hyperacetylation. 
The z-stack images were captured on using a 63X oil immersion lens of the Leica 
Confocal Microscopy system and the processing of images were performed using 
IMARIS 10.0 software. Dieldrin (100µM-25 mins) was used as the assay positive 
control. Data shown represent mean ± SEM from three independent experiments 
performed in triplicate (***p<0.001). 
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Figure 3 : TFAM knockdown CRISPS/Cas9 N27 cells demonstrates an impaired 
mitochondria and induces histones acetylation 
(A) A bioenergetic scheme of the Seahorse XFe24 Bioanalyzer illustrating the 
injection method employed for comparing the mitochondrial dynamic difference 
between Control and TFAM knockdown CRISPR/Cas9 N27 cells. Mitochondrial 
dynamics were measured using one-stage injection of mito-stressors. Injected 1 µg/ml 
oligomycin and the analyzer continuously measures OCR and ECAR. (A) Different 
parameters like basal respiration and  ATP-Linked respiration, basal acidification 
rates and glycolysis rates were estimated from the output OCR and ECAR values 
respectively after completion. Data shown represent mean ± SEM from two 
independent experiments performed in quadruplicate (**p < 0.01 and ***p<0.001). 
(B) Histones lysates were extracted from Control and TFAM knockdown 
CRISPR/Cas9 N27 cells and were subjected to Western blot analysis. Representative 
immunoblots of anti-acety lysine as shown above in section B. Anti-H3 was used as a 
loading control in section B. Data shown represent mean ± SEM from three 
independent experiments performed in triplicate (**p<0.01). 
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Figure 4 : Pyridaben and rotenone exposure mediate loss of heterochormatin 
marker HP-1α in the N27 cells 
N27 cells were treated with (A) pyridaben (3 µM) or (B) rotenone (1 µM) for 1-3 hr 
and cell lysates were prepared and subjected to Western blot analysis. Representative 
immunoblots of HP-1α and β-Actin was used as a loading control for all the western 
blot analysis. Data shown represent mean ± SEM from three independent experiments 
performed in triplicate (**p<0.01 and ***p<0.001). 
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Figure 5 : Pyridaben or rotenone treatment and TFAM knockdown augment 
HAT activity in the dopaminergic neuronal cells 
Pyridaben (3 µM for 3 hr) or rotenone (1 µM for 3 hr) were treated to the N27 cells 
and  TFAM knockdown CRISPR/Cas9 N27 cells, were lysed and the assay was run in 
accordance to the HAT Assay kit's protocol and manufacturer's instructions from 
Millipore (Billerica, MA). The resulting HAT activity was calculated and presented as 
percentage of Control.  Data shown represent mean ± SEM from two independent 
experiments performed in quadruplicate (*p<0.05). 
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Figure 6 : HAT inhibitor anacardic acid attenuates pyridaben - and rotenone 
induced dopaminergic neurotoxicity 
N27 cells were treated with pyridaben (3 µM for 3 hr) or rotenone (1 µM for 3 
hr).Along with the treated anacardic acid was pre-treated (1 hr) and co-treated (8.5 
µM for 3 hr) with the pesticides treatment. (A) Cells were collected and assayed for 
caspase-3 activity using the Ac-DEVD-AMC caspase-3 substrate. (B) Cells were 
collected post treatments and  then assayed for DNA fragmentation using a 
quantitative ELISA technique. (C) Cytoxicity post treatments was measured using  
SYTOX Green assay. Representative SYTOX Green staining images are shown. The 
resulting cytotoxicity parameters correspondingly were calculated and presented as 
percentage of Control. Data shown represent mean ± SEM from three independent 
experiments performed in quadruplicate (*p<0.05 and **p<0.01). 
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Figure 7 : Acetylation of histones post treatment with pyridaben and rotenone in 
the organotypic slice culture of midbrain 
The organotypic slices were sectioned (300 µm thickness) and were maintained for 
10-14 days  and were treated with pyridaben or rotenone (20 nM for 24 hr). (A) 
Histones lysates were extracted and subjected to Western blot analysis. Representative 
immunoblots of anti-acetyl lysine as shown in section A. Anti-H3 was used as a 
loading control. (B-C) Post treatments the slices were fixed and processed for 
immuno-histochemistry analysis and microscopy.(B) Acetylation of H3(K23) 
fluorescently stained for AcH3(K23) (green) and Hoechst (blue). (C) Acetylation of 
H4(K5) fluorescently stained for AcH4(K5) (green) and Hoechst (blue).  The z-stack 
images were captured on using a 63X oil immersion lens of the Leica Confocal 
Microscopy system and the processing of images were performed using IMARIS 10.0 
software. Data shown represent mean ± SEM from two independent experiments 
performed in quadruplicate (***p<0.001). 
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Figure 8 : Age dependent progress of hyperacetylation of H3 and H4 in 
transgenic mitopark mouse. (A) Mitopark mice of age 8-24 weeks were euthanized 
and the substantia nigra tissues were dissected for biochemical analysis. Histones 
lysates were prepared from the substantia nigra tissues and subjected to Western blot 
analysis. Representative immunoblots of anti-acetyl lysine as shown in section A. 
Anti-H3 was used as a loading control. (B) 24 week mitopark and littermate control 
mice were euthanized and the substantia nigra tissues were dissected for biochemical 
analysis. Histones lysates were prepared from the substantia nigra tissues and 
subjected to Western blot analysis. Representative immunoblots of AcH3(K23) or 
AcH4(K5) as shown in section B. Anti-H3 was used as a loading control. (C) 24 week 
mitopark and littermate control mice were euthanized and the substantia nigra tissues 
were dissected, fixed and were sectioned (30 µm) for immunohistochemical staining. 
The fluorescent staining was performed for AcH3(K23) or AcH4(K5) (green) and 
anti-TH (red). The z-stack images were captured on using a 63X oil immersion lens of 
the Leica Confocal Microscopy system and the processing of images were performed 
using IMARIS 10.0 software (Images depicted in maximum intensity projection and 
normal shading formats one below the other respectively). Data shown represent 
mean ± SEM from animals four individual animals in total for each group (**p<0.01).  
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Figure 9 : H3 and H4 hyperacetylation in the substantia nigra of postmortem PD 
brains 
(A) Substantia nigra of postmortem control and PD brain tissues were obtained from 
the brain bank at Miller School of Medicine, University of Miami, FL.  Histones 
lysates were extracted from these tissues and subjected to Western blot analysis. 
Representative immunoblots of anti-acetyl lysine as shown in section A. Anti-H3 was 
used as a loading control. (B) Sections of Substantia nigra from postmortem control 
and PD brains were obtained from the brain bank at Banner Sun Health Research 
Institute, AZ. The fluorescent staining was performed for AcH3(K23) or AcH4(K5) 
(green) and anti-TH (red). The z-stack images were captured on using a 63X oil 
immersion lens of the Leica Confocal Microscopy system and the processing of 
images were performed using IMARIS 10.0 software (Images depicted in maximum 
intensity projection and normal shading formats one below the other respectively). 
Data shown represent mean ± SEM from 11 control and 11 PD individual humans 
post mortem in total for each group (*p<0.05). 
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Figure 10 : A schematic illustrating the effect of mitochondrial inhibition and 
dysfunction mediated H3 and H4 acetylation and nuclear declustering and 
architectural loss leading to DNA fragmentation and apoptotuc cell death. Drawing 
was created by A.Charli using biomedical PowerPoint toolkit from Motifolio. 
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CHAPTER V: GENERAL CONCLUSIONS 
 This section presents an detailed overview of the results and findings of this 
dissertation, with a exclusive emphasis and spotlight on overall findings regarding the 
functional role mitochondrial complex I inhibiting pesticides in its potential in 
triggering mechanistic epigenetic alterations  and pro-apoptotic kinase signalling 
action that possess potential influences in development of pathology and symptoms of 
Parkinson’s disease. The major findings of each research chapter included in this 
dissertation are covered in the discussion section of the relevant chapter. 
Alterations of mitochondrial dynamics in the dopaminergic neurons post 
exposure to mitochondrial complex i inhibiting pesticides.  
 Previous studies in the past decade have shown the effect of mitochondrial 
complex I inhibiting pesticides such as MPTP and rotenone in triggering 
mitochondrial dysfunction in dopamingeric neurons and their association with PD 
(Betarbet and Greenamyre, 2004; Choi et al., 2011; Greenamyre et al., 2001; 
Przedborski and Jackson-Lewis, 1998; Przedborski and Vila, 2003). In the present 
study, we sought to analyze the toxicological effects of two newly classified 
mitochondrial complex I inhibitors, tebufenpyrad and pyridaben on the dopaminergic 
neuronal cells with respect to the alterations and changes in mitochondrial function 
and structural dynamics. Pyridaben accidental off-target exposure has been recently 
reported , causing neurological and respiratory disorders in the farmers in the field 
during this exposure (Calvert et al., 2015). But than this, there have not been major 
studies to understand the effects of exposure to tebufenpyrad and pyridaben. Another 
special interest of ours with tebufenpyrad and pyridaben specifically is because of 
their primary functional use as a greenhouse pesticides. This makes the exposure rates 
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and routes to the workers in the greenhouse a lot higher and further increases the rate 
of incessant exposure to these mitochondrial complex I inhibitors. We have 
demonstrated that exposure of the N27 dopaminergic neuronal cells to tebufenpyrad 
and pyridaben lead to a dose dependent cell death, marked by calculation of the EC50 
(Tebufenpyrad - 3.98±0.21 µM (95% CI) and Pyridaben - 3.77±0.21 µM (95% CI)). 
Tebufenpyrad and pyridaben exposure to the N27 cells also lead to significant 
oxidative damage marked by the augmented increase in ROS, superoxides generation 
and dramatic reduction in the intracellular ATP production. We also shows 
mitochondrial dysfunction and structural morphological impairment in the N27 cells 
exposed to tebufenpyrad and pyridaben. Another important functional role of 
tebufepyrad and pyridaben that we demonstrated was using the Seahorse XF 
bioanlayzer. Both the greenhouse pesticides induced mitochondrial respiration 
inhibition marked by loss of basal, ATP-Linked respiration and maximum respiratory 
capacity. Adding on, in order to validate and compare the mitochondrial toxicity and 
dysfunction potentiated by tebufenpyrad and pyridaben, we had employed the use of 
rotenone as a positive control for all our studies. there are numerous animal models 
and epidemiological studies that demonstrate the potent effect of rotenone on 
dopaminergic neurons and its association to PD (Betarbet et al., 2000; Choi et al., 
2011; Greenamyre et al., 2001; Perier et al., 2003; Richardson et al., 2005; Testa et 
al., 2005).  Hence using rotenone as a positive control enabled us to develop a 
comparative correlation between these two different complex I inhibiting pesticides 
and their effects on the mitochondria of dopaminergic neurons.  
 Cumulatively, from this study we have underlined the toxicological impact 
and effect of tebufenpyrad and pyridaben in the invitro dopaminergic neuronal cell 
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system. Further studies in animal models and epidemiological studies in greenhouse 
workers will clarify the potential risk of tebufenpyrad and pyridaben greenhouse 
pesticides in the etiology of PD. Also, such studies might open newer avenues of 
pathways related to the role of mitochondrial complex I inhibitors contributing to the 
pathology and symptoms of PD.  
Activated PKCδ functions as a LaminB1 kinase and induce nuclear membrane 
damage. 
 We have shown recently that tebufenpyrad induces alterations in 
mitochondrial functional and structural morphological dynamics in the dopaminergic 
neuronal cell culture model (Charli et al., 2016).  In this current study, we further 
extended to understand the potential role of tebufenpyrad mediated mitochondrial 
dysfunction and oxidative stress in terms of its ability to trigger PKCδ kinase activity 
and nuclear membrane damage. Our previous studies in the past couple decades of 
research, has clearly demonstrated the role of PKCδ as kinase, which upon activation 
in an caspase-3 dependent manner functions as a pro-apoptotic signalling factor 
mediating an avalanche of downstream cascades leading to the death of dopamingeric 
neurons (Gordon et al., 2012; Harischandra et al., 2014c; Jin et al., 2011a; Jin et al., 
2011c; Jin et al., 2014c; Kanthasamy et al., 2008; Latchoumycandane et al., 2011a; 
Saminathan et al., 2011). Keeping in mind our expertise in PKCδ characterization, we 
explored the efficiency of tebufenpyrad to trigger PKCδ activation in a caspase-3 
dependent process and its downstream targets leading to the apoptotic cell death of 
dopamingeric neurons.   
 We in this study show that tebufenpyrad (3 µM -3 hrs) induces PKCδ 
activation in a caspase-3 dependent mechanism. The PKCδ activation is marked 
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vividly by the formation of cleavage of PKCδ into its catalytic and regulatory domain 
and also by the upregulation of p-PKCδ (T505). Furthermore, using insilico system of 
analysis and online tools, we identified LaminB1 as a potential downstream target for 
the activated PKCδ. Also, we identified that T575 on LaminB1 is susceptible to 
phosphorylation modification induced by the activated PKCδ. This suggested the 
potential role of PKCδ as a LaminB1 kinase. Previously it has been shown in an 
oncogenic invitro system of study that PKCδ functions as a LaminB1 kinase initiating 
nuclear membrane damage and cell death (Cross et al., 2000). But the exact 
mechanism and essential initiating events of this phenomena is not been well 
characterised or studied. To support and prove this functional role of PKCδ as a 
LaminB1 kinase in the dopaminergic neurons, we had employed several invitro model 
systems. Our studies performed using the PKCδ-CRM and PKCδ CRISPR/Cas9 
knockdown stable N27 cells vividly demonstrated that post exposure to tebufenpyrad, 
these PKCδ dysfunctional and knockdown systems respectively, show protection 
against PKCδ activation, phosphorylation of LaminB1 at T575 and loss of nuclear 
membrane structure. Thus suggesting a protective mechanism in the absence of 
PKCδ, against tebufenpyrad induced mitochondrial toxicity in N27 dopaminergic 
neuronal cells. Moreover, our site-directed mutagenesis study involving the 
replacement of threonine at 575 with glycine in the LaminB1, also validated the site 
specific importance of LaminB1 T575 phosphorylation and LaminB1 loss. Mutant 
N27 cells treated with tebufenpyrad exhibited absence of LaminB1 phosphorylation 
and loss of LaminB1, compared to their corresponding control wildtype N27 cells. 
Adding on, evidences from the organotypic slice culture studies from the PKCδ+/+ 
and PKCδ-/- pup midbrains (9-12 days old pups) and from the control and PD post 
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mortem substantia nigra tissues analyzes, demonstrated the function of activated 
PKCδ as a LaminB1 kinase. These results translated the concept of PKCδ functioning 
as a LaminB1 kinase from an invitro finding to an exvivo and also onto a human 
model system.  
 Suggesting with these results together, we show that activated PKCδ functions 
as a kinase phosphorylating LaminB1 at T575 and causing the loss of LaminB1 and 
hence initiating nuclear membrane damage, resulting in the apoptotic cell death of the 
dopaminergic neuronal cells. The underlying hot point of take from this study is that 
the T575 site on LaminB1, has the potential to serve as a promising target for creating 
pharmacological drug targets, to study neurotoxicity induced by mitochondrial 
inhibiting pesticides leading the apoptotic dopaminergic neuronal cell death.    
Hyperacetylation of histones H3 and H4 induced by mitochondrial inhibiting 
pesticides. 
 Linking the interplay between mitochondrial dysfunction induced by the 
complex I inhibiting pesticides and epigenetic dysregulation such as H3 and H4 
hyeracetylation opens a novel pathway involving prominent nuclear architectural 
changes leading to the death of dopamingeric neuronal cells. We have previously 
shown that environmental pesticides, paraquat and dieldrin induces histones H3 and 
H4 hyperacetylation in the dopaminergic neurons mediating the apoptotic cell death 
(Song et al., 2010; Song et al., 2011). We have also shown previously that pyridaben 
pronounces significant mitochondrial dysfunction and damage post its exposure to 
dopaminergic neuronal cells (Charli et al., 2016). Hence in this present study we have 
identified a novel mechanism bridging the connection of mitochondrial dysfunction 
mediated trigger of histones acetylation. Here we show that pyridaben induces a dose 
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and time dependent increase in H3 and H4 hyperacetylation observed in the N27 cells. 
Analysis by immuno-fluorescence staining study using confocal microscopy 
unravelled a preferential acetylation at lysine sites K23 and K5 on H3 and H4, 
respectively. More detailed analysis using the confocal microscopy and image 
processing software IMARIS, revealed the formation of a nuclear declustered 
structure post pyridaben exposure to the N27 dopamingeric neuronal cells compared 
to the control. Dieldrin and rotenone were used as controls for this findings to validate 
the results of pyridaben exposure induced histones acetylation in the N27 cells. 
Moreover, post pyridaben or rotenone exposure in the N27 cells, HP-1α, a marker of 
heterochromatin, significant decreased in a time dependent manner. Thus suggesting 
there is a topological architectural or remodelling of chromatin induced by the H3 and 
H4 acetylation post exposure to the mitochondrial targeted pesticides. We have shown 
previously that the TFAM CRISPR/Cas9 knockdown exhibited a defective 
mitochondrial structure and function compared to the control CRISPR/Cas9 N27 cells 
(Langley et al., 2017). Since the TFAM CRISPR/Cas9 knockdown N27 cells possess 
a inherently defective mitochondria, we had employed it in our present study to 
understand role of mitochondrial dysfunction in triggering histones acetylation. This 
present study revealed that the TFAM CRISPR/Cas9 knockdown demonstrate up-
regulated levels of H3 and H4 histones acetylation compared to the control 
CRISPR/Cas9 N27 cells. 
 Adding on, we demonstrated that pre-treating the N27 cells with anacardic 
acid (HAT inhibitor), protected against its toxicity induced by pyridaben or rotenone. 
This suggests the functional role of HAT activity during the process of histones 
acetylation mediated cell apoptotic cell death.  Organotypic brain slice culture of the 
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midbrain, post pyridaben or rotenone exposure revealed histones acetylation and also 
the confocal microscopy analysis show-cased the formation of nuclear declustering 
topological structures in the treated slices of midbrain.  
 Next we moved the study onto an invivo transgenic model of PD called the 
mitopark mouse model. It has been previously shown by us and other groups that the 
mitopark mouse model recapitulates the pathological, motor and non-motor symptoms 
and the age progression deficits that are well associated and studied in PD. These 
mice exhibit mitochondrial dysfunction and respiration loss due to the specific 
conditional knockout of TFAM (mitochondrial transcription factor, a regulator of 
mtDNA) in the dopaminergic neurons in the midbrain of these mice (Ay et al., 2017; 
Branch et al., 2016; Cong et al., 2016; Ekstrand et al., 2007; Gordon et al., 2016; 
Langley et al., 2017). We in this current study demonstrated age progressive increase 
in histones acetylation in the mitopark mice (8 to 24 weeks of age). Also, the 24 week 
old mitopark compared to the littermate age controls, exhibited site specific 
significant increase in H3(K23) and H4(K5) acetylation, and nuclear declustering was 
observed using the confocal microscopy analysis. Similar noteworthy trend of H3 and 
H4 acetylation and the nuclear topological surface changes were also observed in the 
human post mortem PD brain tissues and sections respectively.  
 Collectively, our study enables the understanding of a novel mechanism 
highlighting the phenomena of  mitochondrial dysfunction triggering epigenetic 
dysregulation of core histones H3 and H4 acetylation, which together may play a 
critical role in the etiopathology of environmentally pesticides exposure triggering -
linked PD. 
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 In summary, our findings suggests the connective novel interplay between 
mitochondrial dysfunction process and epigenetic dysregulation, triggered by the 
exposure to mitochondrial complex I inhibiting pesticides on the dopamingeric 
neuronal cells. These molecular pathway paves way for discovery of new targets for 
understanding environmentally linked etiopathogenesis of PD.  
 
 
 
 
Figure 5.1 Scheme illustrating the integrated mechanisms triggered by 
mitochondrial complex I inhibiting pesticides 
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